<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.ajronline.org">
<title>American Journal of Roentgenology recent issues</title>
<link>http://www.ajronline.org</link>
<description>American Journal of Roentgenology RSS feed -- recent issues</description>
<prism:eIssn>1546-3141</prism:eIssn>
<prism:publicationName>American Journal of Roentgenology</prism:publicationName>
<prism:issn>0361-803X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W363?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W373?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W381?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W389?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W397?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W403?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W407?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W411?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W416?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W424?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W430?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W437?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W442?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W446?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W452?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/W458?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W464?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W465?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W466?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W468?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W469?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W470?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/W471?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1199?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1203?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1212?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1223?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1228?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1239?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1242?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1243?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1252?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1261?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1268?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1272?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1282?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1289?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1291?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1296?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1305?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1311?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1318?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1324?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1333?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1340?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1347?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1354?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1361?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1367?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1376?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1384?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1388?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1394?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1408?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1414?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1419?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1425?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1434?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1439?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/5/1446?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1460?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1461?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/5/1463?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W259?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W273?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W278?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W283?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W288?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W295?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W301?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W308?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W314?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W321?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W327?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W334?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W339?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/W345?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W350?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W351?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W352?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W354?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W355?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W356?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W357?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W358?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W359?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W361?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/W362?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/915?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/920?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/922?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/928?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/941?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/948?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/955?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/964?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/970?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/978?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/986?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/994?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1001?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1010?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1019?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1025?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1030?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1037?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1044?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1053?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1061?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1070?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1077?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1090?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1097?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1107?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1118?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1136?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1141?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1148?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1155?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1167?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1175?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1180?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/1188?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/1189?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/full/193/4/1190?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.ajronline.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.ajronline.org/icons/banner/title.gif">
<title>American Journal of Roentgenology</title>
<url>http://www.ajronline.org/icons/banner/title.gif</url>
<link>http://www.ajronline.org</link>
</image>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1">
<title><![CDATA[Tree-In-Bud Pattern]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W472?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gosset, N., Bankier, A. A., Eisenberg, R. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3401</dc:identifier>
<dc:title><![CDATA[Tree-In-Bud Pattern]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W477</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W472</prism:startingPage>
<prism:section>Residents' Section</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1">
<title><![CDATA[Coronary Abnormalities in Hyper-IgE Recurrent Infection Syndrome: Depiction at Coronary MDCT Angiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W478?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Hyper-IgE recurrent infection syndrome (HIES or Job's
syndrome) is a rare disorder affecting the immune system and connective
tissues. The purpose of this study is to describe the coronary abnormalities
in genetically confirmed HIES patients as depicted by coronary MDCT
angiography (MDCTA).</p>
<p><b>CONCLUSION.</b> Coronary MDCTA has provided an opportunity for
noninvasive evaluation of the coronary arteries in patients with HIES. These
coronary abnormalities vary from tortuosity to ectatic dilation and focal
aneurysms of the coronary arteries. Such an evaluation has potential value in
identifying new aspects of this disease and thereby providing better
understanding of the pathophysiology of the disorder.</p>
]]></description>
<dc:creator><![CDATA[Gharib, A. M., Pettigrew, R. I., Elagha, A., Hsu, A., Welch, P., Holland, S. M., Freeman, A. F.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2623</dc:identifier>
<dc:title><![CDATA[Coronary Abnormalities in Hyper-IgE Recurrent Infection Syndrome: Depiction at Coronary MDCT Angiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W481</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W478</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1">
<title><![CDATA[Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W482?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate according to
size and degree of cellular differentiation the multiphasic MDCT enhancement
pattern of hepatocellular carcinoma (HCC) smaller than 3 cm in diameter in
patients with cirrhosis.</p>
<p><b>MATERIALS AND METHODS.</b> In 155 consecutively registered patients (126
men, 29 women; mean age, 58.4 years), 204 pathologically proven HCCs smaller
than 3 cm were detected at multiphasic MDCT. Three radiologists in consensus
classified the relative attenuation of the tumors compared with the
surrounding liver parenchyma as hyperattenuation, isoattenuation, or
hypoattenuation on biphasic (<I>n</I> = 86) and triphasic (<I>n</I> = 69)
CT scans.</p>
<p><b>RESULTS.</b> The prevalent enhancement patterns of HCC differed
depending on tumor size. The prevalent pattern of HCC measuring 20&ndash;29 mm
was arterial hyperattenuation with venous washout (47%, 47/101). The prevalent
enhancement patterns of HCC smaller than 10 mm and HCC measuring 10&ndash;19
mm were isoattenuation during the arterial and portal venous phases (29%,
6/21) and hyperattenuation and isoattenuation during the arterial and portal
venous phases (33%, 27/82). The typical HCC enhancement pattern (arterial
hyperattenuation with venous washout) was identified in 48% (67/141) of the
moderately and poorly differentiated HCCs and in 13% (8/63) of
well-differentiated HCCs.</p>
<p><b>CONCLUSION.</b> The prevalent enhancement patterns of HCC smaller than 3
cm on multiphasic MDCT scans differed depending on tumor size and cellular
differentiation. HCCs smaller than 2 cm and well-differentiated HCCs
frequently had atypical enhancement patterns.</p>
]]></description>
<dc:creator><![CDATA[Yoon, S. H., Lee, J. M., So, Y. H., Hong, S. H., Kim, S. J., Han, J. K., Choi, B. I.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1818</dc:identifier>
<dc:title><![CDATA[Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W489</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W482</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1">
<title><![CDATA["Pseudo Washout" Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W490?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to describe the
"pseudo washout" sign of high-flow hepatic hemangioma that mimics
hypervascular tumor on gadoxetic acid&ndash;enhanced MRI.</p>
<p><b>CONCLUSION.</b> High-flow hemangiomas might show relatively low signal
intensity because of gadoxetic acid contrast uptake in the surrounding normal
liver parenchyma during the equilibrium (3-minute delay) phase. Such findings
are called pseudo washout and can mimic hypervascular hepatic tumors. However,
high-flow hemangioma can be diagnosed by observing bright signal intensity on
T2-weighted imaging, arterial phase&ndash;dominant enhancement, pseudo washout
sign during the equilibrium phase, and isointense or slightly increased signal
intensity on subtraction images.</p>
]]></description>
<dc:creator><![CDATA[Doo, K. W., Lee, C. H., Choi, J. W., Lee, J., Kim, K. A., Park, C. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1732</dc:identifier>
<dc:title><![CDATA["Pseudo Washout" Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W496</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W490</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1">
<title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to provide a practical
illustrated review of PET/CT in the imaging evaluation of transitional cell
carcinoma.</p>
<p><b>CONCLUSION.</b> Local evaluation of the primary tumor in patients with
transitional cell carcinoma on PET is often limited by the obscuring effect of
excreted FDG, but assessment of metabolic activity may still be possible
through close correlation with CT images. PET/CT may also be helpful in the
detection of disease outside the bladder at nodal or more distant sites and in
the assessment of recurrent disease.</p>
]]></description>
<dc:creator><![CDATA[Patil, V. V., Wang, Z. J., Sollitto, R. A., Chuang, K.-W., Konety, B. R., Hawkins, R. A., Coakley, F. V.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1945</dc:identifier>
<dc:title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W504</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W497</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1">
<title><![CDATA[CT and MRI of Spinal Neuroarthropathy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W505?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to describe the
different stages of spinal neuroarthropathy as assessed by CT and MRI and to
discuss their contribution to the management of affected patients.</p>
<p><b>CONCLUSION.</b> Early-stage findings consisted of inflammatory changes
involving adjacent vertebral endplates and mimicking degenerative disk disease
with inflammation. Subsequently, progression of the lesions led to complete
destruction of the intervertebral joint. Knowledge of the initial features of
spinal neuroarthropathy may allow earlier treatment, which may improve
outcomes.</p>
]]></description>
<dc:creator><![CDATA[Lacout, A., Lebreton, C., Mompoint, D., Mokhtari, S., Vallee, C. A., Carlier, R. Y.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2268</dc:identifier>
<dc:title><![CDATA[CT and MRI of Spinal Neuroarthropathy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W514</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W505</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1">
<title><![CDATA[Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W515?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Bidimensional tumor measurements indicating a greater
than 25% increase in tumor size are generally accepted as indicating tumor
progression. We hypothesized that use of digital images and a homogeneous
reader population would have lower interobserver variability than in previous
studies.</p>
<p><b>SUBJECTS AND METHODS.</b> Eight board-certified radiologists measured
tumor diameters in three planes in two consecutive MRI examinations of 22
patients with contrast-enhancing high-grade brain tumors. Products of tumor
measurements were calculated, and determinations were made about tumor
progression (&gt; 25% increase in area). A variance components model was run
on diameter products and the ratios of consecutive maximal diameter products.
The variance components included patient examination effect, reader effect,
and residual effect.</p>
<p><b>RESULTS.</b> Complete agreement was found among readers in 10 cases
(45%), all indicating stable disease. In the other 12 cases, at least one
reader considered progressive disease present. The variance components model
showed variance due to readers was small, indicating only modest bias among
readers. The residual variance component was large (0.038), indicating that
repeated measurements on the same image likely are variable even for the same
reader. This variability in measurement implies that repeated measurements by
the typical reader have an inherent 14% false-positive rate in the diagnosis
of progression of tumors that are stable.</p>
<p><b>CONCLUSION.</b> Our hypothesis was disproved. We found substantial
interreader disagreement and indications that the very nature of the
measurement method produces a high rate of false-positive readings of stable
tumors. These findings should be considered in interpretation of images with
this widely accepted criterion for brain tumor progression.</p>
]]></description>
<dc:creator><![CDATA[Provenzale, J. M., Ison, C., DeLong, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2615</dc:identifier>
<dc:title><![CDATA[Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W522</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W515</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1">
<title><![CDATA[Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W523?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to illustrate the spectrum
of appearances of peritoneal diseases on <sup>18</sup>F-FDG PET/CT, show the
usefulness of fused FDG PET/CT as a diagnostic tool for the peritoneum, and
discuss the pitfalls in FDG PET/CT interpretation of peritoneal disease.</p>
<p><b>CONCLUSION.</b> Malignant and benign diseases may have peritoneal
involvement, which can manifest as various imaging patterns on FDG PET/CT.
Awareness of these patterns and of potential interpretation issues is
important to optimize diagnostic accuracy.</p>
]]></description>
<dc:creator><![CDATA[Anthony, M.-P., Khong, P.-L., Zhang, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2936</dc:identifier>
<dc:title><![CDATA[Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W529</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W523</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1">
<title><![CDATA[The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W530?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Thrombotic disorders detected on PET/CT are usually
incidental findings and may change the treatment strategy and patient's
disease prognosis. The purpose of this article is to present the spectrum of
venous thrombotic disorders found on PET/CT.</p>
<p><b>CONCLUSION.</b> The division of thrombotic disorders into metabolically
nonactive and active thrombus may be helpful for differential diagnosis of
underlying diseases causing thrombus formation. IV contrast media
administration during PET/CT makes it possible to visualize the thrombus
itself and helps to distinguish between benign and malignant metabolically
active thrombus.</p>
]]></description>
<dc:creator><![CDATA[Sopov, V., Bernstine, H., Stern, D., Yefremov, N., Sosna, J., Groshar, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2949</dc:identifier>
<dc:title><![CDATA[The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W539</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W530</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1">
<title><![CDATA[Posterior Periosteal Disruption in Salter-Harris Type II Fractures of the Distal Femur: Evidence for a Hyperextension Mechanism]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W540?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Patterns of periosteal disruption are important factors
in assessing the mechanism of injury of radiologically evident Salter-Harris
(SH) fractures. The purpose of this study is to assess the frequency of
posterior periosteal disruption on MRI in radiographically occult or subtle SH
type II fractures of the distal femur and to evaluate associated soft-tissue
findings that support a hyperextension mechanism of injury.</p>
<p><b>CONCLUSION.</b> We found that all children in our experience with occult
or subtle SH type II fractures of the distal femur have posterior periosteal
disruption and other MRI findings to indicate a hyperextension mechanism of
injury. Direct indicators of fracture may be inconspicuous, and the presence
of posterior periosteal disruption is a clue that should prompt a search for
other features of this serious pediatric injury, which may be followed by limb
shortening or angular deformity.</p>
]]></description>
<dc:creator><![CDATA[Kritsaneepaiboon, S., Shah, R., Murray, M. M., Kleinman, P. K.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2353</dc:identifier>
<dc:title><![CDATA[Posterior Periosteal Disruption in Salter-Harris Type II Fractures of the Distal Femur: Evidence for a Hyperextension Mechanism]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W545</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W540</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1">
<title><![CDATA[Clinical Uses of Time-Resolved Imaging in the Body and Peripheral Vascular System]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W546?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Time-resolved MR angiography (MRA) is a technique
designed for fast vascular imaging. The purpose of this article is to
introduce the multiple potential uses for time-resolved MRA in the body and
peripheral vascular system in the hope that time-resolved MRA will become a
more widely used technique.</p>
<p><b>CONCLUSION.</b> Time-resolved MRA is a useful technique with many
clinical applications.</p>
]]></description>
<dc:creator><![CDATA[Cornfeld, D., Mojibian, H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2826</dc:identifier>
<dc:title><![CDATA[Clinical Uses of Time-Resolved Imaging in the Body and Peripheral Vascular System]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W557</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W546</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1">
<title><![CDATA[Evaluation of Uterine Anomalies: 3D FRFSE Cube Versus Standard 2D FRFSE]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W558?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare a novel MRI
sequence&mdash;3D fast-recovery fast spin-echo (FRFSE) cube&mdash;with a
standard 2D FRFSE sequence for the investigation of uterine anomalies.</p>
<p><b>CONCLUSION.</b> Compared with 2D FRFSE, 3D FRFSE cube provides superior
image quality and improved 3D reconstructions in a shorter acquisition time
and enables excellent visualization of uterine anatomy in any orientation,
regardless of the original scanning plane.</p>
]]></description>
<dc:creator><![CDATA[Agrawal, G., Riherd, J. M., Busse, R. F., Hinshaw, J. L., Sadowski, E. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2716</dc:identifier>
<dc:title><![CDATA[Evaluation of Uterine Anomalies: 3D FRFSE Cube Versus Standard 2D FRFSE]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W562</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W558</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1">
<title><![CDATA[Halfpipe Coaxial Cannula for Self-Contained Vacuum-Assisted Biopsy Systems: Feasibility in a Pig Breast Model]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W563?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to discuss the development
of a dedicated halfpipe coaxial cannula for stereotactic vacuum-assisted
biopsy. We evaluated the system by retrieving 18 copper targets from a pig
breast model in the upright position via vertical and lateral approaches.</p>
<p><b>CONCLUSION.</b> Sampling was successful in 15 of 18 cases. Errors
occurred only in superficial lesions biopsied via the vertical approach. The
halfpipe coaxial cannula shows promise for improving positioning accuracy,
avoiding target dislocation, and obviating repeated needle repositioning.</p>
]]></description>
<dc:creator><![CDATA[Teubner, T., Hafner, M. F., Schimmele, M., Teubner, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2876</dc:identifier>
<dc:title><![CDATA[Halfpipe Coaxial Cannula for Self-Contained Vacuum-Assisted Biopsy Systems: Feasibility in a Pig Breast Model]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W566</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W563</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1">
<title><![CDATA[Musculoskeletal MRI, 2nd ed]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W567?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Garner, H. W.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3252</dc:identifier>
<dc:title><![CDATA[Musculoskeletal MRI, 2nd ed]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W567</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W567</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1">
<title><![CDATA[Dialysis Access-Associated Steal Syndrome Presenting as Bidirectional Flow at Duplex Doppler Ultrasound]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W568?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Yilmaz, C., Ozcan, K., Erkan, N.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2899</dc:identifier>
<dc:title><![CDATA[Dialysis Access-Associated Steal Syndrome Presenting as Bidirectional Flow at Duplex Doppler Ultrasound]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W568</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W568</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1">
<title><![CDATA[MR Spectroscopy for Differentiation of Recurrent Glioma From Radiation-Induced Changes]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/W569?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Goenka, A. H., Kumar, A., Sharma, R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3147</dc:identifier>
<dc:title><![CDATA[MR Spectroscopy for Differentiation of Recurrent Glioma From Radiation-Induced Changes]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W570</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W569</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1">
<title><![CDATA[More New Challenges and Opportunities]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1471?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berquist, T. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3802</dc:identifier>
<dc:title><![CDATA[More New Challenges and Opportunities]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1472</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1471</prism:startingPage>
<prism:section>From the Editor's Notebook</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1">
<title><![CDATA[Malpractice Issues in Radiology: Res Ipsa Loquitur]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1475?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berlin, L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3137</dc:identifier>
<dc:title><![CDATA[Malpractice Issues in Radiology: Res Ipsa Loquitur]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1480</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1475</prism:startingPage>
<prism:section>Medical&amp;ndash;Legal</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1">
<title><![CDATA[Bad Money Drives Out Good: Forebodings of a Corporatized American Radiology--The 2009 Eugene Caldwell Lecture]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1481?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hillman, B. J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3144</dc:identifier>
<dc:title><![CDATA[Bad Money Drives Out Good: Forebodings of a Corporatized American Radiology--The 2009 Eugene Caldwell Lecture]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1485</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1481</prism:startingPage>
<prism:section>Special Article</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1">
<title><![CDATA[Conventional Wisdom: Unconventional Virus]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/6/1486?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ketai, L. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3758</dc:identifier>
<dc:title><![CDATA[Conventional Wisdom: Unconventional Virus]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1487</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1486</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1">
<title><![CDATA[Chest Radiographic and CT Findings in Novel Swine-Origin Influenza A (H1N1) Virus (S-OIV) Infection]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1488?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This article reviews the chest radiographic and CT
findings in patients with presumed/laboratory-confirmed novel swine-origin
influenza A (H1N1) virus (S-OIV) infection.</p>
<p><b>MATERIALS AND METHODS.</b> Of 222 patients with novel S-OIV (H1N1)
infection seen from May 2009 to July 2009, 66 patients (30%) who underwent
chest radiographs formed the study population. Group 1 patients (<I>n</I> =
14) required ICU admission and advanced mechanical ventilation, and group 2
(<I>n</I> = 52) did not. The initial radiographs were evaluated for the
pattern (consolidation, ground-glass, nodules, and reticulation),
distribution, and extent of abnormality. Chest CT scans (<I>n</I> = 15) were
reviewed for the same findings and for pulmonary embolism (PE) when performed
using IV contrast medium.</p>
<p><b>RESULTS.</b> Group 1 patients were predominantly male with a higher mean
age (43.5 years versus 22.1 years in group 2; <I>p</I> &lt; 0.001). The
initial radiograph was abnormal in 28 of 66 (42%) subjects. The predominant
radiographic finding was patchy consolidation (14/28; 50%) most commonly in
the lower (20/28; 71%) and central lung zones (20/28; 71%). All group 1
patients had abnormal initial radiographs; extensive disease involving &ge; 3
lung zones was seen in 93% (13/14) versus 9.6% (5/52) in group 2 (<I>p</I>
&lt; 0.001). No group 2 patients had &gt; 20% overall lung involvement on
initial radiographs compared with 93% of group 1 patients (13/14). PEs were
seen on CT in 5/14 (36%) of group 1 patients.</p>
<p><b>CONCLUSION.</b> Chest radiographs are normal in more than half of
patients with S-OIV (H1N1) and progress to bilateral extensive air-space
disease in severely ill patients, who are at a high risk for PE.</p>
]]></description>
<dc:creator><![CDATA[Agarwal, P. P., Cinti, S., Kazerooni, E. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3599</dc:identifier>
<dc:title><![CDATA[Chest Radiographic and CT Findings in Novel Swine-Origin Influenza A (H1N1) Virus (S-OIV) Infection]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1493</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1488</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1">
<title><![CDATA[Swine-Origin Influenza A (H1N1) Viral Infection: Radiographic and CT Findings]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1494?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to review the chest
radiographic and CT findings in patients with swine-origin influenza A (H1N1)
virus (S-OIV) infection.</p>
<p><b>CONCLUSION.</b> The most common radiographic and CT findings in seven
patients with S-OIV infection are unilateral or bilateral ground-glass
opacities with or without associated focal or multifocal areas of
consolidation. On MDCT, the ground-glass opacities and areas of consolidation
had a predominant peribronchovascular and subpleural distribution, resembling
organizing pneumonia.</p>
]]></description>
<dc:creator><![CDATA[Ajlan, A. M., Quiney, B., Nicolaou, S., Muller, N. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3625</dc:identifier>
<dc:title><![CDATA[Swine-Origin Influenza A (H1N1) Viral Infection: Radiographic and CT Findings]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1499</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1494</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1">
<title><![CDATA[Imaging Findings in a Fatal Case of Pandemic Swine-Origin Influenza A (H1N1)]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1500?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Although most cases of swine-origin influenza A (H1N1)
virus (S-OIV) have been self-limited, fatal cases raise questions about
virulence and radiology's role in early detection. We describe the
radiographic and CT findings in a fatal S-OIV infection.</p>
<p><b>CONCLUSION.</b> Radiography showed peripheral lung opacities. CT
revealed peripheral ground-glass opacities suggesting peribronchial injury.
These imaging findings raised suspicion of S-OIV despite negative H1N1
influenza rapid antigen test results from two nasopharyngeal swabs;
subsequently, those results were proven to be false-negatives by reverse
transcriptase polymerase chain reaction. This case suggests a role for CT in
the early recognition of severe S-OIV.</p>
]]></description>
<dc:creator><![CDATA[Mollura, D. J., Asnis, D. S., Crupi, R. S., Conetta, R., Feigin, D. S., Bray, M., Taubenberger, J. K., Bluemke, D. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3365</dc:identifier>
<dc:title><![CDATA[Imaging Findings in a Fatal Case of Pandemic Swine-Origin Influenza A (H1N1)]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1503</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1500</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1">
<title><![CDATA[Imaging of Thoracic Lymphatic Diseases]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1504?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This review will focus on radiographic description of
lymphangiomas, lymphangiohemangiomas, pulmonary lymphangiomatosis,
lymphangiectasis, lymphangioleiomyomatosis, lymphatic dysplasia, and traumatic
lymphatic injury.</p>
<p><b>CONCLUSION.</b> Diseases of the thoracic lymphatic system have a wide
variety of unique radiographic manifestations, all of which can be explained
by the underlying pathophysiology and relationship to the normal distribution
of lymphatics in the chest.</p>
]]></description>
<dc:creator><![CDATA[Raman, S. P., Pipavath, S. N. J., Raghu, G., Schmidt, R. A., Godwin, J. D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2532</dc:identifier>
<dc:title><![CDATA[Imaging of Thoracic Lymphatic Diseases]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1513</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1504</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1">
<title><![CDATA[Image Quality of Coronary 320-MDCT in Patients With Atrial Fibrillation: Initial Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1514?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Noninvasive coronary angiography has generally been
contraindicated in patients with atrial fibrillation because of the difficulty
in synchronizing an irregular heartbeat with table gantry movement. The
objective of this study was to evaluate and compare the quality of 320-MDCT
images obtained in patients with atrial fibrillation and in a control group of
patients in sinus rhythm.</p>
<p><b>MATERIALS AND METHODS.</b> Two reviewers were blinded to the patient
groups and evaluated images of 15 coronary artery segments for each patient
using 320-MDCT. The images were printed on glossy paper and scored
subjectively as 1 or 2, meaning of diagnostic quality, or 3, meaning poor
quality.</p>
<p><b>RESULTS.</b> No statistical difference between the groups was noted in
patient age: The mean age of the patients with atrial fibrillation was 67
years (age range, 52&ndash;82 years) and that of the patients in sinus rhythm
was 59 years (36&ndash;86 years) (<I>p</I> = 0.3). Scores of 1 and 2
(diagnostic quality) were assigned to 100% in sinus rhythm and 96% in atrial
fibrillation (<I>p</I> &lt; 0.05). Scores of 3 were seen only in the atrial
fibrillation group (7/175, 4%). Segment 15, the distal circumflex artery, was
the segment that was most frequently assigned a score of 3 (2/7, 28.6%). A
discrepancy in the two reviewers' scores was seen in 25 segments (7%),
requiring joint consensus. The segments that most frequently required
consensus reading were segments 12 and 15. The overall mean image quality
score for all three coronary arteries in atrial fibrillation was 1.25 &plusmn;
0.47 (SD) and 1.08 &plusmn; 0.26 in sinus rhythm (<I>p</I> &lt; 0.001). The
median effective dose was 19.28 and 13.55 mSv in the atrial fibrillation and
sinus rhythm groups, respectively.</p>
<p><b>CONCLUSION.</b> The analysis of our initial experience shows that
imaging in patients with atrial fibrillation is possible using 320-MDCT, with
images of most segments obtained being of diagnostic quality. Segment 15 was
the most difficult to see on 320-MDCT because of the small caliber of the
vessel; poor visualization of that segment mostly occurred in the setting of a
dominant right coronary arterial system.</p>
]]></description>
<dc:creator><![CDATA[Pasricha, S. S., Nandurkar, D., Seneviratne, S. K., Cameron, J. D., Crossett, M., Schneider-Kolsky, M. E., Troupis, J. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2319</dc:identifier>
<dc:title><![CDATA[Image Quality of Coronary 320-MDCT in Patients With Atrial Fibrillation: Initial Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1521</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1514</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1">
<title><![CDATA[Amplatzer Septal Occluder Closure of Atrial Septal Defect: Evaluation of Transthoracic Echocardiography, Cardiac CT, and Transesophageal Echocardiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1522?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare transthoracic
echocardiography (TTE), cardiac CT, and transesophageal echocardiography (TEE)
in the evaluation of secundum atrial septal defect (ASD) for closure with an
Amplatzer septal occluder in pediatric patients.</p>
<p><b>SUBJECTS AND METHODS.</b> The cases of 28 children with ASD initially
diagnosed with TTE who were scheduled for cardiac CT for evaluation for
insertion of an Amplatzer septal occluder under TEE guidance were reviewed.
The patients were divided into a group with small ASD (long axis &lt; 1.5 cm)
and a group with large ASD (long axis &ge; 1.5 cm). Measurements of the ASD
obtained at TTE, cardiac CT, and TEE were compared. Kappa statistics were used
to correlate the diagnostic value of cardiac CT assessed by two independent
reviewers.</p>
<p><b>RESULTS.</b> After cardiac CT, six patients were excluded from occluder
implantation; therefore, 22 patients (seven boys, 15 girls; mean age, 4.95
years; range, 2&ndash;11 years) were included in the study. There were no
significant differences in the ages and sexes of the patients in the two
groups, but pulmonary-to-systemic blood flow ratio in the large-ASD group was
significantly greater than that in the small-ASD group (3.54 &plusmn; 1.43 vs
1.89 &plusmn; 0.36; <I>p</I> = 0.001). With respect to long- and short-axis
lengths of the ASD, interatrial septum, and four rims and to detection of rim
deficiency, neither group had a significant difference between cardiac CT
findings at ventricular end-systole and TEE findings. The long axis of the ASD
in the large-ASD group measured at cardiac CT at end-systole and TEE was
significantly longer than the long axis measured at TTE (<I>p</I> = 0.012).
A high diagnostic score with good interobserver correlation ( =
0.674&ndash;0.750) validated the feasibility of cardiac CT in the assessment
of ASD for closure with an Amplatzer septal occluder.</p>
<p><b>CONCLUSION.</b> The long axis of a large ASD can be underestimated at
TTE. Cardiac CT seems comparable with TEE in the assessment of ASD and is
helpful in noninvasive evaluation for Amplatzer septal occluder implantation,
especially for large ASD.</p>
]]></description>
<dc:creator><![CDATA[Ko, S.-F., Liang, C.-D., Yip, H.-K., Huang, C.-C., Ng, S.-H., Huang, C.-F., Chen, M.-C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2854</dc:identifier>
<dc:title><![CDATA[Amplatzer Septal Occluder Closure of Atrial Septal Defect: Evaluation of Transthoracic Echocardiography, Cardiac CT, and Transesophageal Echocardiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1529</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1522</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1">
<title><![CDATA[CT Colonography With Decreased Purgation: Balancing Preparation, Performance, and Patient Acceptance]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1531?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Reduction or elimination of catharsis with fecal tagging
enhances the tolerability of CT colonography (CTC) and may increase compliance
with colorectal cancer (CRC) screening recommendations. We systematically
reviewed studies that prospectively evaluated performance and patient
satisfaction with decreased-purgation CTC and with optical colonoscopy.</p>
<p><b>CONCLUSION.</b> The nine studies reviewed showed moderate-to-good
performance for decreased-purgation CTC; however, data are limited, and study
design and data presentation are inconsistent. Further study of
decreased-purgation CTC and standardization of terminology are needed.</p>
]]></description>
<dc:creator><![CDATA[Mahgerefteh, S., Fraifeld, S., Blachar, A., Sosna, J.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2342</dc:identifier>
<dc:title><![CDATA[CT Colonography With Decreased Purgation: Balancing Preparation, Performance, and Patient Acceptance]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1539</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1531</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1">
<title><![CDATA[Percutaneous Aspiration and Ethanolamine Oleate Sclerotherapy for Sustained Resolution of Symptomatic Polycystic Liver Disease: An Initial Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1540?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Surgical therapy for symptomatic polycystic liver disease
is effective but has substantial mortality and morbidity. Minimally invasive
options such as percutaneous aspiration with or without ethanol sclerosis have
had disappointing results. The purpose of this study was to evaluate
percutaneous aspiration with ethanolamine oleate sclerosis in the management
of symptomatic polycystic liver disease.</p>
<p><b>SUBJECTS AND METHODS.</b> The study included 13 patients (11 with
polycystic liver disease, two with simple cysts) with 17 cysts. All patients
underwent percutaneous aspiration of the liver cyst under ultrasound guidance
followed by insertion of a 7-French pigtail catheter, instillation of
ethanolamine oleate (10% of cyst volume), and aspiration of the ethanolamine
oleate. The catheter was kept in place for 24 hours of open drainage and then
removed.</p>
<p><b>RESULTS.</b> All but one of the cysts resolved with one instillation.
The one cyst, in a patient with polycystic liver disease, required two
instillations 3 months apart. The mean initial volume of cysts was 589.8 mL,
and the mean reduction in volume was 88.8%. Both the simple cysts resolved
completely. In the cases of polycystic disease, the volume of cysts larger
than 10 cm in diameter was reduced by 92.8%. Cyst resolution was gradual, and
clinically significant cyst reduction was achieved within 1 year of therapy.
None of the patients needed surgery. The median follow-up period was 54 months
(range, 1 week&ndash;95 months). There were no significant adverse effects,
and all patients had relief of symptoms after therapy.</p>
<p><b>CONCLUSION.</b> This initial experience with a single session of
percutaneous aspiration and ethanolamine oleate sclerosis resulted in
sustained resolution of symptomatic polycystic liver disease with minimal
morbidity, avoidance of surgery, and improvement in quality of life.</p>
]]></description>
<dc:creator><![CDATA[Nakaoka, R., Das, K., Kudo, M., Chung, H., Innoue, T.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1681</dc:identifier>
<dc:title><![CDATA[Percutaneous Aspiration and Ethanolamine Oleate Sclerotherapy for Sustained Resolution of Symptomatic Polycystic Liver Disease: An Initial Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1545</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1540</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1">
<title><![CDATA[Radiologist Performance in Differentiating Polypoid Early From Advanced Gastric Cancer Using Specific CT Criteria: Emphasis on Dimpling Sign]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1546?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to retrospectively
determine whether there are specific CT features that can be used to
differentiate polypoid early from advanced gastric cancer and to assess the
performance of radiologists using specific CT findings for
differentiation.</p>
<p><b>MATERIALS AND METHODS.</b> A review of medical records yielded the cases
of 46 patients, 27 with polypoid early gastric cancer and 19 with polypoid
advanced gastric cancer, whose CT scans were available for review. Two
radiologists retrospectively reviewed the CT images for the presence and depth
of dimpling at the tumor base, the presence of vessel invagination at the
dimpling site, thickening of the low-attenuating outer layer, perigastric
infiltration, and transmural full-thickness enhancement of the lesion.
Individual CT findings relevant as predictors were determined with univariate
and multivariate analyses. Individual review of CT scans subsequently was
performed by two other radiologists, who were blinded to tumor stage but aware
of the results of univariate and multivariate analyses. Individual performance
was evaluated with receiver operating characteristic analysis.</p>
<p><b>RESULTS.</b> The presence of severe dimpling greater than 3.5 mm at the
base of the tumor (odds ratio, 31.3) had the highest odds ratio for
differentiating early from advanced gastric cancer, followed by vessel
invagination (odds ratio, 12.3), the presence of dimpling (odds ratio, 9.8),
perigastric infiltration (odds ratio, 5.2), and transmural full-thickness
enhancement (odds ratio, 4.8). Multivariate analysis showed that the presence
of dimpling greater than 3.5 mm was the only independent variable that
differentiated polypoid advanced gastric cancer from polypoid early gastric
cancer (<I>p</I> = 0.001). Subsequent differentiation of advanced from early
gastric cancer with the described CT findings was very good, yielding areas
under the receiver operating characteristic analysis curves of 0.827 and 0.811
for the two observers.</p>
<p><b>CONCLUSION.</b> Greater than 3.5 mm dimpling and other ancillary CT
findings are helpful in differentiating polypoid advanced gastric cancer from
polypoid early gastric cancer and contribute to good individual accuracy for
differentiation.</p>
]]></description>
<dc:creator><![CDATA[Lee, E. S., Kim, S. H., Lee, J. Y., Kim, S. J., Kim, M. A, Lee, J. M., Han, J. K., Choi, B. I.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2308</dc:identifier>
<dc:title><![CDATA[Radiologist Performance in Differentiating Polypoid Early From Advanced Gastric Cancer Using Specific CT Criteria: Emphasis on Dimpling Sign]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1555</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1546</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1">
<title><![CDATA[Value of Diffusion-Weighted MRI for Assessing Liver Fibrosis and Cirrhosis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1556?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to determine the
usefulness of the apparent diffusion coefficient (ADC) of liver parenchyma for
determining the severity of liver fibrosis.</p>
<p><b>MATERIALS AND METHODS.</b> This study investigated 78 patients who
underwent diffusion-weighted imaging (DWI) with 1.5-T MRI and pathologic
staging of liver fibrosis based on biopsy. DWI was performed with b values of
50 and 400 s/mm<sup>2</sup>. ADCs of liver were measured using 2.0- to
3.0-cm<sup>2</sup> regions of interest in the right and left lobes of the
liver; the mean ADC value was used for analysis. Pathologic METAVIR scores for
liver fibrosis stage were used as a reference standard.</p>
<p><b>RESULTS.</b> The mean ADC values for fibrosis pathologically staged
using the METAVIR classification system as F0 (<I>n</I> = 11), F1
(<I>n</I> = 16), F2 (<I>n</I> = 10), F3 (<I>n</I> = 14), and F4
(<I>n</I> = 27) were 125.9, 105.0, 104.5, 103.2, and 99.1 <FONT FACE="arial,helvetica">x</FONT>
10<sup>-5</sup> s/mm<sup>2</sup>, respectively. The correlation between the
ADC values and the degree of liver fibrosis was moderate (Spearman's test,
 = &ndash;0.36). There was a significant difference in ADC values between
patients with nonfibrotic liver (F0) and those with cirrhotic liver (F4)
(<I>p</I> = 0.008). The best cutoff ADC value to distinguish between these
groups was 118 <FONT FACE="arial,helvetica">x</FONT> 10<sup>-5</sup> s/mm<sup>2</sup>. However, ADC values
were not useful for differentiating viral hepatitis patients with F2 fibrosis
or higher from those with a lower degree of fibrosis (area under the receiver
operating characteristic curve [AUC] = 0.66) or for differentiating low-stage
fibrosis in all patients from high-stage fibrosis in all patients (AUC =
0.54).</p>
<p><b>CONCLUSION.</b> The ADCs in cirrhotic livers are significantly lower
than those in nonfibrotic livers. However, ADC values measured using the
current generation of scanners are not reliable enough to replace liver biopsy
for staging hepatic fibrosis.</p>
]]></description>
<dc:creator><![CDATA[Sandrasegaran, K., Akisik, F. M., Lin, C., Tahir, B., Rajan, J., Saxena, R., Aisen, A. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2436</dc:identifier>
<dc:title><![CDATA[Value of Diffusion-Weighted MRI for Assessing Liver Fibrosis and Cirrhosis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1560</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1556</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1">
<title><![CDATA[Comparison of Polyp Size and Volume at CT Colonography: Implications for Follow-Up CT Colonography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1561?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the reliability
of polyp measurements at CT colonography and the factors that affect the
measurements.</p>
<p><b>MATERIALS AND METHODS.</b> Fifty colonoscopically proven cases of polyps
6 mm in diameter or larger were analyzed by two observers who measured each
polyp in supine and prone views. Manual measurements of 2D volume by summation
of areas, 2D maximum diameter, and 3D maximum diameter and automated
measurements of 3D maximum diameter and volume were recorded for each observer
and were repeated for one of the observers. Intraobserver and interobserver
agreement was calculated. Analysis was performed to determine the measurement
parameter that correlated most with summation-of-areas volume. Supine and
prone measurements as a surrogate for tracking change in polyp size over time
were analyzed to determine the measurement parameter with the least
variation.</p>
<p><b>RESULTS.</b> Maximum diameter measured manually on 3D images had the
highest correlation with summation-of-areas volume. Manual summation-of-areas
volume was found to have the least variation between supine and prone
measurements.</p>
<p><b>CONCLUSION.</b> Linear polyp measurement in the 3D endoluminal view
appears to be the most reliable parameter for use in the decision to excise a
polyp according to current guidelines. In our study, manual calculation of
volume with summation of areas was found to be the most reliable measurement
parameter for observing polyp growth over serial examinations. High
reliability of polyp measurements is essential for adequate assessment of
change in polyp size over serial examinations because many patients with
intermediate-size polyps are expected to choose surveillance.</p>
]]></description>
<dc:creator><![CDATA[Bethea, E., Nwawka, O. K., Dachman, A. H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2618</dc:identifier>
<dc:title><![CDATA[Comparison of Polyp Size and Volume at CT Colonography: Implications for Follow-Up CT Colonography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1567</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1561</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1">
<title><![CDATA[Contrast Material Administration Protocols for 64-MDCT Angiography: Altering Volume and Rate and Use of a Saline Chaser to Better Match the Imaging Window--Physiologic Phantom Study]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1568?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the effect of
varying volumes and rates of contrast material, use of a saline chaser, and
cardiac output on aortic enhancement characteristics in MDCT angiography
(MDCTA) using a physiologic phantom.</p>
<p><b>MATERIALS AND METHODS.</b> Volumes of 75, 100, and 125 mL of iopamidol,
370 mg I/mL, were administered at rates of 4, 6, and 8 mL/s. The effect of a
saline chaser (50 mL of normal saline, 8 mL/s) was evaluated for each volume
and rate combination. Normal, reduced (33% and 50%), and increased (25%)
cardiac outputs were simulated. Peak aortic enhancement and duration of peak
aortic enhancement were recorded. Analysis of variance models were run with
these effects, and the estimated mean levels for the sets of factor
combinations were determined.</p>
<p><b>RESULTS.</b> Lowering the volume of contrast material resulted in
reduced peak enhancement (example, -56.2 HU [<I>p</I> &lt; 0.0001] with 75
vs 125 mL) and reduced duration of 75% peak enhancement (example, -9.0 seconds
[<I>p</I> &lt; 0.0001] with 75 vs 125 mL). Increasing the rate resulted in
increased peak enhancement (example, 104.5 HU [<I>p</I> &lt; 0.0001] with a
rate of 8 vs 4 mL/s) and decreased duration of 75% peak enhancement (example,
-13.0 seconds [<I>p</I> &lt; 0.001]). Use of a saline chaser resulted in
increased peak enhancement, and this increase was inversely proportional to
contrast material volume. Peak enhancement increased when reduced cardiac
output was simulated. Peak enhancement decreased when increased cardiac output
was simulated.</p>
<p><b>CONCLUSION.</b> Reducing contrast material volume from 125 to 75 mL,
increasing the rate to 6 or 8 mL/s, and use of a saline chaser result in an
aortic enhancement profile that better matches the approximately 5-second
imaging window possible with 64-MDCTA of the abdomen and pelvis. Even smaller
volumes of contrast material may be adequate in patients with reduced cardiac
output.</p>
]]></description>
<dc:creator><![CDATA[Coursey, C. A., Nelson, R. C., Weber, P. W., Howle, L. E., Nichols, E. B., Marin, D., DeLong, D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2670</dc:identifier>
<dc:title><![CDATA[Contrast Material Administration Protocols for 64-MDCT Angiography: Altering Volume and Rate and Use of a Saline Chaser to Better Match the Imaging Window--Physiologic Phantom Study]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1575</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1568</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1">
<title><![CDATA[Duodenal Switch Gastric Bypass Surgery for Morbid Obesity: Imaging of Postsurgical Anatomy and Postoperative Gastrointestinal Complications]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1576?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the normal
postsurgical findings and appearance of gastrointestinal tract complications
in patients who have undergone biliopancreatic diversion with duodenal switch
bariatric surgery. We performed a 4-year retrospective review of 218 patients
who underwent duodenal switch surgery.</p>
<p><b>CONCLUSION.</b> The most common complications of duodenal switch surgery
were bowel obstruction, followed by ventral hernias and anastomotic leaks.
Only 2% of cases required repeat surgery for management.</p>
]]></description>
<dc:creator><![CDATA[Mitchell, M. T., Carabetta, J. M., Shah, R. N., O'Riordan, M. A., Gasparaitis, A. E., Alverdy, J. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1941</dc:identifier>
<dc:title><![CDATA[Duodenal Switch Gastric Bypass Surgery for Morbid Obesity: Imaging of Postsurgical Anatomy and Postoperative Gastrointestinal Complications]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1580</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1576</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1">
<title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare apparent
diffusion coefficients, metabolic ratios, and vascularity values within
histologically defined prostate tumors with those in nontumor tissue to
determine which functional parameter or combination of parameters is best for
differentiating tumor from nontumor tissue.</p>
<p><b>SUBJECTS AND METHODS.</b> Twenty patients due for prostatectomy
underwent endorectal MRI at 1.5 T. Transverse T2-weighted, diffusion-weighted,
2D chemical shift, and dynamic contrast-enhanced images were acquired. After
prostatectomy, the gland was sectioned transversely. Fresh slices and stained
whole-mount sections with histologically defined tumor outlines were
photographed. The tumor outlines were mapped onto images, and the apparent
diffusion coefficient (ADC), choline-to-citrate (Cho/cit) ratio, and
vascularity of the histologically defined tumor, normal peripheral zone, and
central gland were quantitatively measured. Area under the receiver operating
characteristics (ROC) curve (A<I><SUB>z</SUB></I>) was used to determine the
sensitivity and specificity of parameter combinations in cancer detection.</p>
<p><b>RESULTS.</b> In tumor regions larger than 1 cm<sup>2</sup>, the Cho/cit
ratio was higher in tumor than in nontumor tissue (<I>p</I> &lt; 0.001), in
the peripheral zone alone (<I>p</I> = 0.007), and in the central gland alone
(<I>p</I> = 0.005). ADC was lower and tumor vascularity greater in tumor
than in nontumor tissue (ADC, <I>p</I> = 0.003; initial area under the
gadolinium plasma concentration&ndash;time curve [initial gadolinium AUC],
<I>p</I> = 0.012; forward rate constant [K<sup>trans</sup>], <I>p</I> =
0.011; return rate constant [k<SUB>ep</SUB>], <I>p</I> = 0.036). No single
parameter had a significantly greater A<SUB><I>z</I></SUB> (ADC, 0.71;
Cho/cit ratio, 0.79; initial gadolinium AUC, 0.60; K<sup>trans</sup>, 0.62;
k<SUB>ep</SUB>, 0.65). Pairs of parameters, however, did increase
A<I><SUB>z</SUB></I>: ADC and initial gadolinium AUC (A<I><SUB>z</SUB></I>
= 0.94) versus ADC (<I>p</I> = 0.001) and initial gadolinium AUC (<I>p</I>
&lt; 0.001); ADC and Cho/cit ratio (A<SUB><I>z</I></SUB> = 0.94) versus ADC
(<I>p</I> = 0.001) and Cho/cit ratio (not significant); and Cho/cit ratio
and initial gadolinium AUC (A<I><SUB>z</SUB></I> = 0.88) versus Cho/cit
ratio (not significant) and initial gadolinium AUC (<I>p</I> &lt; 0.001).
All three functional techniques together had an A<I><SUB>z</SUB></I> of
0.95, showing no further improvement.</p>
<p><b>CONCLUSION.</b> The combination of two functional parameters is
associated with significant improvement in prostate cancer detection over use
of any parameter alone. Use of a third parameter does not increase the rate of
detection.</p>
]]></description>
<dc:creator><![CDATA[Riches, S. F., Payne, G. S., Morgan, V. A., Sandhu, S., Fisher, C., Germuska, M., Collins, D. J., Thompson, A., deSouza, N. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2540</dc:identifier>
<dc:title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1591</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1583</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1">
<title><![CDATA[From Herding Cats Toward Best Practices: Standardizing the Radiologic Work Process]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1593?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Considerable variation in radiologic procedures,
protocols, policies, and workflows exists across the nation, sometimes even
within departments. This lack of standardization fosters idiosyncratic
behavior and outcomes, undermining the effort to implement best practices
across institutions. The purpose of this article is to discuss the need for
rapidly implementing recognized standards and best practices when they
exist.</p>
<p><b>CONCLUSION.</b> The use of information systems to monitor a wide variety
of quality metrics offers managers the opportunity to standardize radiology
and departmental practices, with the goal of transforming these practices into
those that are more efficient and cost-effective and of higher quality.</p>
]]></description>
<dc:creator><![CDATA[Boland, G. W. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2885</dc:identifier>
<dc:title><![CDATA[From Herding Cats Toward Best Practices: Standardizing the Radiologic Work Process]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1595</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1593</prism:startingPage>
<prism:section>Health Care Policy and Quality</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1">
<title><![CDATA[Influence of Verification Bias on the Assessment of MRI in the Diagnosis of Meniscal Tear]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1596?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Previous studies of the sensitivity and specificity of
MRI in the diagnosis of meniscal tear have not included correction for
verification bias. The purpose of this study was to investigate the extent to
which verification bias affected assessment of the utility of MRI in the
diagnosis of meniscal tear.</p>
<p><b>MATERIALS AND METHODS.</b> The patients included in the study were
outpatients who from April 2006 through July 2008 consecutively visited a
single institution for MRI of the meniscus for evaluation of knee pain. For
patients who underwent arthroscopy in addition to MRI, the sensitivity and
specificity of MRI were calculated. Global sensitivity analysis of data on
patients who did not undergo arthroscopy was performed to estimate the
influence of verification bias. Global sensitivity analysis is a method for
graphically determining whether a particular pair of sensitivity and
specificity estimates is compatible with observed data.</p>
<p><b>RESULTS.</b> Eighty-two patients (23%) underwent arthroscopic
verification. The sensitivity and specificity of MRI were 85% and 31%. When
the possibility of meniscal tears in patients who did not undergo arthroscopy
was subjected to global sensitivity analysis, the sensitivity of MRI ranged
from 29% to 95% and the specificity ranged from 3% to 92%. All combinations of
sensitivity and specificity produced a butterfly-shaped curve, but the base
case was not inside the curve.</p>
<p><b>CONCLUSION.</b> Verification bias greatly affected assessment of the
utility of MRI in the diagnosis of meniscal tear. Sensitivity and specificity
from previous studies may be incompatible with our data owing to verification
bias.</p>
]]></description>
<dc:creator><![CDATA[Nishikawa, H., Imanaka, Y., Sekimoto, M., Hayashida, K., Ikai, H.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2223</dc:identifier>
<dc:title><![CDATA[Influence of Verification Bias on the Assessment of MRI in the Diagnosis of Meniscal Tear]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1602</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1596</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1">
<title><![CDATA[Cysts Within and Adjacent to the Lesser Tuberosity and Their Association With Rotator Cuff Abnormalities]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1603?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine the incidence
of cysts in and adjacent to the lesser tuberosity and their association with
rotator cuff abnormalities and subcoracoid impingement.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective review of 1,000 consecutive
MRI examinations of the shoulder was performed by consensus of two
radiologists. Cysts were grouped by location into one of two groups: those
within the lesser tuberosity and those adjacent to the lesser tuberosity. The
rotator cuff was defined as intact, partial tear or tendinosis, or
full-thickness tear. The shortest distance from the coracoid to the humeral
head was measured on axial images.</p>
<p><b>RESULTS.</b> Forty-eight patients (26 women, 22 men; age range,
35&ndash;79 years; mean age, 61 years) had cysts adjacent to or within the
lesser tuberosity. Thirty-two patients (67%) had cysts just superior to the
tuberosity and 16 (33%) had cysts in the lesser tuberosity, resulting in an
incidence of 3.2% and 1.6%, respectively. All 16 patients (100%) with lesser
tuberosity cysts had subscapularis and supraspinatus tendon abnormalities
including 11 (69%) full-thickness supraspinatus tears. Patients with cysts
superior to the tuberosity had 20 (63%, <I>p</I> = 0.004) abnormal
subscapularis tendons and 28 (88%) abnormal supraspinatus tendons, including
six (19%) full-thickness tears (<I>p</I> = 0.002). The coracohumeral
distance was noted to be less than 10 mm in 10 patients (63%) with lesser
tuberosity cysts as compared with 10 patients (31%, <I>p</I> = 0.06) with
cysts superior to the tuberosity.</p>
<p><b>CONCLUSION.</b> Cysts located within the lesser tuberosity are rare and
are indicative of subscapularis and supraspinatus tendon abnormalities.</p>
]]></description>
<dc:creator><![CDATA[Wissman, R. D., Kapur, S., Akers, J., Crimmins, J., Ying, J., Laor, T.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2377</dc:identifier>
<dc:title><![CDATA[Cysts Within and Adjacent to the Lesser Tuberosity and Their Association With Rotator Cuff Abnormalities]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1606</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1603</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1">
<title><![CDATA[MRI of Soft-Tissue Tumors: Fast STIR Sequence as Substitute for T1-Weighted Fat-Suppressed Contrast-Enhanced Spin-Echo Sequence]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1607?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the value of the
fast STIR sequence in comparison with the T1-weighted fat-suppressed
contrast-enhanced sequence in the evaluation of soft-tissue tumors.</p>
<p><b>MATERIALS AND METHODS.</b> Sixty-seven soft-tissue tumors imaged with
both STIR and T1-weighted fat-suppressed contrast-enhanced sequences were
evaluated. The signal-to-noise and contrast-to-noise ratios of the tumors in
comparison with normal muscle, bone marrow, and fat were measured. Subjective
image contrast between soft-tissue tumors and the nearest normal tissue was
evaluated by two observers. The observers classified the soft-tissue tumors as
benign or malignant using a 5-point scale, and sensitivity, specificity, and
accuracy were calculated. The results of the two readings were assessed with
receiver operating characteristic analysis.</p>
<p><b>RESULTS.</b> The contrast-to-noise ratios of all tumors in comparison
with muscle (<I>p</I> &lt; 0.01), bone marrow (<I>p</I> &lt; 0.05), and
fat (<I>p</I> &lt; 0.05) were significantly higher on the fast STIR images
than on the T1-weighted fat-suppressed contrast-enhanced images. Both
observers' mean ratings of benign, malignant, and all tumors in comparison
with muscle on fast STIR images were significantly higher than those on
T1-weighted fat-suppressed contrast-enhanced images. For both observers, the
mean sensitivity, specificity, accuracy, and area under the receiver operating
characteristic curve in evaluation of the fast STIR images did not differ
significantly from those in evaluation of the T1-weighted fat-suppressed
contrast-enhanced images.</p>
<p><b>CONCLUSION.</b> The fast STIR sequence is excellent for evaluation of
soft-tissue tumors, and contrast-enhancement is not always needed.</p>
]]></description>
<dc:creator><![CDATA[Tokuda, O., Harada, Y., Matsunaga, N.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2675</dc:identifier>
<dc:title><![CDATA[MRI of Soft-Tissue Tumors: Fast STIR Sequence as Substitute for T1-Weighted Fat-Suppressed Contrast-Enhanced Spin-Echo Sequence]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1614</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1607</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1">
<title><![CDATA[Sonography of the Lateral Ulnar Collateral Ligament of the Elbow: Study of Cadavers and Healthy Volunteers]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1615?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the utility of
high-resolution sonography in identification and characterization of the size
and echogenicity of the lateral ulnar collateral ligament of the elbow in
cadavers and healthy volunteers.</p>
<p><b>SUBJECTS AND METHODS.</b> The lateral ulnar collateral ligaments of four
cadaveric elbows were imaged with a high-resolution linear-array ultrasound
transducer. On localization, the ligaments were injected with 0.1% methylene
blue under sonographic guidance. For confirmation of identification of the
ligaments, the elbows were immediately dissected to reveal the exact location
of the stain. The ligaments of both elbows of 35 healthy adult volunteers were
imaged.</p>
<p><b>RESULTS.</b> Surgical dissection confirmed injection of methylene blue
into all four cadaveric ligaments. The lateral ulnar collateral ligament was
identified bilaterally over the radial head in all 35 volunteers. The mean
thickness of the ligament at this point was 1.2 mm in women and men. The
proximal attachment of the ligament to the humerus was well visualized
bilaterally in 94.3% of volunteers. The mean thickness at this point was 1.7
mm in women and 1.6 mm in men. The distal attachment on the ulna was well
visualized in 90% of elbows. The ligament was hyperechoic in relation to
muscle in all volunteers. Differences in ligament measurements with regard to
sex and hand dominance were not significant. Ligament thickness correlated
weakly with volunteer weight, height, body mass index, and age.</p>
<p><b>CONCLUSION.</b> High-resolution ultrasound imaging is accurate for
identification and measurement of normal lateral ulnar collateral ligaments.
Therefore, ultrasound may prove valuable in assessment of abnormal lateral
ulnar collateral ligaments.</p>
]]></description>
<dc:creator><![CDATA[Stewart, B., Harish, S., Oomen, G., Wainman, B., Popowich, T., Moro, J. K.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2812</dc:identifier>
<dc:title><![CDATA[Sonography of the Lateral Ulnar Collateral Ligament of the Elbow: Study of Cadavers and Healthy Volunteers]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1619</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1615</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1">
<title><![CDATA[Radiation Dose and Excess Risk of Cancer in Children Undergoing Neuroangiography]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1621?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The primary goal of this study was to determine the
radiation dose received during diagnostic and interventional neuroangiographic
procedures in a group of pediatric patients. A second goal was to approximate
the total average radiation dose from all angiographic and CT studies that
pediatric patients underwent during the study period and to estimate the
increased risk of cancer incidence in this patient group.</p>
<p><b>MATERIALS AND METHODS.</b> The study subjects were pediatric patients
who had undergone one or more neuroangiographic procedures at Harborview
Medical Center between December 1, 2004, and April 30, 2008. Recorded
radiation doses were converted to entrance skin dose (ESD) and effective dose
(ED) to indicate deterministic and stochastic damage, respectively. The
Biologic Effects of Ionizing Radiation (BEIR) VII, phase 2, report was used to
estimate the expected increased risk of cancer in the study population.</p>
<p><b>RESULTS.</b> For diagnostic and therapeutic procedures, a mean ED of
10.4 and 34.0 mSv per procedure was calculated, respectively. The ESD values
proved too low to cause deterministic harm. The estimated number of excess
cases of malignancy projected from the total average radiation exposure was
890.6 per 100,000 exposed male children and 1,222.5 per 100,000 exposed
females, an overall increase of approximately 1% to the lifetime attributable
risk of cancer.</p>
<p><b>CONCLUSION.</b> Although both angiography and CT have revolutionized the
practice of medicine and confer benefits to patients, it is important that we
continue to investigate the possible adverse effects of these technologies.
Protocols that minimize radiation dose without compromising a study should be
implemented.</p>
]]></description>
<dc:creator><![CDATA[Raelson, C. A., Kanal, K. M., Vavilala, M. S., Rivara, F. P., Kim, L. J., Stewart, B. K., Cohen, W. A.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2352</dc:identifier>
<dc:title><![CDATA[Radiation Dose and Excess Risk of Cancer in Children Undergoing Neuroangiography]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1628</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1621</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1">
<title><![CDATA[Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1629?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate cerebral blood
flow, cerebral blood volume, mean transit time, time to peak, and delay in a
selected sample of patients with visually normal or increased cerebral blood
volume to facilitate detection of a postischemic CT perfusion
hyperperfusion&ndash;reperfusion phenomenon that may mask subacute and acute
infarcts.</p>
<p><b>MATERIALS AND METHODS.</b> Ten patients were included who had visually
normal or elevated cerebral blood volume in infarcts larger than 1.5 cm
confirmed on diffusion-weighted MR images within 48 hours of perfusion CT. The
cases were selected from 371 perfusion CT studies of stroke patients (99
associated with positive diffusion-weighted imaging findings) reviewed over
2.5 years on a 64-MDCT scanner. The perfusion CT images were fused to the
diffusion-weighted images for measurement of cerebral blood volume, cerebral
blood flow, mean transit time, time to peak, and delay in each infarct versus
the contralateral hemisphere. Two neuroradiologists reviewed the images in
consensus.</p>
<p><b>RESULTS.</b> The mean time between symptom onset and perfusion CT was
3.9 days. Infarcts were in the middle cerebral artery (<I>n</I> = 7) and
posterior cerebral artery (<I>n</I> = 3) distributions. Significant
differences versus the contralateral finding were found in cerebral blood
volume (<I>p</I> = 0.016; mean increase, 30.0%), mean transit time
(<I>p</I> = 0.007; mean increase, 38.1%), time to peak (<I>p</I> = 0.005;
mean increase, 17.7%), and delay (<I>p</I> = 0.030; mean increase, 124.9%).
The difference in cerebral blood flow (<I>p</I> = 0.785; mean increase,
1.8%) was not statistically significant. Infarcts became enhanced on the
dynamic perfusion CT images of eight of 10 patients and on the
contrast-enhanced T1-weighted MR images of six of nine patients.</p>
<p><b>CONCLUSION.</b> Visual inspection of cerebral blood volume and cerebral
blood flow maps alone is insufficient in the evaluation of infarcts. Mean
transit time, time to peak, and delay maps also should be reviewed with
dynamic source images to prevent misinterpretation of findings as
false-negative. This phenomenon is unlikely to occur hyperacutely (&lt; 8
hours after onset).</p>
]]></description>
<dc:creator><![CDATA[Nagar, V. A., McKinney, A. M., Karagulle, A. T., Truwit, C. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2664</dc:identifier>
<dc:title><![CDATA[Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1638</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1629</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1">
<title><![CDATA[Respiratory Gating Enhances Imaging of Pulmonary Nodules and Measurement of Tracer Uptake in FDG PET/CT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1640?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aim of this study was to evaluate prospectively the
effects of respiratory gating during FDG PET/CT on the determination of lesion
size and the measurement of tracer uptake in patients with pulmonary nodules
in a clinical setting.</p>
<p><b>SUBJECTS AND METHODS.</b> Eighteen patients with known pulmonary nodules
(nine women, nine men; mean age, 61.4 years) underwent conventional FDG PET/CT
and respiratory-gated PET acquisitions during their scheduled staging
examinations. Maximum, minimum, and average standardized uptake values (SUVs)
and lesion size and volume were determined with and without respiratory
gating. The results were then compared using the two-tailed Student's
<I>t</I> test and the nonparametric Wilcoxon's test to assess the effects of
respiratory gating on PET acquisitions.</p>
<p><b>RESULTS.</b> Respiratory gating reduced the measured area of lung
lesions by 15.5%, the axial dimension by 10.3%, and the volume by 44.5%
(<I>p</I> = 0.014, <I>p</I> = 0.007, and <I>p</I> = 0.025,
respectively). The lesion volumes in gated studies were closer to those
assessed by standard CT (difference decreased by 126.6%, <I>p</I> = 0.025).
Respiratory gating increased the measured maximum SUV by 22.4% and average SUV
by 13.3% (<I>p</I> &lt; 0.001 and <I>p</I> = 0.002).</p>
<p><b>CONCLUSION.</b> Our findings suggest that the use of PET respiratory
gating in PET/CT results in lesion volumes closer to those assessed by CT and
improved measurements of tracer uptake for lesions in the lungs.</p>
]]></description>
<dc:creator><![CDATA[Werner, M. K., Parker, J. A., Kolodny, G. M., English, J. R., Palmer, M. R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2516</dc:identifier>
<dc:title><![CDATA[Respiratory Gating Enhances Imaging of Pulmonary Nodules and Measurement of Tracer Uptake in FDG PET/CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1645</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1640</prism:startingPage>
<prism:section>Nuclear Medicine and Molecular Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1">
<title><![CDATA[Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1648?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to compare chest ultrasound
and chest CT in children with complicated pneumonia and parapneumonic
effusion.</p>
<p><b>MATERIALS AND METHODS.</b> We retrospectively compared chest ultrasound
and chest CT in 19 children (nine girls and 10 boys; age range, 8
months&ndash;17 years) admitted with complicated pneumonia and parapneumonic
effusion between December 2006 and January 2009. Images were evaluated for
effusion, loculation, fibrin strands, parenchymal consolidation, necrosis, and
abscess. In the subset of patients who underwent surgical management, imaging
findings were correlated with operative findings.</p>
<p><b>RESULTS.</b> Eighteen of 19 patients had an effusion on both chest
ultrasound and chest CT. The findings of effusion loculation as well as
parenchymal consolidation and necrosis or abscess were similar between the two
techniques. Chest ultrasound was better able to visualize fibrin strands
within the effusions. Of the 14 patients who underwent video-assisted
thoracoscopy, five had surgically proven parenchymal abscess or necrosis.
Preoperatively, chest ultrasound was able to show parenchymal abscess or
necrosis in four patients, whereas chest CT was able to show parenchymal
abscess or necrosis in three.</p>
<p><b>CONCLUSION.</b> In our series, chest ultrasound and chest CT were
similar in their ability to detect loculated effusion and lung necrosis or
abscess resulting from complicated pneumonia. Chest CT did not provide any
additional clinically useful information that was not also seen on chest
ultrasound. We suggest that the imaging workup of complicated pediatric
pneumonia include chest radiography and chest ultrasound, reserving chest CT
for cases in which the chest ultrasound is technically limited or discrepant
with the clinical findings.</p>
]]></description>
<dc:creator><![CDATA[Kurian, J., Levin, T. L., Han, B. K., Taragin, B. H., Weinstein, S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2791</dc:identifier>
<dc:title><![CDATA[Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1654</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1648</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1">
<title><![CDATA[Coagulation Concepts Update]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1656?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Since the previous comprehensive radiology review on
coagulation concepts that was done in 1990, many studies have been published
in the medical and surgical literature that can guide the approach of a
radiology practice. The purpose of this article is to provide an analysis of
these works, updating the radiologist on proper use and interpretation of
coagulation assessment tools, medications that modify the hemostatic system,
and the use of transfusions prior to interventions.</p>
<p><b>CONCLUSION.</b> The basic tools for coagulation assessment have not
changed; however, results from subspecialty research have suggested ways in
which the use of these tools can be modified and streamlined to safely reduce
time and expense for the patient and the health care system.</p>
]]></description>
<dc:creator><![CDATA[O'Connor, S. D., Taylor, A. J., Williams, E. C., Winter, T. C.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2191</dc:identifier>
<dc:title><![CDATA[Coagulation Concepts Update]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1664</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1656</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1">
<title><![CDATA[Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1665?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to describe survival
outcome in 124 patients with unresectable hepatocellular carcinoma treated
with triple-drug transcatheter arterial chemoembolization (TACE) using
doxorubicin, cisplatin, and mitomycin C using a standardized regimen.</p>
<p><b>MATERIALS AND METHODS.</b> One hundred twenty-four patients underwent
TACE using a standardized triple-drug regimen. Embolization was performed
using subselective coaxial embolization technique. Fifty-six patients (group
1) received triple-drug TACE in conjunction with a nonpermanent embolic agent,
microfibrillar collagen (Avitene), and 68 patients (group 2) had triple-drug
TACE with a permanent embolic agent, Embosphere Microspheres.</p>
<p><b>RESULTS.</b> Twenty-eight patients underwent liver transplantation after
TACE, and survival in these patients was significantly longer than those who
did not receive a transplant (<I>p</I> &le; 0.001). The mean survival for
the no-transplant group (<I>n</I> = 96) was longer in patients with
Child-Pugh class A cirrhosis than in those with Child-Pugh class B cirrhosis
(30.3 &plusmn; 2.92 [standard error] vs 11.6 &plusmn; 2.84 months,
respectively; <I>p</I> &lt; 0.001), in those with Okuda stage I versus stage
II disease (31.4 &plusmn; 3.03 vs 17.4 &plusmn; 3.16 months; <I>p</I> =
0.002), and in those with a pre-TACE bilirubin level of less than 2.5 mg/dL
(42.75 &micro;mol/L; 28.3 &plusmn; 2.75 vs 13.2 &plusmn; 3.83 months; <I>p</I>
= 0.007). Improved survival was seen in the no-transplant patients receiving
TACE with the permanent embolic agent (group 2) than in those receiving TACE
with the nonpermanent agent (group 1) out to 30 months (<I>p</I> = 0.002).
Complications occurred in 16 patients (12.9%). The 30-day mortality was
2.4%.</p>
<p><b>CONCLUSION.</b> Patients with hepatocellular carcinoma who underwent
triple-drug TACE followed by liver transplantation showed the longest
survival. Patients who did not receive a transplant and were treated with
triple-drug TACE with a permanent embolic agent showed longer survival to 30
months after TACE than those receiving a nonpermanent embolic agent.</p>
]]></description>
<dc:creator><![CDATA[Gomes, A. S., Rosove, M. H., Rosen, P. J., Amado, R. G., Sayre, J. W., Monteleone, P. A., Busuttil, R. W.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1806</dc:identifier>
<dc:title><![CDATA[Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1671</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1665</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1">
<title><![CDATA[Long-Term Results of Angioplasty and Stent Placement for Treatment of Central Venous Obstruction in 126 Hemodialysis Patients: A 10-Year Single-Center Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1672?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to report and compare
long-term results of percutaneous transluminal angioplasty and stenting of
central venous obstruction in hemodialysis patients.</p>
<p><b>MATERIALS AND METHODS.</b> Hemodialysis patients who underwent
successful endovascular treatment of central venous obstruction were
retrospectively evaluated. Stenotic lesions greater than 50% or inducing
extremity swelling were subject to treatment. The primary treatment was
angioplasty, and stent placement was accomplished in angioplasty-resistant
obstructions. Angioplasty was the primary treatment of recurrence after stent
placement. Additional stenting was reserved for angioplasty-resistant
recurrences.</p>
<p><b>RESULTS.</b> One hundred forty-seven veins in 126 patients (63 males, 63
females) between 15 and 82 years old primarily underwent 101 angioplasties and
46 stent placements. The mean follow-up was 22.1 &plusmn; 16.3 (SD) months.
The average number of interventions per vein in the stent group (2.7 &plusmn;
2.4 interventions) was significantly higher than that in the angioplasty group
(1.5 &plusmn; 1.0 interventions). Primary patency was significantly higher in
the angioplasty group (mean, 24.5 &plusmn; 1.7 months) than that in the stent
group (mean, 13.4 &plusmn; 2.0 months). Assisted primary patency of the
angioplasty group (mean, 31.4 &plusmn; 2.0 months) and that of the stent group
(mean, 31.0 &plusmn; 4.7 months) were equivalent. The overall mean primary
patency was 21.1 &plusmn; 1.4 months, and the overall mean assisted primary
patency was 31.7 &plusmn; 2.5 months. There were no significant differences in
patency rates with regard to patient sex, the type of stent used, the vein or
veins treated, or the type of lesions.</p>
<p><b>CONCLUSION.</b> Endovascular treatment of central venous obstruction is
a safe and effective procedure in hemodialysis patients. Stenting has a
significantly lower primary patency rate than angioplasty but adds to the
longevity of vein patency in angioplasty-resistant lesions; therefore, stent
placement should be considered in angioplasty-resistant lesions.</p>
]]></description>
<dc:creator><![CDATA[Ozyer, U., Harman, A., Yildirim, E., Aytekin, C., Karakayali, F., Boyvat, F.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2654</dc:identifier>
<dc:title><![CDATA[Long-Term Results of Angioplasty and Stent Placement for Treatment of Central Venous Obstruction in 126 Hemodialysis Patients: A 10-Year Single-Center Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1679</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1672</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1">
<title><![CDATA[Radiation Dose of Interventional Radiology System Using a Flat-Panel Detector]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1680?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Currently, cardiac interventional radiology equipment has
tended toward using flat-panel detectors (FPDs) instead of image intensifiers
(IIs) because FPDs offer better imaging performance. However, the radiation
dose from an FPD in cardiac interventional radiology is not clear. The purpose
of our study was to measure the radiation doses during cineangiography and
fluoroscopy of many cardiac radiology systems that use FPDs or IIs, in
clinical settings.</p>
<p><b>MATERIALS AND METHODS.</b> This study examined 20 radiology systems in
15 cardiac catheterization laboratories (11 used FPD and nine used II). The
entrance surface doses with digital cineangiography and fluoroscopy were
compared for the 20 systems using acrylic plates (20-cm thick) and a skin dose
monitor.</p>
<p><b>RESULTS.</b> For fluoroscopy, the average entrance surface doses of the
20-cm-thick acrylic plates were identical for FPD (average &plusmn; SD, 16.63
&plusmn; 7.89 mGy/min; range, 5.7&ndash;26.4 mGy/min; maximum/minimum, 4.63)
and II (17.81 &plusmn; 12.52 mGy/min; range, 6.5&ndash;42.2 mGy/min;
maximum/minimum, 6.49) (<I>p</I> = 0.799). For digital cineangiography, the
average entrance surface dose of the 20-cm-thick acrylic plate was slightly
lower with FPD (29.68 &plusmn; 16.40 mGy/10 s; range, 8.9&ndash;58.5 mGy/10 s;
maximum/minimum, 6.57) than with II (38.50 &plusmn; 33.71 mGy/10 s; range,
15.2&ndash;117.1 mGy/10 s; maximum/minimum, 7.70), although the difference was
not significant (<I>p</I> = 0.487).</p>
<p><b>CONCLUSION.</b> We found that the average entrance doses of
cineangiography and fluoroscopy in FPD systems were not significantly
different from those in II systems. Hence, FPDs did not inherently reduce the
radiation dose, although FPDs possess good detective quantum efficiency.
Therefore, to reduce the radiation dose of cardiac interventional radiology
systems, even FPD systems, practical measures are necessary.</p>
]]></description>
<dc:creator><![CDATA[Chida, K., Inaba, Y., Saito, H., Ishibashi, T., Takahashi, S., Kohzuki, M., Zuguchi, M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2747</dc:identifier>
<dc:title><![CDATA[Radiation Dose of Interventional Radiology System Using a Flat-Panel Detector]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1685</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1680</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1">
<title><![CDATA[Percutaneous CT-Guided Radiofrequency Ablation of Renal Cell Carcinoma: Efficacy of Organ Displacement by Injection of 5% Dextrose in Water Into the Retroperitoneum]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1686?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this study was to evaluate the
effectiveness of CT-guided injection of 5% dextrose in water solution (D5W)
into the retroperitoneum to displace organs adjacent to renal cell
carcinoma.</p>
<p><b>MATERIALS AND METHODS.</b> An interventional radiology database was
searched to identify the cases of patients who underwent CT-guided
percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma in
which D5W was injected into the retroperitoneal space to displace structures
away from the targeted renal tumor. The number of organs displaced and the
distance between the renal tumor and adjacent organs before and after
displacement with D5W were assessed.</p>
<p><b>RESULTS.</b> The cases of 135 patients with 139 biopsy-proven renal cell
carcinomas who underwent 154 percutaneous CT-guided radiofrequency ablation
procedures were found in the search. Thirty-one patients with 33 renal cell
carcinomas underwent 36 ablation procedures after injection of D5W into the
retroperitoneal space. Fifty-five organs were displaced away from renal cell
carcinoma with this technique. The average distance between adjacent
structures and renal cell carcinomas before displacement was 0.36 cm (range,
0.1&ndash;1.0 cm). The average distance between structures and adjacent renal
cell carcinomas after displacement was 1.94 cm (range, 1.1&ndash;4.3 cm)
(<I>p</I> &lt; 0.0001). The average volume of D5W used to achieve organ
displacement was 273.5 mL. No complications were associated with this
technique.</p>
<p><b>CONCLUSION.</b> CT-guided injection of D5W into the retroperitoneum is
an effective method for displacing vital structures away from renal cell
carcinoma.</p>
]]></description>
<dc:creator><![CDATA[Arellano, R. S., Garcia, R. G., Gervais, D. A., Mueller, P. R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2904</dc:identifier>
<dc:title><![CDATA[Percutaneous CT-Guided Radiofrequency Ablation of Renal Cell Carcinoma: Efficacy of Organ Displacement by Injection of 5% Dextrose in Water Into the Retroperitoneum]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1690</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1686</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1">
<title><![CDATA[Ultrasound-Guided Percutaneous Fine-Needle Aspiration of 545 Focal Pancreatic Lesions]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1691?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess the accuracy and
short-term complication rate of ultrasound-guided fine-needle aspiration
cytologic sampling of focal pancreatic lesions.</p>
<p><b>MATERIALS AND METHODS.</b> We reviewed 545 consecutive ultrasound-guided
fine-needle aspiration cytologic sampling procedures for focal pancreatic
lesions from January 2004 through June 2008. The procedures were performed
with a 20- or 21-gauge needle. The onsite cytopathologist evaluated the
appropriateness of the sample and made a diagnosis. We reviewed the final
diagnosis and the radiologic and medical records of all patients for onset of
complications during or within 7 days of the procedure.</p>
<p><b>RESULTS.</b> The study sample included 262 women and 283 men (mean age,
62 years; range, 25&ndash;86 years). The head or uncinate process of the
pancreas was the location of 63.0% of the lesions, and 35.2% of the lesions
were located in the body or tail of the pancreas. The site of 10 lesions
(1.8%) was not specified. Sampling was diagnostic in 509 of the 545 cases
(93.4%). Excluding the 36 nondiagnostic samples, ultrasound-guided fine-needle
aspiration cytologic sampling had 99.4% sensitivity, 100% specificity, and
99.4% accuracy. In 537 of the 545 cases (98.5%), the procedure was uneventful.
In two cases, abdominal fluid was found after the procedure that was not
present before the procedure. Six patients experienced postprocedural pain
without abnormal findings at subsequent imaging. No major complications
occurred.</p>
<p><b>CONCLUSION.</b> Ultrasound-guided cytologic sampling is safe and
accurate for the diagnosis and planning of management of focal pancreatic
lesions. With a cytologist on site, the rate of acquisition of samples
adequate for diagnosis is high, reducing the need for patient recall.</p>
]]></description>
<dc:creator><![CDATA[Zamboni, G. A., D'Onofrio, M., Idili, A., Malago, R., Iozzia, R., Manfrin, E., Mucelli, R. P.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2958</dc:identifier>
<dc:title><![CDATA[Ultrasound-Guided Percutaneous Fine-Needle Aspiration of 545 Focal Pancreatic Lesions]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1695</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1691</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1">
<title><![CDATA[Management of Refractory Hepatic Encephalopathy After Insertion of TIPS: Long-Term Results of Shunt Reduction With Hourglass-Shaped Balloon-Expandable Stent-Graft]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1696?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to review the use of an
hourglass-shaped expanded polytetrafluoroethylene (ePTFE) stent-graft to
reduce transjugular intrahepatic portosystemic shunts in patients with hepatic
encephalopathy refractory to conventional medical therapy.</p>
<p><b>MATERIALS AND METHODS.</b> From January 2000 through December 2008, 189
transjugular intrahepatic portosystemic shunt procedures were performed with
self-expanding stent-grafts. After a mean period of 43.4 &plusmn; 57 weeks,
hepatic encephalopathy developed in 12 patients and did not respond to
conventional medical therapy with lactulose, nonabsorbable antibiotics, and a
protein-restricted diet. In all cases, shunt reduction was performed with an
hourglass-shaped balloon-expandable ePTFE stent-graft inserted into the
original shunt.</p>
<p><b>RESULTS.</b> Technically successful shunt reduction with an immediate
increase in portosystemic gradient was achieved in all patients. Symptoms of
hepatic encephalopathy disappeared a mean of 22.3 hours (range, 18&ndash;26
hours) after the procedure. After a mean follow-up period of 73.9 &plusmn;
61.88 weeks, no recurrence of hepatic encephalopathy was found. One patient
(8.3%) needed dilation of the hourglass-shaped stent-graft after 37 weeks
because of recurrence of ascites. At the end of the study, five patients
(41.6%) were alive in good clinical condition. Four patients (33.3%) died of
cardiovascular failure 1, 2, 24, and 96 weeks after the corrective procedure.
Eight months after the reduction procedure, one patient (8.3%) underwent
orthotopic liver transplantation, which resulted in clinical improvement. Two
patients (16.6%) were lost to follow-up 15.6 and 46.8 weeks after the
procedure.</p>
<p><b>CONCLUSION.</b> Shunt reduction with an hourglass-shaped ePTFE
balloon-expandable stent-graft seems effective in reducing shunt flow and
rapidly improving the patient's clinical condition. With this technique, shunt
diameter can be modified on the basis of the patient's clinical condition.</p>
]]></description>
<dc:creator><![CDATA[Fanelli, F., Salvatori, F. M., Rabuffi, P., Boatta, E., Riggio, O., Lucatelli, P., Passariello, R.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2968</dc:identifier>
<dc:title><![CDATA[Management of Refractory Hepatic Encephalopathy After Insertion of TIPS: Long-Term Results of Shunt Reduction With Hourglass-Shaped Balloon-Expandable Stent-Graft]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1702</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1696</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1">
<title><![CDATA[Percutaneous Intervention of the C2 Vertebral Body Using a CT-Guided Posterolateral Approach]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1703?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to present two cases of
percutaneous biopsy and one case of vertebroplasty of the C2 vertebral body
using a CT-guided posterolateral approach under local anesthesia.</p>
<p><b>CONCLUSION.</b> The CT-guided posterolateral approach was safe,
feasible, and effective for percutaneous intervention of the C2 vertebral
body.</p>
]]></description>
<dc:creator><![CDATA[Sun, H. Y., Lee, J. W., Kim, K.-J., Yeom, J. S., Kang, H. S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2783</dc:identifier>
<dc:title><![CDATA[Percutaneous Intervention of the C2 Vertebral Body Using a CT-Guided Posterolateral Approach]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1705</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1703</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1">
<title><![CDATA[MRI of the Urethra in Women With Lower Urinary Tract Symptoms: Spectrum of Findings at Static and Dynamic Imaging]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1708?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine the findings at
both static and dynamic MRI in women with a clinically suspected urethral
abnormality.</p>
<p><b>MATERIALS AND METHODS.</b> MRI of the urethra was performed in 84 women
with lower urinary tract symptoms using multiplanar T2-weighted turbo
spin-echo and unenhanced and contrast-enhanced gradient-echo sequences. A
dynamic true fast imaging with steady-state free precession sequence was
performed during straining in the sagittal plane. Images were evaluated by two
radiologists for urethral pathology and pelvic organ prolapse. MRI findings
were correlated with clinical symptoms using the Fisher's exact and
Mann-Whitney tests.</p>
<p><b>RESULTS.</b> Urethral abnormalities were found in 10 of 84 patients
(11.9%), including two urethral diverticula, five Skene's gland cysts or
abscesses, and three periurethral cysts. Thirty-three patients (39.3%) were
diagnosed with pelvic organ prolapse, of whom 29 (87.9%) were diagnosed
exclusively on dynamic imaging. In 29 of 33 patients with prolapse (87.9%),
the urethra was structurally normal. MRI showed 13 cystoceles and 17 cases of
urethral hypermobility not detected on physical examination. Patients with a
greater number of vaginal deliveries, stress urinary incontinence, frequency
of voiding, and voiding difficulty were statistically more likely to have
anterior compartment prolapse (<I>p</I> &lt; 0.05).</p>
<p><b>CONCLUSION.</b> Including a dynamic sequence permits both structural and
functional evaluation of the urethra, which may be of added value in women
with lower urinary tract symptoms. Dynamic MRI allows detection of pelvic
organ prolapse that may not be evident on conventional static sequences.</p>
]]></description>
<dc:creator><![CDATA[Bennett, G. L., Hecht, E. M., Tanpitukpongse, T. P., Babb, J. S., Taouli, B., Wong, S., Rosenblum, N., Kanofsky, J. A., Lee, V. S.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1547</dc:identifier>
<dc:title><![CDATA[MRI of the Urethra in Women With Lower Urinary Tract Symptoms: Spectrum of Findings at Static and Dynamic Imaging]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1715</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1708</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1">
<title><![CDATA[Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1716?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to investigate whether
adding diffusion-weighted imaging (DWI) to dynamic contrast-enhanced MRI
(DCE-MRI) could improve the positive predictive value (PPV) of breast MRI.</p>
<p><b>MATERIALS AND METHODS.</b> The retrospective study included 70 women
with 83 suspicious breast lesions on DCE-MRI (BI-RADS 4 or 5) who underwent
subsequent biopsy. DWI was acquired during clinical breast MRI using b = 0 and
600 s/mm<sup>2</sup>. Apparent diffusion coefficient (ADC) values were
compared for benign and malignant lesions. PPV was calculated for DCE-MRI
alone (based on biopsy recommendations) and DCE-MRI plus DWI (adding an ADC
threshold) for the same set of lesions. Results were further compared by
lesion type (mass, nonmasslike enhancement) and size.</p>
<p><b>RESULTS.</b> Of the 83 suspicious lesions, 52 were benign and 31 were
malignant (11 ductal carcinoma in situ [DCIS], 20 invasive carcinoma). Both
DCIS (mean ADC, 1.31 &plusmn; 0.24 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup>
mm<sup>2</sup>/s) and invasive carcinoma (mean ADC, 1.29 &plusmn; 0.29 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s) exhibited lower mean ADC than benign
lesions (1.70 &plusmn; 0.44 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup> mm<sup>2</sup>/s,
<I>p</I> &lt; 0.001). Applying an ADC threshold of 1.81 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s for 100% sensitivity produced a PPV of
47% versus 37% for DCE-MRI alone, which would have avoided biopsy for 33%
(17/52) of benign lesions without missing any cancers. DWI increased PPV
similarly for masses and nonmasslike enhancement and preferentially improved
PPV for smaller (&le; 1 cm) versus larger lesions.</p>
<p><b>CONCLUSION.</b> DWI shows potential for improving the PPV of breast MRI
for lesions of varied types and sizes. However, considerable overlap in ADC of
benign and malignant lesions necessitates validation of these findings in
larger studies.</p>
]]></description>
<dc:creator><![CDATA[Partridge, S. C., DeMartini, W. B., Kurland, B. F., Eby, P. R., White, S. W., Lehman, C. D.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2139</dc:identifier>
<dc:title><![CDATA[Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1722</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1716</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1">
<title><![CDATA[Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1723?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the feasibility
of short-term follow-up of palpable masses that have benign imaging
features.</p>
<p><b>MATERIALS AND METHODS.</b> The cases of all women with round, oval, or
lobular palpable masses with circumscribed margins and homogeneous ultrasound
echotexture for which short-term follow-up was recommended from July 1997
through December 2003 were retrospectively identified. Evaluation was by
ultrasound and/or mammography and focused clinical examination. Outcome was
assessed with imaging or clinical follow-up lasting at least 12 months. The
cancer incidence for palpable lesions was compared with that for nonpalpable
lesions recommended for short-term follow-up.</p>
<p><b>RESULTS.</b> In 379 women, 443 palpable masses with benign features for
which short-term follow-up was recommended were identified. Outcome data were
available on 375 masses in 320 women. Lesions were evaluated with mammography
and ultrasound (<I>n</I> = 186) or ultrasound alone (<I>n</I> = 189).
Masses were typically identified only with ultrasound (<I>n</I> = 258,
68.8%); were oval (<I>n</I> = 275, 73.3%), of equal density to normal breast
tissue on mammograms (<I>n</I> = 95 on 117 mammograms, 81.2%), and
hypoechoic (<I>n</I> = 336 in 372 ultrasound examinations, 90.3%); and were
prospectively believed to be fibroadenoma (<I>n</I> = 304, 81.1%).
Eighty-five lesions (22.7%) were biopsied soon after evaluation, and one
1.5-mm ductal carcinoma in situ was diagnosed. At follow-up (mean, 2.7 years),
26 lesions (6.9%) had grown. Twenty-four of the 26 lesions were biopsied, and
no cancer was diagnosed. The overall cancer prevalence was similar for
palpable (0.3%) and nonpalpable (1.6%) masses. The cost of short-term
follow-up was less than that of biopsy.</p>
<p><b>CONCLUSION.</b> Short-term follow-up is a reasonable alternative to
biopsy of palpable breast lesions with benign imaging features, particularly
for young women with probable fibroadenoma.</p>
]]></description>
<dc:creator><![CDATA[Harvey, J. A., Nicholson, B. T., LoRusso, A. P., Cohen, M. A., Bovbjerg, V. E.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2811</dc:identifier>
<dc:title><![CDATA[Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1730</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1723</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1">
<title><![CDATA[Preoperative Sonographic Classification of Axillary Lymph Nodes in Patients With Breast Cancer: Node-to-Node Correlation With Surgical Histology and Sentinel Node Biopsy Results]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1731?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to prospectively evaluate
the role of axillary lymph node classification by sonography in breast cancer
patients by node-to-node correlation with surgical histology and sentinel node
biopsy results.</p>
<p><b>SUBJECTS AND METHODS.</b> Between June 2006 and December 2006,
preoperative axillary sonography was performed in 191 consecutive breast
cancer patients (median age, 46 years; age range, 24&ndash;79 years) who had
been scheduled to undergo breast cancer surgery with sentinel node biopsy. The
axillary lymph node that had the thickest cortex or that was closest to the
primary tumor was prospectively classified and then removed through
sonographically guided needle localization. Correspondence about and
histologic results for the needle-localized nodes and the radioactive sentinel
nodes were analyzed. The rate of malignancy, according to the sonographic
classification, and the area under a receiver operating characteristic curve
were analyzed.</p>
<p><b>RESULTS.</b> Of the 191 needle-localized nodes, 41 (21%) had metastases
and 150 (79%) did not have metastases. When a cutoff point of a cortical
thickness of 2.5 mm was used, sonographic classification showed 85% (35/41)
sensitivity, 78% (117/150) specificity, and an area under the curve of 0.861
(95% CI, 0.796&ndash;0.926). Of the 54 patients with metastases at sentinel
node biopsy or axillary lymph node dissection, 13 (24%) had false-negative
results of sonographically guided needle localization. Unsuccessful lymphatic
mapping because of absent radiotracer uptake during sentinel node biopsy was
found in 4% (7/191), whereas all needle-localized nodes with a cortical
thickness of more than 2.5 mm were confirmed as metastases.</p>
<p><b>CONCLUSION.</b> Sonographic classification of axillary lymph nodes is
effective for predicting the presence of metastases to avoid sentinel node
biopsy or to reduce unsuccessful lymphatic mapping during sentinel node
biopsy.</p>
]]></description>
<dc:creator><![CDATA[Cho, N., Moon, W. K., Han, W., Park, I. A., Cho, J., Noh, D.-Y.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3122</dc:identifier>
<dc:title><![CDATA[Preoperative Sonographic Classification of Axillary Lymph Nodes in Patients With Breast Cancer: Node-to-Node Correlation With Surgical Histology and Sentinel Node Biopsy Results]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1737</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1731</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1">
<title><![CDATA[Optimal Timing of Breast MRI Examinations for Premenopausal Women Who Do Not Have a Normal Menstrual Cycle]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1738?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to describe a method for
timing breast MRI examinations corresponding to the follicular phase of the
menstrual cycle in premenopausal women without cyclical menses, thereby
reducing the number of false-positive findings and nondiagnostic
examinations.</p>
<p><b>CONCLUSION.</b> Serum progesterone concentrations corresponding to the
follicular phase of a normal menstrual cycle can aid in optimal scheduling of
breast MRI examinations for premenopausal women who lack cyclical menses.</p>
]]></description>
<dc:creator><![CDATA[Ellis, R. L.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2657</dc:identifier>
<dc:title><![CDATA[Optimal Timing of Breast MRI Examinations for Premenopausal Women Who Do Not Have a Normal Menstrual Cycle]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1740</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1738</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W363?rss=1">
<title><![CDATA[Colonic Dilation]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W363?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Krajewski, K., Siewert, B., Eisenberg, R. L.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3353</dc:identifier>
<dc:title><![CDATA[Colonic Dilation]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W372</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W363</prism:startingPage>
<prism:section>Residents' Section</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W373?rss=1">
<title><![CDATA[Spectrum of Imaging Findings in Immunocompromised Patients With HHV-6 Infection]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W373?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aim of this article is to review systemic
manifestations of human herpes virus 6 (HHV-6) associated diseases in
immunocompromised patients.</p>
<p><b>CONCLUSION.</b> The spectrum of HHV-6 associated disorders is broad, but
radiologists are frequently not familiar with these disorders. In the clinical
setting of acute infection in an immunocompromised patient, the presence of
one of these findings (e.g., limbic encephalitis; atypical interstitial
pneumonia; pericarditis or myocarditis; or, less commonly, gastrointestinal or
hepatobiliary disorders) should raise the suspicion of a possible HHV-6
related complication.</p>
]]></description>
<dc:creator><![CDATA[Sauter, A., Ernemann, U., Beck, R., Klingel, K., Mahrholdt, H., Bitzer, M., Horger, M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2687</dc:identifier>
<dc:title><![CDATA[Spectrum of Imaging Findings in Immunocompromised Patients With HHV-6 Infection]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W380</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W373</prism:startingPage>
<prism:section>Special Article</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W381?rss=1">
<title><![CDATA[Three-Dimensional Phase-Sensitive Inversion-Recovery Turbo FLASH Sequence for the Evaluation of Left Ventricular Myocardial Scar]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W381?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate a new
free-breathing 3D phase-sensitive inversion-recovery (PSIR) turbo FLASH pulse
sequence for the detection of left ventricular myocardial scar.</p>
<p><b>SUBJECTS AND METHODS.</b> Patients with suspected myocardial scar were
examined on a 1.5-T MR scanner for myocardial late enhancement after the
administration of gadopentetate dimeglumine using a segmented 2D PSIR turbo
FLASH sequence followed by a navigator-gated 3D PSIR turbo FLASH sequence.
Image quality was scored by two independent readers using a 4-point Likert
scale (0 = poor, nondiagnostic; 1 = fair, diagnostics may be impaired; 2 =
good, some artifacts but not interfering in diagnostics; 3 = excellent, no
artifacts). Scars were compared quantitatively in volume and graded
qualitatively on the basis of size (area) and location.</p>
<p><b>RESULTS.</b> Thirty-three patients were scanned using both techniques.
In 25 patients, the quality of the 3D PSIR images was acceptable. Scars were
detected in 12 patients. Hyperenhanced scar volumes (<I>p</I> = 0.43),
qualitative analysis of scar area (<I>p</I> = 0.78), and scar location
(<I>p</I> = 0.68) were similar for both techniques. More small hyperenhanced
scars, corresponding mostly to nonischemic distribution patterns, were
detected using 3D PSIR than 2D PSIR. Although 2D and 3D results were found to
be highly correlated for scar volume, Bland-Altman analysis indicated a
systematic smaller infarct volume on the 2D PSIR scans (<I>R</I><sup>2</sup>
= 0.84).</p>
<p><b>CONCLUSION.</b> Free-breathing 3D PSIR turbo FLASH imaging is a
promising technique for the assessment of left ventricular scar particularly
for scar quantification and the detection of small nonischemic scars in the
myocardium.</p>
]]></description>
<dc:creator><![CDATA[Kino, A., Zuehlsdorff, S., Sheehan, J. J., Weale, P. J., Carroll, T. J., Jerecic, R., Carr, J. C.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1952</dc:identifier>
<dc:title><![CDATA[Three-Dimensional Phase-Sensitive Inversion-Recovery Turbo FLASH Sequence for the Evaluation of Left Ventricular Myocardial Scar]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W388</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W381</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W389?rss=1">
<title><![CDATA[Evaluation of Mechanical Heart Valve Size and Function With ECG-Gated 64-MDCT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W389?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine whether CT can
accurately evaluate mechanical heart valve size and function.</p>
<p><b>MATERIALS AND METHODS.</b> Sixty-two patients with mechanical valves (37
single-disc, 27 bileaflet; 59 aortic, 5 mitral) were evaluated with ECG-gated
64-MDCT and transthoracic echocardiography; a subset of 10 patients underwent
cinefluoroscopy. Two readers independently interpreted each study.</p>
<p><b>RESULTS.</b> The mean age of the patients was 46.4 &plusmn; 14.4 years;
50 were men and 12 were women. There was excellent correlation, and
differences between CT readers were absent to small in measuring the opening
angle (<I>r</I> = 0.96, <I>p</I> &lt; 0.001; 76.7 &plusmn; 9.0&deg; vs
76.8 &plusmn; 9.6&deg;, <I>p</I> = 0.73), annulus diameter (<I>r</I> =
0.96, <I>p</I> &lt; 0.001; 25.9 &plusmn; 3.3 vs 25.9 &plusmn; 3.2 mm,
<I>p</I> = 0.62), and geometric orifice area (<I>r</I> = 0.98, <I>p</I>
&lt; 0.001; 3.8 &plusmn; 0.9 vs 3.6 &plusmn; 0.8 cm<sup>2</sup>, <I>p</I>
&lt; 0.001). There was strong correlation without difference in opening angle
between CT and cinefluoroscopy (<I>r</I> = 0.77, <I>p</I> &lt; 0.001;
79.2&deg; &plusmn; 9.8&deg; vs 77.2&deg; &plusmn; 15.5&deg;, <I>p</I> =
0.45). Compared with manufacturer specifications, CT reported opening angles
that were smaller for single-disc valves (<I>n</I> = 36, 67.4&deg; &plusmn;
5.7&deg; vs 75&deg;, <I>p</I> &lt; 0.001) and similar for bileaflet valves
(<I>n</I> = 42 for 21 valves, 83.8&deg; &plusmn; 3.9&deg; vs 85&deg;,
<I>p</I> = 0.05), valves, with small underestimation with CT versus
specifications in annulus diameter (<I>n</I> = 41; <I>r</I> = 0.75,
<I>p</I> &lt; 0.001; 26.4 &plusmn; 3.0 vs 27.5 &plusmn; 3.3 mm, <I>p</I> =
0.003), and geometric orifice area (<I>n</I> = 35; <I>r</I> = 0.90,
<I>p</I> &lt; 0.001; 3.7 &plusmn; 0.7 vs 3.8 &plusmn; 0.8 cm<sup>2</sup>,
<I>p</I> = 0.04). Each disc closed fully on CT; none had more than mild
regurgitation on echocardiography.</p>
<p><b>CONCLUSION.</b> CT can measure the size and function of mechanical
valves with high interobserver agreement and results similar to
specifications. The opening angle with CT strongly correlates with
cinefluoroscopy. CT is promising for the assessment of mechanical valves.</p>
]]></description>
<dc:creator><![CDATA[LaBounty, T. M., Agarwal, P. P., Chughtai, A., Bach, D. S., Wizauer, E., Kazerooni, E. A.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2178</dc:identifier>
<dc:title><![CDATA[Evaluation of Mechanical Heart Valve Size and Function With ECG-Gated 64-MDCT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W396</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W389</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W397?rss=1">
<title><![CDATA[Performance of Radiologists in Detection of Small Pulmonary Nodules on Chest Radiographs: Effect of Rib Suppression With a Massive-Training Artificial Neural Network]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W397?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> A massive-training artificial neural network is a
nonlinear pattern recognition tool used to suppress rib opacity on chest
radiographs while soft-tissue contrast is maintained. We investigated the
effect of rib suppression with a massive-training artificial neural network on
the performance of radiologists in the detection of pulmonary nodules on chest
radiographs.</p>
<p><b>MATERIALS AND METHODS.</b> We used 60 chest radiographs; 30 depicted
solitary pulmonary nodules, and 30 showed no nodules. A stratified
random-sampling scheme was used to select the images from the standard digital
image database developed by the Japanese Society of Radiologic Technology. The
mean diameter of the 30 pulmonary nodules was 14.7 &plusmn; 4.1 (SD) mm.
Receiver operating characteristic analysis was used to evaluate observer
performance in the detection of pulmonary nodules first on the chest
radiographs without and then on the radiographs with rib suppression. Seven
board-certified radiologists and five radiology residents participated in this
observer study.</p>
<p><b>RESULTS.</b> For all 12 observers, the mean values of the area under the
best-fit receiver operating characteristic curve for images without and with
rib suppression were 0.816 &plusmn; 0.077 and 0.843 &plusmn; 0.074; the
difference was statistically significant (<I>p</I> = 0.019). The mean areas
under the curve for images without and with rib suppression were 0.848
&plusmn; 0.059 and 0.883 &plusmn; 0.050 for the seven board-certified
radiologists (<I>p</I> = 0.011) and 0.770 &plusmn; 0.081 and 0.788 &plusmn;
0.074 for the five radiology residents (<I>p</I> = 0.310).</p>
<p><b>CONCLUSION.</b> In the detection of pulmonary nodules, evaluation of a
combination of rib-suppressed and original chest radiographs significantly
improved the diagnostic performance of radiologists over the use of chest
radiographs alone.</p>
]]></description>
<dc:creator><![CDATA[Oda, S., Awai, K., Suzuki, K., Yanaga, Y., Funama, Y., MacMahon, H., Yamashita, Y.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2431</dc:identifier>
<dc:title><![CDATA[Performance of Radiologists in Detection of Small Pulmonary Nodules on Chest Radiographs: Effect of Rib Suppression With a Massive-Training Artificial Neural Network]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W402</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W397</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W403?rss=1">
<title><![CDATA[Identification and Management of Persistently Active Brachytherapy Seed Implants]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W403?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to review the history of
permanently implanted brachytherapy sources and to establish methods of
identifying radon sources and discussing appropriate management.</p>
<p><b>CONCLUSION.</b> There are likely thousands of people bearing radon seeds
that continue to emit radiation decades after implantation. They can be
identified by clinical history and emission of characteristic x-rays. Surgical
removal of these sources is rarely warranted.</p>
]]></description>
<dc:creator><![CDATA[Aronowitz, J. N., Gay, H. A., Clark, T. J., Mota, H., Bushe, H.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2868</dc:identifier>
<dc:title><![CDATA[Identification and Management of Persistently Active Brachytherapy Seed Implants]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W406</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W403</prism:startingPage>
<prism:section>Medical Physics and Informatics</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W407?rss=1">
<title><![CDATA[Bone Biopsy of New Suspicious Bone Lesions in Patients With Primary Carcinoma: Prevalence and Probability of an Alternative Diagnosis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W407?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> We sought to assess the probability that a new suspicious
bone lesion is an alternative diagnosis, that is, a benign lesion or a second
malignant tumor as opposed to metastatic disease from the malignant tumor, in
a person with known primary malignant disease.</p>
<p><b>MATERIALS AND METHODS.</b> We reviewed the radiologic and pathologic
records of bone biopsies scheduled at our institution between 2002 and 2007.
The following parameters were recorded: indication, type of primary cancer,
date of diagnosis, complications of biopsy, whether the sample was of
diagnostic quality, pathologic finding, and thus whether the primary malignant
tumor was concordant with the lesion sampled.</p>
<p><b>RESULTS.</b> Fifty-four of 55 patients (17 men, 37 women; mean age, 67
years) with known primary cancer and suspicious bone lesions underwent biopsy.
One of the 55 patients did not undergo biopsy because a sacral insufficiency
fracture was confidently diagnosed at CT. The primary malignant disease had
been diagnosed up to 16 years before the new bone lesion was suspected and
bone biopsy performed. Cancer types included those of genitourinary tract,
breast, thyroid, gastrointestinal tract, and lung and lymphoma and myeloma.
Diagnostic material was obtained in 43 of 54 cases (80%), and nondiagnostic
material was obtained in 11 of 54 cases (20%). Forty-two of 43 positive biopsy
findings (98%) were consistent with the primary malignant tumor. The other
positive finding was a new malignant tumor. This new tumor was myelofibrosis
in a man with chronic myelocytic leukemia. The primary diagnosis correlated
highly with that of the new bone lesion (Spearman's test, <I>R</I> = 0.842;
<I>p</I> &lt; 0.001). No complications, including hemorrhage, infection,
sinus track formation, fracture, and pneumothorax, were encountered.</p>
<p><b>CONCLUSION.</b> In a patient with known primary malignant disease, the
probability is low (2%) that biopsy of a new suspicious bone lesion will show
the lesion is other than metastasis from the primary tumor.</p>
]]></description>
<dc:creator><![CDATA[Cronin, C. G., Cashell, T., Mhuircheartaigh, J. N., Swords, R., Murray, M., O'Sullivan, G. J., O'Keeffe, D.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1882</dc:identifier>
<dc:title><![CDATA[Bone Biopsy of New Suspicious Bone Lesions in Patients With Primary Carcinoma: Prevalence and Probability of an Alternative Diagnosis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W410</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W407</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W411?rss=1">
<title><![CDATA[T2 Measurements of Cartilage in Osteoarthritis Patients With Meniscal Tears]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W411?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this study was to quantitatively assess
cartilage degeneration via T2 mapping to compare patients with and those
without meniscal tears.</p>
<p><b>SUBJECTS AND METHODS.</b> Thirty-seven patients (18 men, mean age
&plusmn; SD, 65.7 &plusmn; 7.8 years; 19 women, mean age, 63.8 &plusmn; 12.0
years) with clinical symptoms of osteoarthritis were studied on 3-T MRI using
a 2D multiecho spin-echo sequence for T2 mapping. Meniscal signal and
morphology were qualitatively graded and correlated to the T2 values of
cartilage. Analysis of covariance, Bonferroni multiple comparison correction,
and Spearman's correlation coefficients were used for statistical
analysis.</p>
<p><b>RESULTS.</b> Patients with meniscal tears (median &plusmn; interquartile
range, 50.1 &plusmn; 6.1 milliseconds) had significantly (<I>p</I> = 0.021)
higher T2 values of cartilage than those without meniscal tears (45.7 &plusmn;
4.8 milliseconds). T2 values of cartilage were significantly higher in the
medial compartment than in the lateral compartment in patients with medial
meniscal tears (<I>p</I> = 0.018).</p>
<p><b>CONCLUSION.</b> T2 measurements are increased in patients with meniscal
tears; this finding adds support to the theory of an association of
osteoarthritis with damage to both the menisci and hyaline cartilage.</p>
]]></description>
<dc:creator><![CDATA[Friedrich, K. M., Shepard, T., de Oliveira, V. S., Wang, L., Babb, J. S., Schweitzer, M., Regatte, R.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2256</dc:identifier>
<dc:title><![CDATA[T2 Measurements of Cartilage in Osteoarthritis Patients With Meniscal Tears]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W415</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W411</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W416?rss=1">
<title><![CDATA[Interobserver Agreement in Assessing the Sonographic and Elastographic Features of Malignant Thyroid Nodules]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W416?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to investigate
interobserver agreement for the diagnosis of malignant thyroid nodules using
conventional B-mode ultrasound and real-time freehand ultrasound
elastography.</p>
<p><b>MATERIALS AND METHODS.</b> Between December 2007 and February 2008, 45
patients (age range, 19&ndash;73 years; mean age &plusmn; SD, 45.0 &plusmn;
12.2 years) with 52 thyroid nodules were examined with conventional B-mode
ultrasound and real-time freehand ultrasound elastography. All the patients
were scheduled to undergo thyroid surgery because a thyroid nodule had been
proven malignant on aspiration cytology. Three radiologists independently
performed conventional ultrasound and elastography and analyzed the ultrasound
images. Using conventional ultrasound, observers recorded the following
information about nodular features: composition (solid, cystic, or mixed
cystic&ndash;solid), echogenicity (hyperechoic, isoechoic, hypoechoic, or
markedly hypoechoic), margin (well circumscribed, microlobulated, or
irregular), calcification (negative [no calcifications]; microcalcification,
macrocalcification, or mixed-type calcifications), and shape (parallel or
nonparallel). Observers determined the Ueno classification and area ratio for
each nodule using ultrasound elastography. Interobserver agreement was
evaluated with Spearman's correlation analysis for all findings except the
area ratio, for which Pearson's correlation analysis was used. A <I>p</I>
&lt; 0.05 was considered to indicate statistical significance.</p>
<p><b>RESULTS.</b> Statistically significant (<I>p</I> &lt; 0.05)
concordance among the three radiologists was found on conventional ultrasound
for most features except echogenicity and margin of thyroid nodules. The
highest value of concordance on conventional ultrasound was achieved for
composition (Spearman's correlation coefficient, 0.70&ndash;1.00), followed by
shape (0.48&ndash;0.79) and calcification (0.47&ndash;0.62). The least
concordant findings on conventional ultrasound were nodular echogenicity
(0.04&ndash;0.45) and margin (0.03&ndash;0.29). However, there was no
statistically significant concordance on elastography for the Ueno
classification (Spearman's correlation coefficient, 0.08&ndash;0.22;
<I>p</I> &gt; 0.05) or the area ratio (Pearson's correlation coefficient,
&ndash;0.03 to 0.23; <I>p</I> &gt; 0.05).</p>
<p><b>CONCLUSION.</b> Statistically significant concordance among radiologists
about most features of malignant thyroid nodules was seen with conventional
ultrasound; however, ultrasound elastography did not show reliable
interobserver agreement for the diagnosis of malignant thyroid nodules.</p>
]]></description>
<dc:creator><![CDATA[Park, S. H., Kim, S. J., Kim, E.-K., Kim, M. J., Son, E. J., Kwak, J. Y.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2541</dc:identifier>
<dc:title><![CDATA[Interobserver Agreement in Assessing the Sonographic and Elastographic Features of Malignant Thyroid Nodules]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W423</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W416</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W424?rss=1">
<title><![CDATA[Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma: Assessment of Safety in Patients With Ascites]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W424?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to assess whether
percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC)
is a safe procedure in patients with ascites.</p>
<p><b>MATERIALS AND METHODS.</b> From October 2005 to January 2008, 35
patients with one or more HCCs and ascites were referred to our department for
planning sonography of RFA. In 15 patients, RFA was determined to be
unfeasible. One patient was excluded from the study because of the absence of
ascites at the time of RFA. Percutaneous ultrasound-guided RFA was performed
in the remaining 19 patients with 24 HCCs. The electrode tract was cauterized
at the time of electrode removal. Retrospective assessments of the
preprocedural platelet counts and prothrombin times were performed, and
patients were evaluated for bleeding complication by checking vital signs,
checking serum hemoglobin level, and using CT to determine whether the
attenuation value of ascites had increased &gt; 30 HU.</p>
<p><b>RESULTS.</b> There were no cases of mortality or major complications
that developed after RFA. No significant difference in the maximum thickness
of the perihepatic ascites and in the hemoglobin level between the pre- and
postprocedural measurements was detected. Hemoperitoneum as a minor
complication was noted in two (10.5%) of 19 patients. However, in those two
patients, vital signs were stable, follow-up laboratory data were normal, and
hemoperitoneum had been completely absorbed on CT images obtained 1 month
after RFA.</p>
<p><b>CONCLUSION.</b> Percutaneous RFA for HCC can be performed safely in
patients with ascites.</p>
]]></description>
<dc:creator><![CDATA[Cha, J., Rhim, H., Lee, J. Y., Kim, Y.-s., Choi, D., Lee, M. W., Lee, W. J., Lim, H. K.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1836</dc:identifier>
<dc:title><![CDATA[Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma: Assessment of Safety in Patients With Ascites]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W429</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W424</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W430?rss=1">
<title><![CDATA[Air Embolism and Needle Track Implantation Complicating CT-Guided Percutaneous Thoracic Biopsy: Single-Institution Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W430?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to present the details and
incidence of air embolism and needle track implantation in patients who
underwent percutaneous CT-guided thoracic biopsy.</p>
<p><b>MATERIALS AND METHODS.</b> We retrospectively reviewed 1,400
percutaneous CT-guided thoracic biopsies during the period from August 1993 to
August 2008. A case with air embolism was considered to be a patient with
hypotension during or after biopsy and with an air embolism confirmed on CT. A
needle track implantation was considered to be a mass in the needle track on
the postbiopsy follow-up CT.</p>
<p><b>RESULTS.</b> There were three (0.21%) cases of air embolism. Air
embolisms were confirmed in the left ventricle, coronary artery, ascending
aorta, and pulmonary vein. The pulmonary venous wall was pathologically
identified in one case. Although there were no fatalities, two patients needed
resuscitation. Left hemiplegia occurred in one case, but it gradually
disappeared. There were four (0.56%) cases of needle track implantation in 713
pathologically proven malignant thoracic biopsy cases with follow-up CT scans.
Two were primary lung cancer and the others were lung metastasis (renal cell
carcinoma and osteosarcoma). Implantation was found 4&ndash;7 months (mean,
5.6 months) after the biopsy, and size was 2.5&ndash;5.6 cm (mean, 3.5
cm).</p>
<p><b>CONCLUSION.</b> The incidence of air embolism with clinical symptoms and
needle track implantation complicating percutaneous thoracic biopsy is more
frequent than the previously reported rate.</p>
]]></description>
<dc:creator><![CDATA[Ibukuro, K., Tanaka, R., Takeguchi, T., Fukuda, H., Abe, S., Tobe, K.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2214</dc:identifier>
<dc:title><![CDATA[Air Embolism and Needle Track Implantation Complicating CT-Guided Percutaneous Thoracic Biopsy: Single-Institution Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W436</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W430</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W437?rss=1">
<title><![CDATA[In Vivo Imaging of the Aneurysm Wall With MRI and a Macrophage-Specific Contrast Agent]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W437?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Because of their capability of secreting proteinases,
macrophages play a central role in the growth and rupture of aneurysms.
Noninvasive imaging of macrophages therefore may yield valuable information
about the pathogenesis of aneurysm disease. We studied uptake of the
macrophage-specific contrast agent ultrasmall paramagnetic iron oxide (USPIO)
in the walls of aneurysms and normal-sized aortas.</p>
<p><b>MATERIALS AND METHODS.</b> Six patients with an aortic and five patients
with an iliac aneurysm and 11 age-matched controls were identified in a
database of 239 patients who underwent evaluations for the staging of prostate
cancer. USPIO-enhanced MRI and contrast-enhanced MDCT were performed for all
patients. The presence of USPIO was assessed with an iron-sensitive MRI
sequence. Quantification consisted of counting the number of quadrants with
USPIO-induced subendothelial signal voids. A chi-square test was used to
analyze the significance of the difference between the number of
USPIO-positive quadrants in the aneurysm group and that in the control
group.</p>
<p><b>RESULTS.</b> The number of USPIO-positive quadrants was significantly
higher in the aneurysm than in the control group: 158 quadrants (4.2%) in the
aneurysm group and 13 quadrants (0.4%) in the control group (<I>p</I> &lt;
0.001). Two abdominal aortic aneurysms accounted for 90% (154/171) of all
USPIO-positive quadrants.</p>
<p><b>CONCLUSION.</b> USPIO uptake is limited or absent in the wall of
normal-sized aortas and most aneurysms. However, individual abdominal aortic
aneurysms exhibit high levels of USPIO uptake, indicative of extensive
macrophage infiltration in the aneurysm wall. Future research should focus on
the predictive value of USPIO uptake for growth and rupture of aneurysms.</p>
]]></description>
<dc:creator><![CDATA[Truijers, M., Futterer, J. J., Takahashi, S., Heesakkers, R. A., Blankensteijn, J. D., Barentsz, J. O.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2619</dc:identifier>
<dc:title><![CDATA[In Vivo Imaging of the Aneurysm Wall With MRI and a Macrophage-Specific Contrast Agent]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W441</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W437</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W442?rss=1">
<title><![CDATA[Cement Leakage in Percutaneous Vertebroplasty for Osteoporotic Compression Fractures With or Without Intravertebral Clefts]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W442?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to compare the incidence and
location of cement leakage in percutaneous vertebroplasty for osteoporotic
compression fractures with and without intravertebral clefts.</p>
<p><b>MATERIALS AND METHODS.</b> Percutaneous vertebroplasty was performed in
120 consecutive patients with 300 osteoporotic compression fractures. The
cement volume injected was recorded. The cement leakage was evaluated using
spinal radiography, MRI, and fluoroscopy during the procedure and CT after the
procedure.</p>
<p><b>RESULTS.</b> One hundred seven vertebrae contained intervertebral
clefts, and 193 vertebrae had no clefts. The cement volume injected (&plusmn;
SD) was 4.0 &plusmn; 2.0 and 3.6 &plusmn; 1.6 mL into vertebrae with clefts
and without clefts, respectively, with no statistically significant difference
(<I>p</I> = 0.14). There was no statistically significant difference in the
incidence of cement leakage between vertebrae with clefts (53 of 107) and
those without clefts (78 of 193) (<I>p</I> = 0.13). Leakage occurred into
the epidural veins (12 of 107), perivertebral soft tissues (7 of 107), disks
(41 of 107), intervertebral foramen (1 of 107), and spinal canal (1 of 107) in
fractures with clefts and into the epidural veins (47 of 193), perivertebral
soft tissues (13 of 193), disks (25 of 193), paravertebral veins (5 of 193),
large vein (2 of 193), lung (2 of 193), intervertebral foramen (1 of 193), and
spinal canal (1 of 193) in fractures without clefts. Cement leakage into the
epidural vein was significantly more frequent in vertebrae without clefts
(<I>p</I> &lt; 0.01). Disk leakage was significantly more frequent in
vertebrae with clefts compared with those without clefts (<I>p</I> &lt;
0.01).</p>
<p><b>CONCLUSION.</b> There was no statistically significant difference in the
incidence of cement leakage between vertebrae with clefts and without clefts.
However, cement leakage into the epidural vein was significantly more frequent
in vertebrae without clefts and disk leakage was significantly more frequent
in vertebrae with clefts.</p>
]]></description>
<dc:creator><![CDATA[Tanigawa, N., Kariya, S., Komemushi, A., Tokuda, T., Nakatani, M., Yagi, R., Sawada, S.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2774</dc:identifier>
<dc:title><![CDATA[Cement Leakage in Percutaneous Vertebroplasty for Osteoporotic Compression Fractures With or Without Intravertebral Clefts]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W445</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W442</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W446?rss=1">
<title><![CDATA[Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma After Attempted Portal Vein Embolization in 25 Patients]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W446?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Portal vein embolization (PVE) has been widely used to
facilitate major liver resection; however, curative surgery even after PVE may
not be possible mainly because of inadequate hypertrophy of remnant liver or
disease progression. For these patients, transcatheter arterial
chemoembolization (TACE) is the next therapeutic option. We evaluated the
safety and efficacy of TACE after PVE in 25 patients with hepatocellular
carcinoma (HCC).</p>
<p><b>CONCLUSION.</b> TACE using a single chemotherapeutic agent can be
performed safely and effectively in HCC patients who previously underwent PVE.
TACE after PVE allowed two of the patients to be downstaged so they could
undergo surgical resection.</p>
]]></description>
<dc:creator><![CDATA[Kang, B.-K., Kim, J. H., Kim, K. M., Ko, G.-Y., Yoon, H.-K., Gwon, D. I., Sung, K.-B.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2479</dc:identifier>
<dc:title><![CDATA[Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma After Attempted Portal Vein Embolization in 25 Patients]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W451</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W446</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W452?rss=1">
<title><![CDATA[Biopsy Method: A Major Predictor of Adherence After Benign Breast Biopsy?]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W452?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Adopting a longitudinal approach to assess women after
breast biopsy with a benign result, this study aimed to comparatively evaluate
the effect of the biopsy method on compliance with clinical recommendations
for follow-up.</p>
<p><b>MATERIALS AND METHODS.</b> For this study, 410 patients who underwent
biopsy of a breast lesion were included: fine-needle aspiration biopsy,
<I>n</I> = 95 patients; core biopsy, <I>n</I> = 84; local excision under
local anesthesia, <I>n</I> = 72; vacuum-assisted breast biopsy, <I>n</I> =
100; and hookwire localization, <I>n</I> = 59. Information about patient
age, place of residence, whether complications occurred, and type of lesion
was collected.</p>
<p><b>RESULTS.</b> Compliance was higher among women who had undergone
vacuum-assisted breast biopsy than those who had undergone one of the other
biopsy methods. The superiority (carryover effect) of vacuum-assisted breast
biopsy persisted for 18 months after the biopsy procedure. Patient compliance
for all of the other biopsy methods followed an M pattern, with the peaks
corresponding to the follow-up mammography sessions. In patients who had
undergone vacuum-assisted breast biopsy, a gradual decrease in compliance over
time was observed. Older women were more compliant than younger women with
follow-up recommendations regardless of biopsy method. A subanalysis of the
vacuum-assisted breast biopsy group indicated that complications are
associated with better compliance.</p>
<p><b>CONCLUSION.</b> Women more often adhere to clinical recommendations for
follow-up sessions comprising mammography. Patient age and whether biopsy
complications occurred also seem to modify compliance. Further studies should
assess whether superior compliance after vacuum-assisted breast biopsy
persists in other settings, such as with stereotactic or ultrasound guidance,
different numbers of cores, and procedures of various durations.</p>
]]></description>
<dc:creator><![CDATA[Sergentanis, T. N., Zagouri, F., Domeyer, P., Giannakopoulou, G., Tsigris, C., Bramis, J., Zografos, G. C.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1061</dc:identifier>
<dc:title><![CDATA[Biopsy Method: A Major Predictor of Adherence After Benign Breast Biopsy?]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W457</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W452</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/W458?rss=1">
<title><![CDATA[Time-Resolved MR Angiography as a Useful Sequence for Assessment of Ovarian Vein Reflux]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/W458?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this retrospective study was to assess the
imaging characteristics of ovarian vein reflux using time-resolved MR
angiography (TR-MRA). One hundred consecutive female patients underwent TR-MRA
of the pelvis to evaluate suspected or known pelvic pathology. Findings of
ovarian vein reflux, ovarian vein dilation, and periuterine varices were
analyzed and correlated with symptoms of pelvic pain.</p>
<p><b>CONCLUSION.</b> Overall, TR-MRA is a useful sequence for the assessment
of ovarian vein reflux, which may aid the evaluation of pelvic congestion
syndrome.</p>
]]></description>
<dc:creator><![CDATA[Kim, C. Y., Miller, M. J., Merkle, E. M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2557</dc:identifier>
<dc:title><![CDATA[Time-Resolved MR Angiography as a Useful Sequence for Assessment of Ovarian Vein Reflux]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W463</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W458</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W464?rss=1">
<title><![CDATA[Musculoskeletal Imaging: Cases]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W464?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Runyan, B. R.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3006</dc:identifier>
<dc:title><![CDATA[Musculoskeletal Imaging: Cases]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W464</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W464</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W465?rss=1">
<title><![CDATA[MR Imaging of the Body]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W465?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Bestic, J. M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3248</dc:identifier>
<dc:title><![CDATA[MR Imaging of the Body]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W465</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W465</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W466?rss=1">
<title><![CDATA[Ability to Reduce the Incidence of Pneumothorax in Transthoracic CT-Guided Biopsy]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W466?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[De Filippo, M., Averna, R., Zompatori, M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2280</dc:identifier>
<dc:title><![CDATA[Ability to Reduce the Incidence of Pneumothorax in Transthoracic CT-Guided Biopsy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W467</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W466</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W468?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W468?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Souza, C. A.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2928</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W468</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W468</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W469?rss=1">
<title><![CDATA[Partial Versus Partial-Thickness Tears of the Scapholunate and Lunatotriquetral Ligaments]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W469?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Moser, T., Cardinal, E., Dosch, J.-C.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2898</dc:identifier>
<dc:title><![CDATA[Partial Versus Partial-Thickness Tears of the Scapholunate and Lunatotriquetral Ligaments]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W469</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W469</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W470?rss=1">
<title><![CDATA[Extracolonic Findings From CTC: Balancing Risks and Benefits]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W470?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Rutter, C. M., Kuntz, K. M., Zauber, A. G., the Colorectal Cancer Modeling Group in the Cancer Intervention and Surveillance Modeling Network (CISNET)]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2977</dc:identifier>
<dc:title><![CDATA[Extracolonic Findings From CTC: Balancing Risks and Benefits]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W470</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W470</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/W471?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/W471?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Pickhardt, P. J., Hassan, C., Kim, D. H.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:35 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3034</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W471</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>W471</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1199?rss=1">
<title><![CDATA[Peer Review and Biomedical Publications: We All Have the Same Issues]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1199?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berquist, T. H.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3639</dc:identifier>
<dc:title><![CDATA[Peer Review and Biomedical Publications: We All Have the Same Issues]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1200</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1199</prism:startingPage>
<prism:section>From the Editor's Notebook</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1203?rss=1">
<title><![CDATA[Staging of Non-Small Cell Lung Cancer Using Integrated PET/CT]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1203?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kligerman, S., Digumarthy, S.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3193</dc:identifier>
<dc:title><![CDATA[Staging of Non-Small Cell Lung Cancer Using Integrated PET/CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1211</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1203</prism:startingPage>
<prism:section>Residents' Section</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1212?rss=1">
<title><![CDATA[Coping With War Mass Casualties in a Hospital Under Fire: The Radiology Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1212?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> We report the role of the imaging department at a level 1
trauma center during the Second Lebanon War (summer 2006). Our institution
received 849 military and civilian casualties, an average of 25 war-injured
patients per day, 338 with acute traumatic stress disorders and 511 physically
injured, coming in waves after a rocket attack or a battle confrontation.
About 12 potentially critical physically injured patients per day were
referred to the imaging department for sometimes complex imaging procedures.
The unpredictable waves of casualties and nature of the injuries forced us to
reorganize our routine workflow to provide adequate care to casualties and to
nonemergent patients. Our nurses' station was transformed into a small
emergency department. The radiology staff was distributed into 12 diagnostic
stations, providing 24-hour service. Communication was improved by means of
walkie-talkies. Three ultrasound units were placed at the emergency department
for immediate focused assessment with sonography for trauma performance
enabling initial triage of patients. The site and extent of injuries were
accurately diagnosed on CT and CT angiography. Digital angiography allowed
definitive vascular diagnosis and interventional procedures.</p>
<p><b>CONCLUSION.</b> Adequate communication, strict workflow, and correct use
of imaging protocols ensured optimal triage, diagnosis, and therapy of
casualties while maintaining care for nonwar patients.</p>
]]></description>
<dc:creator><![CDATA[Engel, A., Soudack, M., Ofer, A., Nitecki, S. S., Ghersin, E., Fischer, D., Gaitini, D. E.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2375</dc:identifier>
<dc:title><![CDATA[Coping With War Mass Casualties in a Hospital Under Fire: The Radiology Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1221</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1212</prism:startingPage>
<prism:section>Special Article</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1223?rss=1">
<title><![CDATA[Pulmonary Embolism in Pregnancy: Comparison of Pulmonary CT Angiography and Lung Scintigraphy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1223?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to retrospectively compare
the diagnostic adequacy of lung scintigraphy with that of pulmonary CT
angiography (CTA) in the care of pregnant patients with suspected pulmonary
embolism.</p>
<p><b>MATERIALS AND METHODS.</b> Patient characteristics, radiology report
content, additional imaging performed, final diagnosis, and diagnostic
adequacy were recorded for pregnant patients consecutively referred for lung
scintigraphy or pulmonary CTA according to physician preference. Measurements
of pulmonary arterial enhancement were performed on all pulmonary CTA images
of pregnant patients. Lung scintigraphy and pulmonary CTA studies deemed
inadequate for diagnosis at the time of image acquisition were further
assessed, and the cause of diagnostic inadequacy was determined. The relative
contribution of the inferior vena cava to the right side of the heart was
measured on nondiagnostic CTA images and compared with that on CTA images of
age-matched nonpregnant women, who were the controls.</p>
<p><b>RESULTS.</b> Twenty-eight pulmonary CTA examinations were performed on
25 pregnant patients, and 25 lung scintigraphic studies were performed on 25
pregnant patients. Lung scintigraphy was more frequently adequate for
diagnosis than was pulmonary CTA (4% vs 35.7%) (<I>p</I> = 0.0058).
Pulmonary CTA had a higher diagnostic inadequacy rate among pregnant than
nonpregnant women (35.7% vs 2.1%) (<I>p</I> &lt; 0.001). Transient
interruption of contrast material by unopacified blood from the inferior vena
cava was identified in eight of 10 nondiagnostic pulmonary CTA studies.</p>
<p><b>CONCLUSION.</b> We found that lung scintigraphy was more reliable than
pulmonary CTA in pregnant patients. Transient interruption of contrast
material by unopacified blood from the inferior vena cava is a common finding
at pulmonary CTA of pregnant patients.</p>
]]></description>
<dc:creator><![CDATA[Ridge, C. A., McDermott, S., Freyne, B. J., Brennan, D. J., Collins, C. D., Skehan, S. J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2360</dc:identifier>
<dc:title><![CDATA[Pulmonary Embolism in Pregnancy: Comparison of Pulmonary CT Angiography and Lung Scintigraphy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1227</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1223</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1228?rss=1">
<title><![CDATA[CT-Guided Core Biopsy of Lung Lesions: A Primer]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1228?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> CT-guided core biopsy is playing an increasing role in
the diagnosis of benign disease, cellular differentiation, somatic mutation
analysis, and molecular fingerprint analysis.</p>
<p><b>CONCLUSION.</b> In this article, we summarize the basic concepts,
protocols, and techniques that we use for CT-guided core biopsy of lung
lesions to assist radiologists in obtaining diagnostic specimens while
reducing preventable complications.</p>
]]></description>
<dc:creator><![CDATA[Tsai, I-C., Tsai, W.-L., Chen, M.-C., Chang, G.-C., Tzeng, W.-S., Chan, S.-W., Chen, C. C.-C.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2113</dc:identifier>
<dc:title><![CDATA[CT-Guided Core Biopsy of Lung Lesions: A Primer]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1235</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1228</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1239?rss=1">
<title><![CDATA[CT Colonography: Coming of Age]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1239?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to highlight key issues in
CT colonography (CTC) for radiologists so they can represent the technology
accurately to referring physicians and provide a perspective that will
hopefully augment best care for their patients.</p>
<p><b>CONCLUSION.</b> With publication of the National CT Colonography Trial
and the endorsement of CTC for screening by a multisociety task force that
included the American Cancer Society, American College of Radiology, and U.S.
Multisociety Task Force on Colorectal Cancer, the clinical validation of CTC
has been completed, and CTC is now ready for widespread clinical application.
Radiologists must be skilled in CTC and knowledgeable about colorectal cancer
screening issues.</p>
]]></description>
<dc:creator><![CDATA[Johnson, C. D.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1859</dc:identifier>
<dc:title><![CDATA[CT Colonography: Coming of Age]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1242</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1239</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1242?rss=1">
<title><![CDATA[ACR Colon Cancer Committee White Paper: Status of CT Colonography 2009]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1242?rss=1</link>
<description><![CDATA[
<p><b>Purpose:</b> To review the current status and rationale of the updated
ACR practice guidelines for CT colonography (CTC).</p>
<p><b>Methods:</b> Clinical validation trials in both the U.S. and Europe are
reviewed. Key technical aspects of the CTC examination are emphasized,
including low-dose protocols, proper insufflation, and bowel preparation.
Important issues of implementation are discussed, including training and
certification, definition of target lesion, reporting of colonic and
extracolonic findings, quality metrics, reimbursement, and
cost-effectiveness.</p>
<p><b>Results:</b> Successful validation trials in screening cohorts both in
the U.S. with ACRIN&reg; and in Germany demonstrated sensitivity of 90% or
greater for patients with polyps 10 mm or greater. Proper technique is
critical, including low-dose techniques in screening cohorts with upper limits
in CTDI<SUB>vol</SUB> of 12.5 mGy per exam. Training of new readers includes
the requirement of interactive workstation training with 2-D and 3-D image
display techniques. The target lesion is defined as a polyp 6 mm or greater,
consistent with the American Cancer Society joint guidelines. Five quality
metrics have been defined for CTC, with pilot data entered. Although the CMS
national noncoverage decision in May 2009 was a disappointment, multiple
third-party payers are reimbursing for screening CTC. Cost-effective modeling
has shown CTC to be a dominant strategy, including in a Medicare cohort.</p>
<p><b>Conclusion:</b> Supported by third party payer reimbursement for
screening, CTC will continue to further transition into community practice and
can provide an important adjunctive examination for colorectal screening.</p>
]]></description>
<dc:creator><![CDATA[McFarland, E. G., Fletcher, J. G., Pickhardt, P. P., Dachman, A., Yee, J., McCollough, C. H., Macari, M., Knechtges, P., Zalis, M., Barish, M., Kim, D. H., Keysor, K., Johnson, C. D.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:title><![CDATA[ACR Colon Cancer Committee White Paper: Status of CT Colonography 2009]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1242</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1242</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1243?rss=1">
<title><![CDATA[Epiploic Appendagitis: An Entity Frequently Unknown to Clinicians--Diagnostic Imaging, Pitfalls, and Look-Alikes]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1243?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Epiploic appendagitis is an ischemic infarction of an
epiploic appendage caused by torsion or spontaneous thrombosis of the epiploic
appendage central draining vein. When it occurs on the right side of the
abdomen, it can mimic appendicitis and right-sided diverticulitis; whereas
when it occurs on the left side of the abdomen, it is often mistaken for
sigmoid diverticulitis. The purpose of this article is to review the
diagnostic imaging of this entity.</p>
<p><b>CONCLUSION.</b> Epiploic appendagitis is self-limited and spontaneously
resolves without surgery within 5&ndash;7 days. Therefore, it is imperative
for radiologists to be familiar with this entity.</p>
]]></description>
<dc:creator><![CDATA[Almeida, A. T., Melao, L., Viamonte, B., Cunha, R., Pereira, J. M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2071</dc:identifier>
<dc:title><![CDATA[Epiploic Appendagitis: An Entity Frequently Unknown to Clinicians--Diagnostic Imaging, Pitfalls, and Look-Alikes]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1251</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1243</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1252?rss=1">
<title><![CDATA[Preliminary Estimate of Triphasic CT Enterography Performance in Hemodynamically Stable Patients With Suspected Gastrointestinal Bleeding]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1252?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to retrospectively
evaluate the performance of triphasic CT enterography and identify causes of
false-negative CT results in hemodynamically stable patients with suspected
gastrointestinal bleeding.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective review of 48 patients
(male&ndash;female ratio, 22:26) with suspected gastrointestinal bleeding
(first-episode gastrointestinal bleed, <I>n</I> = 19; obscure
gastrointestinal bleed, <I>n</I> = 29) who underwent triphasic CT
enterography was performed. All patients had endoscopic, pathologic, or other
imaging confirmation within 3 months of triphasic CT enterography. The
sensitivity and specificity of triphasic CT enterography were calculated using
pathology, endoscopy, or other imaging confirmation as the reference standard.
Results were retrospectively reviewed to determine the cause of missed
findings at triphasic CT enterography.</p>
<p><b>RESULTS.</b> The overall sensitivity and specificity of triphasic CT
enterography for detecting gastrointestinal bleeding was 33% (7/21) and 89%
(24/27), respectively. Sensitivity and specificity were higher in
first-episode gastrointestinal bleed cases (42% and 100%, respectively) than
in obscure gastrointestinal bleed cases (22% and 85%). In the subset of
patients undergoing capsule endoscopy (<I>n</I> = 17), only triphasic CT
enterography identified two of three bleeding sources. Triphasic CT
enterography did not identify six ulcers, four vascular malformations, two
hemorrhoids, a duodenal mass, and a bleeding colonic diverticulum. The missed
findings at triphasic CT enterography were attributed to being CT occult
(<I>n</I> = 9), perception errors (<I>n</I> = 4), and technical errors
(<I>n</I> = 1). If perception errors are excluded, the sensitivity of
triphasic CT enterography increases to 52% (11/21).</p>
<p><b>CONCLUSION.</b> Triphasic CT enterography can be a useful and
complementary test in the evaluation of clinically stable patients with
suspected gastrointestinal bleeding by identifying the bleeding source in one
third to one half of patients. Because of the potential for perception errors,
radiologists should familiarize themselves with the appearance of bleeding
sources at CT enterography.</p>
]]></description>
<dc:creator><![CDATA[Hara, A. K., Walker, F. B., Silva, A. C., Leighton, J. A.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1494</dc:identifier>
<dc:title><![CDATA[Preliminary Estimate of Triphasic CT Enterography Performance in Hemodynamically Stable Patients With Suspected Gastrointestinal Bleeding]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1260</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1252</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1261?rss=1">
<title><![CDATA[Hepatic Iron Deposition in Patients With Liver Disease: Preliminary Experience With Breath-Hold Multiecho T2*-Weighted Sequence]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1261?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to conduct, using
histopathologic examination as the reference standard, a preliminary
evaluation of the use of a breath-hold multiecho T2<sup>*</sup>-weighted MRI
sequence in the detection and quantification of hepatic iron deposition in
patients with liver disease.</p>
<p><b>MATERIALS AND METHODS.</b> The images of 43 patients with liver disease
who underwent 1.5-T MRI of the liver that included a multiecho
T2<sup>*</sup>-weighted sequence who also underwent concomitant liver biopsy
or liver transplantation were assessed. Two independent observers measured
hepatic T2<sup>*</sup> by placing regions of interest in the hepatic
parenchyma. Hepatic T2<sup>*</sup> values were compared between patients
stratified by hepatic iron grade and were correlated with histopathologic iron
grade. Receiver operating characteristics analysis was performed to assess the
accuracy of images obtained with the hepatic T2<sup>*</sup>-weighted sequence
in the diagnosis of iron deposition.</p>
<p><b>RESULTS.</b> Patients with iron deposition had shorter hepatic
T2<sup>*</sup> values than did patients without iron deposition (mean
T2<sup>*</sup>, 17.7 vs 32.3 milliseconds with pooled data from both
observers; <I>p</I> &lt; 0.0001). Patients with iron grade 3 or greater had
shorter T2<sup>*</sup> values than those with iron grade 2 or less (10.1 vs
20.8 milliseconds; <I>p</I> &lt; 0.0001). There was a strong negative
correlation between hepatic T2<sup>*</sup> and histopathologic iron grade
(<I>r</I> = &ndash;0.849; <I>p</I> &lt; 0.0001). For the prediction of
iron grades 1 or greater and 3 or greater, area under the curve, sensitivity,
and specificity were 0.968&ndash;0.982, 90.5&ndash;100%, and 100&ndash;97.3%
at T2<sup>*</sup> cutoffs of less than 24 and less than 14 milliseconds,
respectively.</p>
<p><b>CONCLUSION.</b> Hepatic iron overload in patients with liver disease can
be assessed rapidly and accurately with MRI performed with a breath-hold
T2<sup>*</sup>-weighted sequence.</p>
]]></description>
<dc:creator><![CDATA[Chandarana, H., Lim, R. P., Jensen, J. H., Hajdu, C. H., Losada, M., Babb, J. S., Huffman, S., Taouli, B.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1996</dc:identifier>
<dc:title><![CDATA[Hepatic Iron Deposition in Patients With Liver Disease: Preliminary Experience With Breath-Hold Multiecho T2*-Weighted Sequence]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1267</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1261</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1268?rss=1">
<title><![CDATA[CT Protocols for Acute Appendicitis: Time for Change]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1268?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Paulson, E. K., Coursey, C. A.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3313</dc:identifier>
<dc:title><![CDATA[CT Protocols for Acute Appendicitis: Time for Change]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1271</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1268</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1272?rss=1">
<title><![CDATA[MDCT for Suspected Acute Appendicitis in Adults: Impact of Oral and IV Contrast Media at Standard-Dose and Simulated Low-Dose Techniques]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1272?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this study was to prospectively
investigate the influence of oral, IV, and oral and IV contrast media on the
information provided by MDCT at standard and simulated low radiation doses in
adults suspected of having acute appendicitis.</p>
<p><b>SUBJECTS AND METHODS.</b> One hundred thirty-one consecutive patients
(80 women, 51 men; age range, 18&ndash;87 years; mean age, 37 years) suspected
of having appendicitis were randomly assigned to either ingest or not ingest
iodinated contrast material. Thereafter, all patients underwent IV unenhanced
and enhanced abdominopelvic MDCT with a 4 <FONT FACE="arial,helvetica">x</FONT> 2.5 mm collimation at 120
kVp and 100 mAs<SUB>eff</SUB>. Dose reduction corresponding to 30
mAs<SUB>eff</SUB> was simulated. Two radiologists independently read scans
during separate sessions, assessed appendix visualization, and proposed a
diagnosis (i.e., appendicitis or an alternative diagnosis). The final
diagnosis was based on either surgical findings or clinical follow-up. Data
were analyzed by factorial analysis of multiple correspondences followed by an
ascending hierarchic classification method.</p>
<p><b>RESULTS.</b> Factorial analysis and ascending hierarchic classification
revealed that, in terms of diagnostic correctness, reader influence
predominated over the influence of IV and oral contrast media use and
radiation dose but that correctness was also influenced by the patient's sex
(<I>p</I> = 0.048) and was lower in cases of alternative diseases
(<I>p</I> &lt; 0.001). Visualization of the appendix depended predominantly
on the reader rather than on the use of IV, oral, or oral and IV contrast
agents or on radiation dose.</p>
<p><b>CONCLUSION.</b> Diagnostic correctness is much more influenced by the
reader than by the use of contrast medium (oral, IV, or both) or of simulated
low-radiation-dose technique.</p>
]]></description>
<dc:creator><![CDATA[Keyzer, C., Cullus, P., Tack, D., De Maertelaer, V., Bohy, P., Gevenois, P. A.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1959</dc:identifier>
<dc:title><![CDATA[MDCT for Suspected Acute Appendicitis in Adults: Impact of Oral and IV Contrast Media at Standard-Dose and Simulated Low-Dose Techniques]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1281</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1272</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1282?rss=1">
<title><![CDATA[Abdominal 64-MDCT for Suspected Appendicitis: The Use of Oral and IV Contrast Material Versus IV Contrast Material Only]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1282?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to compare the diagnostic
accuracy of IV contrast-enhanced 64-MDCT with and without the use of oral
contrast material in diagnosing appendicitis in patients with abdominal
pain.</p>
<p><b>MATERIALS AND METHODS.</b> We conducted a randomized trial of a
convenience sample of adult patients presenting to an urban academic emergency
department with acute nontraumatic abdominal pain and clinical suspicion of
appendicitis, diverticulitis, or small-bowel obstruction. Patients were
enrolled between 8 am and 11 pm when research assistants were present.
Consenting subjects were randomized into one of two groups: Group 1 subjects
underwent 64-MDCT performed with oral and IV contrast media and group 2
subjects underwent 64-MDCT performed solely with IV contrast material. Three
expert radiologists independently reviewed the CT examinations, evaluating for
the presence of appendicitis. Each radiologist interpreted 202 examinations,
ensuring that each examination was interpreted by two radiologists. Individual
reader performance and a combined interpretation performance of the two
readers assigned to each case were calculated. In cases of disagreement, the
third reader was asked to deliver a tiebreaker interpretation to be used to
calculate the combined reader performance. Final outcome was based on
operative, clinical, and follow-up data. We compared radiologic diagnoses with
clinical outcomes to calculate the diagnostic accuracy of CT in both
groups.</p>
<p><b>RESULTS.</b> Of the 303 patients enrolled, 151 patients (50%) were
randomized to group 1 and the remaining 152 (50%) were randomized to group 2.
The combined reader performance for the diagnosis of appendicitis in group 1
was a sensitivity of 100% (95% CI, 76.8&ndash;100%) and specificity of 97.1%
(95% CI, 92.7&ndash;99.2%). The performance in group 2 was a sensitivity of
100% (73.5&ndash;100%) and specificity of 97.1% (92.9&ndash;99.2%).</p>
<p><b>CONCLUSION.</b> Patients presenting with nontraumatic abdominal pain
imaged using 64-MDCT with isotropic reformations had similar characteristics
for the diagnosis of appendicitis when IV contrast material alone was used and
when oral and IV contrast media were used.</p>
]]></description>
<dc:creator><![CDATA[Anderson, S. W., Soto, J. A., Lucey, B. C., Ozonoff, A., Jordan, J. D., Ratevosian, J., Ulrich, A. S., Rathlev, N. K., Mitchell, P. M., Rebholz, C., Feldman, J. A., Rhea, J. T.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2336</dc:identifier>
<dc:title><![CDATA[Abdominal 64-MDCT for Suspected Appendicitis: The Use of Oral and IV Contrast Material Versus IV Contrast Material Only]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1288</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1282</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1289?rss=1">
<title><![CDATA[Comparison of Optical Colonoscopy and CT Colonography for Polyp Detection]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1289?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Dachman, A. H.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3311</dc:identifier>
<dc:title><![CDATA[Comparison of Optical Colonoscopy and CT Colonography for Polyp Detection]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1290</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1289</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1291?rss=1">
<title><![CDATA[CT Colonography Predictably Overestimates Colonic Length and Distance to Polyps Compared With Optical Colonoscopy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1291?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to determine the
discrepancy between CT colonography (CTC) and optical colonoscopy (OC)
measurements for both anus-to-cecum length and anus-to-polyps distance and
then determine whether a conversion factor could be generated to equate these
CTC and OC distances.</p>
<p><b>MATERIALS AND METHODS.</b> We retrospectively reviewed CTC and OC
reports from patients who had undergone both procedures as part of an
established protocol. The anus-to-cecum measurement recorded on a single
proprietary CTC workstation was compared with the OC cecal length for each
patient. Likewise, anus-to-polyp distances were compared as measured by the
radiologist and endoscopist.</p>
<p><b>RESULTS.</b> Three hundred thirty-eight patients and 437 polyps were
identified with complete data from both CTC and same-day OC. The average
anus-to-cecum distance measured at CTC was 189 cm (range, 75&ndash;257 cm) and
at OC, 108 cm (range, 65&ndash;150 cm). For polyps proximal to the splenic
flexure (<I>n</I> = 145), the CTC anus-to-polyp measurement was on average
1.7 times that measured at OC. For left-sided polyps (<I>n</I> = 292), the
CTC measurement was, on average, within 12 cm or 1.3 times that of the OC
anus-to-polyp measurement. All the differences between CTC and OC measurements
of cecal length and polyp distances were found to be statistically significant
using a paired Student's <I>t</I> test of means (<I>p</I> &lt; 0.001).</p>
<p><b>CONCLUSION.</b> Anus-to-cecum and anus-to-polyp distances are disparate
but comparable using a conversion factor of 0.57 for the CTC anus-to-cecum
measurement and 0.59 for right-sided CTC anus-to-polyp or 0.78 for left-sided
CTC anus-to-polyp measurements. These anus-to-polyp conversion factors could
potentially augment current CTC guidelines for accurate and precise polyp
localization and removal at endoscopy.</p>
]]></description>
<dc:creator><![CDATA[Duncan, J. E., McNally, M. P., Sweeney, W. B., Gentry, A. B., Barlow, D. S., Jensen, D. W., Cash, B. D.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2365</dc:identifier>
<dc:title><![CDATA[CT Colonography Predictably Overestimates Colonic Length and Distance to Polyps Compared With Optical Colonoscopy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1295</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1291</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1296?rss=1">
<title><![CDATA[Normalized Distance Along the Colon Centerline: A Method for Correlating Polyp Location on CT Colonography and Optical Colonoscopy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1296?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The ability to accurately locate a polyp found on CT
colonography (CTC) at subsequent optical colonoscopy (OC) is an important part
of the successful implementation of CTC for colorectal cancer screening. The
purpose of this study was to determine whether a polyp's normalized distance
along the colon centerline derived from CTC data can accurately predict its
location on OC.</p>
<p><b>MATERIALS AND METHODS.</b> The polyp population consisted of 152 polyps
in 121 patients. CTC polyp findings were verified by same-day
segmentally-unblinded OC. Each polyp's normalized distance along the colon
centerline was computed by dividing its distance from the anorectal junction
measured along the colon centerline by the length of the colon at CTC. The
predicted polyp location at OC was computed by multiplying the normalized
distance along the colon centerline by the colon length at OC (i.e., the
distance to the cecum as determined at full colonoscope insertion). The
differences between the true and predicted polyp locations at OC were compared
using paired Student's <I>t</I> tests, linear regression, prediction
interval assessment, and Bland-Altman analyses.</p>
<p><b>RESULTS.</b> The differences between the true and predicted polyp
locations at OC using the supine and prone CTC-normalized distances along the
colon centerline were 2.2 &plusmn; 10.5 cm (mean &plusmn; SD; <I>n</I> =
136) and 1.5 &plusmn; 10.5 cm (<I>n</I> = 135), respectively. The predicted
location was within 10 cm of its true location for 71.3% (97/136) to 74.8%
(101/135) of polyps and within 20 cm of its true location for 93.3% (126/135)
to 93.4% (127/136) of polyps.</p>
<p><b>CONCLUSION.</b> By computing the normalized distance along the colon
centerline of a polyp found at CTC, the location of a polyp at OC can be
predicted to within 10 cm (i.e., 1 colonoscope mark) for the majority of
polyps.</p>
]]></description>
<dc:creator><![CDATA[Summers, R. M., Swift, J. A., Dwyer, A. J., Choi, J. R., Pickhardt, P. J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2611</dc:identifier>
<dc:title><![CDATA[Normalized Distance Along the Colon Centerline: A Method for Correlating Polyp Location on CT Colonography and Optical Colonoscopy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1304</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1296</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1305?rss=1">
<title><![CDATA[Automated Measurement of Colorectal Polyp Height at CT Colonography: Hyperplastic Polyps Are Flatter Than Adenomatous Polyps]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1305?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Hyperplastic polyps are more difficult to detect than
adenomatous polyps at CT colonography (CTC), and it has been theorized that
this difference in detectability is because hyperplastic polyps are flatter.
Using automated software that computes polyp height, we determined whether
hyperplastic colonic polyps on CTC are indeed flatter than adenomatous polyps
of comparable width.</p>
<p><b>MATERIALS AND METHODS.</b> At three medical centers, 1,186 patients
underwent oral contrast-enhanced CTC and same-day optical colonoscopy (OC)
with segment unblinding for colorectal cancer screening. One hundred
eighty-five of the patients had at least one hyperplastic or adenomatous polyp
6&ndash;10 mm visible at both OC and CTC, where size was determined by a
calibrated guidewire at OC. To assess flatness, the heights of the polyps at
CTC were measured using a validated automated software program. The heights
and height-to-width ratios of the hyperplastic polyps were compared with those
of the adenomatous polyps using a Student's <I>t</I> test (two-tailed,
unpaired, unequal variance).</p>
<p><b>RESULTS.</b> There were 176 adenomatous and 83 hyperplastic polyps
visible at segment-unblinded OC. The fraction of these polyps that were
measurable at CTC using the automated software was not significantly different
for adenomatous versus hyperplastic polyps (158/176 [89.8%] vs 73/87 [83.9%],
respectively; <I>p</I> = 0.2). The average height-to-width ratios using
automated width measurements were 15% less for hyperplastic polyps: 0.39
&plusmn; 0.20 (<I>n</I> = 158) and 0.33 &plusmn; 0.19 (<I>n</I> = 73) for
adenomatous and hyperplastic polyps, respectively (<I>p</I> = 0.03). When
polyps of comparable OC size or CTC width were considered, the heights of
hyperplastic polyps were up to 27% less than those of adenomatous polyps.</p>
<p><b>CONCLUSION.</b> For 6&ndash;10 mm polyps of a given size as determined
by OC or a given width at CTC, hyperplastic polyps tend to be flatter (i.e.,
have lower height) compared with adenomatous polyps.</p>
]]></description>
<dc:creator><![CDATA[Summers, R. M., Liu, J., Yao, J., Brown, L., Choi, J. R., Pickhardt, P. J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2442</dc:identifier>
<dc:title><![CDATA[Automated Measurement of Colorectal Polyp Height at CT Colonography: Hyperplastic Polyps Are Flatter Than Adenomatous Polyps]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1310</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1305</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1311?rss=1">
<title><![CDATA[Intraabdominal Complications Secondary to Ventriculoperitoneal Shunts: CT Findings and Review of the Literature]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1311?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the
abdominopelvic CT findings of various intraabdominal complications secondary
to ventriculoperitoneal shunts for hydrocephalus and to review the
literature.</p>
<p><b>MATERIALS AND METHODS.</b> The CT images of 70 patients (33 men and 37
women; mean age, 48.5 years) who underwent ventriculoperitoneal shunt
placement and abdominopelvic CT because of shunt-related abdominal symptoms
were reviewed retrospectively. CT images were analyzed with regard to the
location of the shunting catheter tip; site, size, wall, and septa of
localized fluid collection; peritoneal thickening; omentomesentery
infiltration; abscess; bowel perforation; abdominal wall infiltration; and
thickening of the catheter track wall.</p>
<p><b>RESULTS.</b> The mean period between the last ventriculoperitoneal
shunting operation and CT was 11 months (range, 1 week to 115 months), and the
mean number of ventriculoperitoneal shunting operations undergone was 1.4
(range, 1&ndash;6). A total of 76 ventriculoperitoneal shunting catheters were
introduced in 70 patients: 64 patients had a unilateral catheter inserted and
six patients had bilateral catheters inserted. Sixteen patients (22.9%) were
pathologically diagnosed with ventriculoperitoneal shunt&ndash;related
complications: 11 cases (15.7%) of shunt infection, six cases (8.6%) of CSF
pseudocyst, four cases (5.7%) of abdominal abscess, three cases (4.3%) of
infected fluid collection, and one case (1.4%) of bowel perforation.
Microorganisms were cultured from the tip of the shunting catheter or
peritoneal fluid in 11 patients (15.7%).</p>
<p><b>CONCLUSION.</b> On abdominopelvic CT, various intraabdominal
complications secondary to ventriculoperitoneal shunt were shown, of which,
shunt infection was the most common, followed by CSF pseudocyst, abscess, and
infected fluid collection.</p>
]]></description>
<dc:creator><![CDATA[Chung, J.-J., Yu, J.-S., Kim, J. H., Nam, S. J., Kim, M.-J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2463</dc:identifier>
<dc:title><![CDATA[Intraabdominal Complications Secondary to Ventriculoperitoneal Shunts: CT Findings and Review of the Literature]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1317</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1311</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1318?rss=1">
<title><![CDATA[Normal Dynamic MRI Enhancement Patterns of the Upper Abdominal Organs: Gadoxetic Acid Compared With Gadobutrol]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1318?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to investigate whether, at
dynamic MRI of the upper abdominal organs, contrast enhancement with gadoxetic
acid, a hepatobiliary contrast agent, is comparable with that achieved with an
extracellular contrast agent.</p>
<p><b>SUBJECTS AND METHODS.</b> Dynamic gadoxetic acid&ndash;enhanced MRI of
the pancreas, spleen, kidney, liver, and abdominal aorta was performed on 50
patients; dynamic gadobutrol&ndash;enhanced MRI was performed on a control
group of 50 patients; and the images were compared. Dynamic imaging with a
T1-weighted volumetric interpolated breath-hold examination gradient-echo
sequence (TR/TE, 3.35/1.35; flip angle, 12&deg;) was performed before and 20
(arterial phase), 55 (portal venous phase), and 90 (hepatic venous phase)
seconds after bolus injection of gadoxetic acid (0.25 mmol/mL) or gadobutrol
(1.0 mmol/mL). Signal-to-noise ratios and enhancement indexes were calculated
for each organ and time.</p>
<p><b>RESULTS.</b> All MR images in both groups were of diagnostic quality.
During the early dynamic phases, significantly lower mean enhancement indexes
were found in the gadoxetic acid group than in the gadobutrol group in the
pancreas (portal venous phase, 0.66, 1.39, <I>p</I> &le; 0.001; hepatic
venous phase, 0.51, 1.36, <I>p</I> &le; 0.001), spleen (portal venous phase,
1.54, 2.41, <I>p</I> &le; 0.001; hepatic venous phase, 1.19, 2.23,
<I>p</I> &le; 0.001), renal cortex (portal venous phase, 1.76, 2.63,
<I>p</I> &le; 0.001; hepatic venous phase, 1.60, 2.63, <I>p</I> &le;
0.001), and liver (portal venous phase, 0.76, 0.94, <I>p</I> = 0.016;
hepatic venous phase, 0.76, 1.04, <I>p</I> &le; 0.001). In the abdominal
aorta, the mean enhancement index was greater after bolus injection of
gadoxetic acid (arterial phase, 3.33, 2.24, <I>p</I> &le; 0.005).</p>
<p><b>CONCLUSION.</b> Early dynamic MRI of the upper abdominal organs,
especially the spleen, pancreas, and kidney, benefits from the higher
gadolinium concentration of gadobutrol than in the organ-specific contrast
agent gadoxetic acid. Higher protein binding resulting in increased relaxivity
of gadoxetic acid compensates for the low gadolinium concentration in the
abdominal aorta.</p>
]]></description>
<dc:creator><![CDATA[Kuhn, J.-P., Hegenscheid, K., Siegmund, W., Froehlich, C.-P., Hosten, N., Puls, R.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2412</dc:identifier>
<dc:title><![CDATA[Normal Dynamic MRI Enhancement Patterns of the Upper Abdominal Organs: Gadoxetic Acid Compared With Gadobutrol]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1323</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1318</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1324?rss=1">
<title><![CDATA[The Actual Role of CT and Ventilation-Perfusion Scanning in Workup for Suspected Pulmonary Embolism: Evidence From Hospitals]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1324?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Over the past two decades, CT has been found valuable in
the diagnosis of pulmonary embolism (PE). We sought to ascertain the relative
roles of CT and ventilation&ndash;perfusion (V/Q) scanning, the previously
preferred technique, in the diagnosis of PE in recent practice and whether
there is variation among hospital types.</p>
<p><b>MATERIALS AND METHODS.</b> Using the Medicare anonymized 5% of
beneficiaries complete claims file for 2005, we studied the use of relevant CT
and V/Q scanning in the evaluation of patients with a diagnosis of PE and of
patients with symptoms that might have been due to PE (chest pain, syncope,
difficulty breathing). In 2008, we surveyed the radiology departments of
Pennsylvania hospitals about the use of CT and V/Q scanning for PE, service
availability hours, and what equipment was used.</p>
<p><b>RESULTS.</b> In all data, we found that CT was used approximately six
times as frequently as V/Q scanning. In the Medicare data, only small
differences in frequency of use of CT and V/Q scanning were associated with
hospital characteristics. Academic hospitals did not differ in a major way
from other hospitals, nor did small or rural hospitals. In the survey, 97% of
radiology departments reported that CT was available for evaluation of PE 24
hours a day 7 days a week. Ninety-three percent of departments reported V/Q
scanning was available at some times; 77% reported V/Q available at all
times.</p>
<p><b>CONCLUSION.</b> CT was a fully disseminated and dominant technique for
the diagnosis of PE by 2005, and it was readily available at small and rural
hospitals. The lack of availability of off-hours V/Q scanning at a substantial
fraction of hospitals may be a problem for patients with contraindications to
CT.</p>
]]></description>
<dc:creator><![CDATA[Bhargavan, M., Sunshine, J. H., Hervey, S. L., Jha, S., Vializ, J., Owen, J. B.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2677</dc:identifier>
<dc:title><![CDATA[The Actual Role of CT and Ventilation-Perfusion Scanning in Workup for Suspected Pulmonary Embolism: Evidence From Hospitals]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1332</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1324</prism:startingPage>
<prism:section>Health Care Policy and Quality</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1333?rss=1">
<title><![CDATA[Radiology Practices' Use of External Off-Hours Teleradiology Services in 2007 and Changes Since 2003]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1333?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Our objective is to report patterns of utilization of
external off-hours teleradiology services (EOTSs) in 2007 and changes since
2003.</p>
<p><b>MATERIALS AND METHODS.</b> We analyzed non&ndash;individually identified
data from the American College of Radiology's 2007 Survey of Member
Radiologists and its 2003 Survey of Radiologists. Responses were weighted to
be nationally representative of individual radiologists and radiology
practices. We present descriptive statistics and multivariable regression
analysis results on the use of EOTSs in 2007 and comparisons with 2003.</p>
<p><b>RESULTS.</b> Overall, 44% of all radiology practices in the United
States reported using EOTSs in 2007. These practices included 45% of all U.S.
radiologists. Out-of-practice teleradiology had been used by 15% of practices
in 2003. Regression analysis indicates that, other practice characteristics
being equal, in 2007, primarily academic practices had lower odds of using
EOTSs than private radiology practices. Also, large practices (&ge; 30
radiologists) had lower odds of using EOTSs than practices with 15&ndash;29
radiologists. Small practices (1&ndash;10 radiologists) had high odds, but
nonmetropolitan practices did not. There were no significant differences by
geographic region of the United States.</p>
<p><b>CONCLUSION.</b> Use of EOTSs was widespread by 2007, and it had been
increasing rapidly in the preceding few years. Patterns of use were generally
as might be expected except that nonmetropolitan practices did not have high
odds of using EOTSs.</p>
]]></description>
<dc:creator><![CDATA[Lewis, R. S., Sunshine, J. H., Bhargavan, M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2984</dc:identifier>
<dc:title><![CDATA[Radiology Practices' Use of External Off-Hours Teleradiology Services in 2007 and Changes Since 2003]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1339</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1333</prism:startingPage>
<prism:section>Health Care Policy and Quality</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1340?rss=1">
<title><![CDATA[Dose to Radiosensitive Organs During Routine Chest CT: Effects of Tube Current Modulation]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1340?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aims of this study were to estimate the dose to
radiosensitive organs (glandular breast and lung) in patients of various sizes
undergoing routine chest CT examinations with and without tube current
modulation; to quantify the effect of tube current modulation on organ dose;
and to investigate the relation between patient size and organ dose to breast
and lung resulting from chest CT examinations.</p>
<p><b>MATERIALS AND METHODS.</b> Thirty voxelized models generated from images
of patients were extended to include lung contours and were used to represent
a cohort of women of various sizes. Monte Carlo simulation&ndash;based virtual
MDCT scanners had been used in a previous study to estimate breast dose from
simulations of a fixed-tube-current and a tube current&ndash;modulated chest
CT examinations of each patient model. In this study, lung doses were
estimated for each simulated examination, and the percentage organ dose
reduction attributed to tube current modulation was correlated with patient
size for both glandular breast and lung tissues.</p>
<p><b>RESULTS.</b> The average radiation dose to lung tissue from a chest CT
scan obtained with fixed tube current was 23 mGy. The use of tube current
modulation reduced the lung dose an average of 16%. Reductions in organ dose
(up to 56% for lung) due to tube current modulation were more substantial
among smaller patients than larger. For some larger patients, use of tube
current modulation for chest CT resulted in an increase in organ dose to the
lung as high as 33%. For chest CT, lung dose and breast dose estimates had
similar correlations with patient size. On average the two organs receive
approximately the same dose effects from tube current modulation.</p>
<p><b>CONCLUSION.</b> The dose to radiosensitive organs during
fixed-tube-current and tube current&ndash;modulated chest CT can be estimated
on the basis of patient size. Organ dose generally decreases with the use of
tube current&ndash;modulated acquisition, but patient size can directly affect
the dose reduction achieved.</p>
]]></description>
<dc:creator><![CDATA[Angel, E., Yaghmai, N., Jude, C. M., DeMarco, J. J., Cagnon, C. H., Goldin, J. G., McCollough, C. H., Primak, A. N., Cody, D. D., Stevens, D. M., McNitt-Gray, M. F.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2886</dc:identifier>
<dc:title><![CDATA[Dose to Radiosensitive Organs During Routine Chest CT: Effects of Tube Current Modulation]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1345</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1340</prism:startingPage>
<prism:section>Medical Physics and Informatics</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1347?rss=1">
<title><![CDATA[Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1347?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to determine the MRI
findings of rheumatoid arthritis (RA) and tuberculous arthritis, with emphasis
on differential diagnostic features.</p>
<p><b>MATERIALS AND METHODS.</b> MR images of 63 joints in 62 patients with
clinically or pathologically proven RA (36 joints in 35 patients) or
tuberculous arthritis (27 joints in 27 patients) were evaluated
retrospectively with regard to pattern and degree of synovial thickening, size
of bone erosions, rim enhancement at bone erosions, degree of bone marrow and
periarticular soft-tissue edema, and presence and number of extraarticular
cystic masses. MRI findings were compared between RA and tuberculous arthritis
by statistical analysis using kappa statistics, the Mann-Whitney <I>U</I>
test, linear-by-linear association, and the chi-square test.</p>
<p><b>RESULTS.</b> Nonuniform and greater degree of synovial thickening was
more frequent in RA (<I>p</I> &lt; 0.01); the thicker the synovial membrane,
the greater the likelihood of RA (<I>p</I> &lt; 0.01). Bone erosions of
tuberculous arthritis were larger (<I>p</I> &lt; 0.01), and the likelihood
of tuberculous arthritis increased proportionally to the increment of size of
the bone erosions (<I>p</I> &lt; 0.01). Rim enhancement at bone erosion was
more frequent in tuberculous arthritis (<I>p</I> &lt; 0.01). Extraarticular
cystic masses were more frequently seen and more numerous in tuberculous
arthritis (<I>p</I> &lt; 0.01).</p>
<p><b>CONCLUSION.</b> Uniform synovial thickening, large size of bone erosion,
rim enhancement at site of bone erosion, and extraarticular cystic masses were
more frequent and more numerous in tuberculous arthritis. MRI may be helpful
in the differentiation between RA and tuberculous arthritis.</p>
]]></description>
<dc:creator><![CDATA[Choi, J.-A., Koh, S. H., Hong, S.-H., Koh, Y. H., Choi, J.-Y., Kang, H. S.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2164</dc:identifier>
<dc:title><![CDATA[Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1353</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1347</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1354?rss=1">
<title><![CDATA[Postoperative MDCT of Tibial Plateau Fractures]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1354?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purposes of this retrospective study were to
elaborate our experience in postoperative MDCT of tibial plateau fractures, to
establish the frequency of these fractures and the indications for MDCT, and
to assess the common findings and their clinical importance.</p>
<p><b>MATERIALS AND METHODS.</b> A total of 782 knee injuries were imaged with
MDCT at a level 1 trauma center over 86 months. A total of 592 knees had a
tibial plateau fracture; 381 of these fractures were managed surgically, and
postoperative MDCT was performed on 36 of these knees (9%). At postoperative
image analysis, an orthopedic surgeon evaluated reduction as good or
suboptimal using the first postoperative radiographs. Fracture healing was
determined as complete ossification, partial ossification, or nonunion on MDCT
images acquired later in follow-up. The MDCT findings were compared with the
radiographic findings to assess the usefulness and clinical importance of
MDCT.</p>
<p><b>RESULTS.</b> The main indications for MDCT were assessment and follow-up
of the joint articular surface and evaluation of fracture healing. Orthopedic
hardware caused no diagnostic problems at MDCT. Postoperative MDCT revealed
additional clinically important information on 29 patients (81%), and 14
patients (39%) underwent reoperation.</p>
<p><b>CONCLUSION.</b> Postoperative MDCT of tibial plateau fractures is
performed infrequently, even in a large trauma center. When it is performed,
however, because of suspicion of increasing articular step-off or fracture
nonunion, postoperative MDCT reveals clinically significant information in
most cases.</p>
]]></description>
<dc:creator><![CDATA[Mustonen, A. O. T., Koivikko, M. P., Kiuru, M. J., Salo, J., Koskinen, S. K.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2260</dc:identifier>
<dc:title><![CDATA[Postoperative MDCT of Tibial Plateau Fractures]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1360</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1354</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1361?rss=1">
<title><![CDATA[Patella Alta: Lack of Correlation Between Patellotrochlear Cartilage Congruence and Commonly Used Patellar Height Ratios]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1361?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purposes of this study were to assess the degree of
patellotrochlear chondral overlap (patellotrochlear index), correlate it with
the Insall-Salvati and modified Insall-Salvati indexes, and determine the
association between these measurements and patellofemoral chondral
defects.</p>
<p><b>MATERIALS AND METHODS.</b> Sagittal 1.5-T and 3-T MR images of 100
consecutively registered patients with symptoms were analyzed, and the
Insall-Salvati index, modified Insall-Salvati index, patellotrochlear index,
and patellophyseal index (ratio of the height of patella above the physeal
line to the length of the patellar articular cartilage) were calculated. The
upper and lower limits of 2 SDs were used to define patella alta and baja, and
the correlation coefficient curves were plotted to compare techniques. The
indexes in normal knees were compared with those in knees with severe chondral
defects.</p>
<p><b>RESULTS.</b> The mean patellotrochlear index was 0.49 &plusmn; 0.15 (SD)
(range, 0&ndash;0.88). On the basis of calculation of 2 SDs, patella alta was
determined to have a patellotrochlear index less than 0.18 and patella baja,
an index greater than 0.80. Weak correlation was found between the measured
patellotrochlear index and Insall-Salvati index (<I>r</I> = &ndash;0.224)
and between the patellotrochlear index and modified Insall-Salvati index
(<I>r</I> = &ndash;0.073). A strong correlation was found between the
patellotrochlear index and patellophyseal index (<I>r</I> = &ndash;0.813). A
statistically significant (<I>p</I> &lt; 0.05) difference in the modified
Insall-Salvati index and patellophyseal index was found between knees with
normal and those with severe cartilage defects.</p>
<p><b>CONCLUSION.</b> Our results indicate that the commonly used
Insall-Salvati and modified Insall-Salvati indexes do not correlate with
patellotrochlear articular cartilage congruence. We did find an association
between the modified Insall-Salvati and patellophyseal indexes and the
presence of severe chondral defects.</p>
]]></description>
<dc:creator><![CDATA[Ali, S. A., Helmer, R., Terk, M. R.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2729</dc:identifier>
<dc:title><![CDATA[Patella Alta: Lack of Correlation Between Patellotrochlear Cartilage Congruence and Commonly Used Patellar Height Ratios]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1366</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1361</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1367?rss=1">
<title><![CDATA[Degeneration of the Long Biceps Tendon: Comparison of MRI With Gross Anatomy and Histology]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1367?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to relate alterations in
biceps tendon diameter and signal on MR images to gross anatomy and
histology.</p>
<p><b>MATERIALS AND METHODS.</b> T1-weighted, T2-weighted fat-saturated, and
proton density&ndash;weighted fat-saturated spin-echo sequences were acquired
in 15 cadaveric shoulders. Biceps tendon diameter (normal, flattened,
thickened, and partially or completely torn) and signal intensity (compared
with bone, fat, muscle, and joint fluid) were graded by two readers
independently and in a blinded fashion. The distance of tendon abnormalities
from the attachment at the glenoid were noted in millimeters. MRI findings
were related to gross anatomic and histologic findings.</p>
<p><b>RESULTS.</b> On the basis of gross anatomy, there were six normal, five
flattened, two thickened, and two partially torn tendons. Reader 1 graded nine
diameter changes correctly, missed two, and incorrectly graded four. The
corresponding values for reader 2 were seven, one, and five, respectively,
with  = 0.75. Histology showed mucoid degeneration (<I>n</I> = 13),
lipoid degeneration (<I>n</I> = 7), and fatty infiltration (<I>n</I> = 6).
At least one type of abnormality was found in each single tendon. Mucoid
degeneration was hyperintense compared with fatty infiltration on T2-weighted
fat-saturated images and hyperintense compared with magic-angle artifacts on
proton density&ndash;weighted fat-saturated images. MRI-based localization of
degeneration agreed well with histologic findings.</p>
<p><b>CONCLUSION.</b> Diameter changes are specific but not sensitive in
diagnosing tendinopathy of the biceps tendon. Increased tendon signal is most
typical for mucoid degeneration but should be used with care as a sign of
tendon degeneration.</p>
]]></description>
<dc:creator><![CDATA[Buck, F. M., Grehn, H., Hilbe, M., Pfirrmann, C. W. A., Manzanell, S., Hodler, J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2738</dc:identifier>
<dc:title><![CDATA[Degeneration of the Long Biceps Tendon: Comparison of MRI With Gross Anatomy and Histology]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1375</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1367</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1376?rss=1">
<title><![CDATA[MDCT Arthrography Features of Ulnocarpal Impaction Syndrome]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1376?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aim of this article is to present the imaging
patterns of ulnocarpal impaction syndrome (Palmer class II lesions) on MDCT
arthrography.</p>
<p><b>CONCLUSION.</b> MDCT arthrography is an excellent tool for imaging
patients with clinically suspected ulnocarpal impaction syndrome, allowing
identification of the spectrum of findings and proper classification according
to Palmer class II (degenerative) lesions, which directly affects
management.</p>
]]></description>
<dc:creator><![CDATA[Crema, M. D., Marra, M. D., Guermazi, A., Roemer, F. W., Bohndorf, K., Jomaah, N.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2567</dc:identifier>
<dc:title><![CDATA[MDCT Arthrography Features of Ulnocarpal Impaction Syndrome]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1381</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1376</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1384?rss=1">
<title><![CDATA[Water Diffusivity: Comparison of Primary CNS Lymphoma and Astrocytic Tumor Infiltrating the Corpus Callosum]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1384?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to determine whether
lymphoma and astrocytic tumor infiltrating the corpus callosum can be reliably
differentiated with measurement of water diffusivity.</p>
<p><b>MATERIALS AND METHODS.</b> Echo-planar diffusion-weighted MR images of
27 patients with glioblastoma multiforme, five patients with low-grade
astrocytoma, five patients with gliomatosis cerebri, and nine patients with
primary lymphoma infiltrating the corpus callosum were reviewed
retrospectively. Regions of interest were drawn on apparent diffusion
coefficient (ADC) maps inside the callosal tumor. ADCs were normalized by
calculation of the ratio between the ADC of the tumor and the ADC of an
uninvolved region of corpus callosum.</p>
<p><b>RESULTS.</b> The mean ADC of glioblastoma multiforme was 1.13 &plusmn;
0.31 (SD) <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup> mm<sup>2</sup>/s, and the mean tumor
to corpus callosum ADC ratio was 1.51 &plusmn; 0.46; of low-grade astrocytoma,
1.14 &plusmn; 0.23 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup> mm<sup>2</sup>/s and 1.54
&plusmn; 0.28; gliomatosis cerebri, 1.01 &plusmn; 0.20 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s and 1.31 &plusmn; 0.36; and lymphoma,
0.71 &plusmn; 0.13 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;3</sup> mm<sup>2</sup>/s and 0.93
&plusmn; 0.19. The difference between the mean tumor to corpus callosum ADC
ratio of lymphoma and that of all grades of astrocytoma (1.48 &plusmn; 0.43)
was statistically significant (<I>p</I> &lt; 0.001). The optimal ADC
threshold for discriminating astrocytic tumor and lymphoma was 0.90 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s (sensitivity, 84%; specificity, 89%).
The optimal threshold for tumor to corpus callosum ADC ratio was 1.22
(sensitivity, 73%; specificity, 100%).</p>
<p><b>CONCLUSION.</b> The water diffusivity and the ADC ratio of the tumor to
normal-appearing corpus callosum of astrocytic tumor differ significantly from
those of lymphoma infiltrating the corpus callosum, allowing reliable
differentiation of the two types of tumor.</p>
]]></description>
<dc:creator><![CDATA[Horger, M., Fenchel, M., Nagele, T., Moehle, R., Claussen, C. D., Beschorner, R., Ernemann, U.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2486</dc:identifier>
<dc:title><![CDATA[Water Diffusivity: Comparison of Primary CNS Lymphoma and Astrocytic Tumor Infiltrating the Corpus Callosum]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1387</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1384</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1388?rss=1">
<title><![CDATA[Evaluation of the C1-C2 Articulation on MDCT in Healthy Children and Young Adults]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1388?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> We aimed to establish normal values on MDCT images for
the atlantoaxial relationships including the atlantoaxial interval and lateral
atlantodens interval (ADI) that could be used to detect atlantoaxial
ligamentous injuries in adults and children.</p>
<p><b>MATERIALS AND METHODS.</b> One hundred seventy-eight healthy adult
patients between 20 and 40 years old and 112 pediatric patients between 2
months and 10 years old underwent cervical spine MDCT with multiplanar
reconstructions. The width of the joint space between the lateral mass of C1
and the lateral mass of C2 was measured at three equidistant points on both
the left and right sides on coronal reformatted images to determine the
atlantoaxial interval. The distance between the lateral surface of the dens
and the medial surface of the lateral mass of C1 was measured in the coronal
plane to determine the lateral ADI bilaterally.</p>
<p><b>RESULTS.</b> The upper limit of the normal range of values for the
atlantoaxial interval in adults was 3.34 mm on the right and 3.39 mm on the
left. The upper limit of normal for the lateral ADI was 4.67 mm on the right
and 5.6 mm on the left. More than 95% of the pediatric population was found to
have an atlantoaxial interval of less than 3.9 mm on either side, a right
lateral ADI of less than 7.4 mm, and a left lateral ADI of less than 8.0
mm.</p>
<p><b>CONCLUSION.</b> We propose that the obtained normal values be considered
as the upper limits of the normal range for the atlantoaxial interval in adult
and pediatric populations on MDCT images.</p>
]]></description>
<dc:creator><![CDATA[Rojas, C. A., Hayes, A., Bertozzi, J. C., Guidi, C., Martinez, C. R.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2688</dc:identifier>
<dc:title><![CDATA[Evaluation of the C1-C2 Articulation on MDCT in Healthy Children and Young Adults]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1392</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1388</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1394?rss=1">
<title><![CDATA[MRI of Legg-Calve-Perthes Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1394?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Legg-Calv&eacute;-Perthes disease is a common cause of
hip pain in children that may be initially clinically and radiographically
difficult to diagnose and stage. The purpose of this article is to describe
and illustrate the various MRI appearances of this condition.</p>
<p><b>CONCLUSION.</b> MRI may show proximal femoral abnormalities before
radiography in the setting of Legg-Calv&eacute;-Perthes disease, allowing
appropriate diagnosis and prompt treatment. MRI can also assess for
revascularization, healing, and multiple complications.</p>
]]></description>
<dc:creator><![CDATA[Dillman, J. R., Hernandez, R. J.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2444</dc:identifier>
<dc:title><![CDATA[MRI of Legg-Calve-Perthes Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1407</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1394</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1408?rss=1">
<title><![CDATA[Radiographic Predictors of Disease Severity in Neonates and Infants With Necrotizing Enterocolitis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1408?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to validate a radiographic
scale, the Duke abdominal assessment scale (DAAS), as a tool for predicting
the severity of disease in neonates and infants with suspected necrotizing
enterocolitis (NEC).</p>
<p><b>MATERIALS AND METHODS.</b> Study group patients (<I>n</I> = 43)
underwent at least two two-view abdominal radiographic series within 48 hours
of surgical intervention for suspected NEC complications. Control group
patients (<I>n</I> = 86) were patients with suspected NEC who did not
undergo surgery for suspected NEC complications. DAAS scores were assigned by
two pediatric radiologists with 20 and 6 years' experience.</p>
<p><b>RESULTS.</b> The initial radiographs of 26 of 43 (60.5%) patients in the
study group showed fixed bowel loops (10/43, 23.3%), highly probable or
definite pneumatosis (9/43, 20.9%), or portal venous gas (7/43, 16.3%). These
findings had progressed to pneumoperitoneum on the follow-up series in 20
(46.5%) study group patients. Among the control group, three patients (3.5%)
had highly probable or definite pneumatosis, and none had fixed bowel loops,
portal venous gas, or pneumoperitoneum. Patients with higher DAAS scores were
more likely to undergo surgical intervention than patients with lower scores
(odds ratio, 1.69; 95% CI, 1.40&ndash;2.03). A receiver operating
characteristic curve analysis showed good overall performance (c statistic =
0.83) for predicting eventual surgical intervention in the study group with
higher DAAS scores.</p>
<p><b>CONCLUSION.</b> The DAAS provides a standardized 10-point radiographic
scale that increases with disease severity when using need for surgical
intervention as a surrogate for severe NEC. For every 1-point increase in the
DAAS score, patients were statistically significantly more likely to have
severe disease as measured by need for surgical intervention.</p>
]]></description>
<dc:creator><![CDATA[Coursey, C. A., Hollingsworth, C. L., Wriston, C., Beam, C., Rice, H., Bisset, G.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2306</dc:identifier>
<dc:title><![CDATA[Radiographic Predictors of Disease Severity in Neonates and Infants With Necrotizing Enterocolitis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1413</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1408</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1414?rss=1">
<title><![CDATA[Motion Artifact on High-Resolution CT Images of Pediatric Patients: Comparison of Volumetric and Axial CT Methods]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1414?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to address the controversy
whether the quality of volumetric high-resolution CT (HRCT) images is as good
as that of axial nonvolumetric HRCT images by assessing the degree of motion
artifact on images acquired with the two methods at MDCT of pediatric patients
with known or suspected lung disease.</p>
<p><b>MATERIALS AND METHODS.</b> A search of the hospital information system
was conducted to identify the cases of pediatric patients with clinically
suspected or known interstitial lung disease who underwent 16-MDCT of the
chest with both volumetric and axial HRCT acquisitions (both 1.25-mm slice
thickness) from March 2005 to July 2008. Two pediatric radiologists reviewed
the images for the presence of motion artifacts at three anatomic levels
(upper, middle, and lower lung zones). Motion artifacts were given numerical
grades representing no artifact to severe artifact, and the paired Student's
<I>t</I> test was used to compare the scores for the two acquisition
methods. A total motion score for each acquisition was calculated by summing
the scores for each of the three lung zones, and the scores for the two
imaging methods were compared. Correlation between degree of motion artifact
and age was evaluated. Effective radiation doses were estimated for volumetric
and axial CT acquisitions.</p>
<p><b>RESULTS.</b> The study population consisted of 54 children (28 boys, 26
girls; mean age, 11.7 &plusmn; 3.8 years; range, 5&ndash;18 years; eight
inpatients, 46 outpatients) who underwent a total of 54 MDCT chest studies
with volumetric and axial HRCT acquisitions. Motion artifact scores were
higher for axial than for volumetric HRCT images of the upper (1.2 vs 1.0),
middle (1.6 vs 1.2), and lower (2.2 vs 1.5) lung zones (<I>p</I> &lt; 0.05
at each level). The total motion score of the axial HRCT images (mean, 5;
range, 1&ndash;9) was higher than that of the volumetric HRCT images (mean,
3.6; range, 1&ndash;8) (<I>p</I> &lt; 0.05). Younger age correlated with
higher motion artifact score on axial HRCT images (<I>r</I> = &ndash;0.36,
<I>p</I> &lt; 0.01), whereas no correlation was found between age and motion
artifact score on volumetric HRCT images (<I>r</I> = &ndash;0.12, <I>p</I>
= 0.38). The effective radiation doses were 0.57 mSv for axial HRCT
acquisition and 7.6 mSv for volumetric acquisition. The addition of axial
acquisition increased the total radiation dose of the MDCT examination
7.1%.</p>
<p><b>CONCLUSION.</b> At CT of pediatric patients, reconstructed HRCT images
from volumetric MDCT acquisition have significantly less motion artifact than
images obtained with traditional axial acquisition.</p>
]]></description>
<dc:creator><![CDATA[Bastos, M. d., Lee, E. Y., Strauss, K. J., Zurakowski, D., Tracy, D. A., Boiselle, P. M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2843</dc:identifier>
<dc:title><![CDATA[Motion Artifact on High-Resolution CT Images of Pediatric Patients: Comparison of Volumetric and Axial CT Methods]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1418</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1414</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1419?rss=1">
<title><![CDATA[Inflammatory Myofibroblastic Tumors of the Abdomen as Mimickers of Malignancy: Imaging Features in Nine Children]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1419?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate retrospectively
the CT and sonographic features in nine children with pathologically proven
inflammatory myofibroblastic tumors of the abdomen.</p>
<p><b>CONCLUSION.</b> Although inflammatory myofibroblastic tumors occur in
various sites and the imaging characteristics are variable, tumors showed
different imaging patterns that were dependent on the site at which the tumor
had originated.</p>
]]></description>
<dc:creator><![CDATA[Kim, S. J., Kim, W. S., Cheon, J.-E., Shin, S.-M., Youn, B. J., Kim, I.-O., Yeon, K. M.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2433</dc:identifier>
<dc:title><![CDATA[Inflammatory Myofibroblastic Tumors of the Abdomen as Mimickers of Malignancy: Imaging Features in Nine Children]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1424</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1419</prism:startingPage>
<prism:section>Pediatric Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1425?rss=1">
<title><![CDATA[Imaging Arteriovenous Fistulas]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1425?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Arteriovenous fistulas (AVFs) are abnormal communications
with shunting of blood from an artery to a vein. AVFs mainly involve the
peripheral vascular system but can affect virtually any organ or system in the
body. They may be congenital, created surgically for hemodialysis, or caused
by pathologic processes. This review describes the diverse origins of AVFs and
illustrates the spectrum of imaging findings at radiography, ultrasound, CT,
MRI, and digital angiography for AVFs in different locations: the CNS, thorax,
abdomen, musculoskeletal system, and peripheral vascular system. We also
discuss syndromes associated with AVFs and describe recent interventional
techniques for treating AVFs.</p>
<p><b>CONCLUSION.</b> Familiarity with the spectrum of imaging findings in
AVFs is essential for the accurate interpretation of images and facilitates
diagnosis and therapeutic management. Radiologists can play a critical role in
the diagnosis and treatment of AVFs. Digital angiography is helpful in
elaborating a vascular map for endovascular treatment.</p>
]]></description>
<dc:creator><![CDATA[Gonzalez, S. B., Busquets, J. C. V., Figueiras, R. G., Martin, C. V., Pose, C. S., de Alegria, A. M., Mourenza, J. A. C.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2631</dc:identifier>
<dc:title><![CDATA[Imaging Arteriovenous Fistulas]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1433</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1425</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1434?rss=1">
<title><![CDATA[Color Doppler Imaging Evaluation of Proximal Vertebral Artery Stenosis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1434?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The sonographic diagnostic criteria for vertebral artery
stenosis have not been fully investigated. The purpose of this study was to
assess hemodynamic parameters at color Doppler imaging and to determine, with
digital subtraction angiography as the reference standard, the optimal
thresholds for evaluation of proximal vertebral artery stenosis.</p>
<p><b>MATERIALS AND METHODS.</b> Among 653 patients with symptoms of ischemia
of the posterior circulation, 247 subjects with normal arteries or stenosis of
the proximal vertebral artery confirmed with digital subtraction angiography
were included in the study. Peak systolic velocity at the origin of the
vertebral artery (PSV<SUB>origin</SUB>) and in intervertebral segments of the
vertebral artery (PSV<SUB>IV</SUB>), end-diastolic velocity at the origin and
in the intervertebral segments of the vertebral artery, and the diameter of
the vascular lumen were measured. The cutoff values for the diagnosis of &lt;
50%, 50&ndash;69%, and 70&ndash;99% stenosis were determined with receiver
operating characteristics analysis.</p>
<p><b>RESULTS.</b> The optimal cutoff values of hemodynamic parameters in
evaluation of stenosis of the proximal vertebral artery for &lt; 50% stenosis
were PSV<SUB>origin</SUB> &ge; 85 cm/s, PSV<SUB>origin</SUB> /
PSV<SUB>IV</SUB> &ge; 1.3, and end-diastolic velocity at the origin &ge; 27
cm/s; for 50&ndash;69% stenosis were PSV<SUB>origin</SUB> &ge; 140 cm/s,
PSV<SUB>origin</SUB> / PSV<SUB>IV</SUB> &ge; 2.1, and end-diastolic velocity
at the origin &ge; 35 cm/s; and for 70&ndash;99% stenosis were
PSV<SUB>origin</SUB> &ge; 210 cm/s, PSV<SUB>origin</SUB> / PSV<SUB>IV</SUB>
&ge; 4.0, and end-diastolic velocity at the origin &ge; 50 cm/s.
PSV<SUB>origin</SUB> was the most useful hemodynamic parameter, having
accuracy of 94.5%, 96.2%, and 88.7% for the diagnosis of &lt; 50%,
50&ndash;69%, and 70&ndash;99% stenosis.</p>
<p><b>CONCLUSION.</b> Color Doppler imaging is a reliable method for
evaluation of vertebral artery stenosis. The results derived from this study
can be used as a reference for establishing sonographic criteria for proximal
vertebral artery stenosis.</p>
]]></description>
<dc:creator><![CDATA[Hua, Y., Meng, X.-F., Jia, L.-Y., Ling, C., Miao, Z.-R., Ling, F., Liu, J.-B.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2624</dc:identifier>
<dc:title><![CDATA[Color Doppler Imaging Evaluation of Proximal Vertebral Artery Stenosis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1438</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1434</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1439?rss=1">
<title><![CDATA[MDCT Angiography of Mesenteric Bypass Surgery for the Treatment of Chronic Mesenteric Ischemia]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1439?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Chronic mesenteric ischemia (CMI) is a serious condition
that requires surgical or endovascular intervention. Surgical
revascularization for the treatment of CMI uses different operative techniques
including endarterectomy, vessel reimplantation, and mesenteric bypass. A
basic understanding of the operative techniques is essential for the adequate
interpretation of imaging studies in patients who have undergone surgery for
CMI. In this article, we review the different operative techniques used in the
treatment of CMI, discuss the results of surgical intervention for CMI, and
illustrate how MDCT angiography (MDCTA) can be used for follow-up and for the
detection of early and late complications after surgery.</p>
<p><b>CONCLUSION.</b> MDCTA is a powerful tool for the postoperative
evaluation of patients with CMI. Early detection of graft dysfunction is
critical to prevent graft occlusion and the development of potentially fatal
mesenteric ischemia. MDCTA can detect early and late complications after
surgery and guide additional surgical or endovascular interventions.</p>
]]></description>
<dc:creator><![CDATA[Lopera, J. E., Trimmer, C. K., Lamba, R., Suri, R., Cura, M. A., El-Merhi, F. M., Kroma, G.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2372</dc:identifier>
<dc:title><![CDATA[MDCT Angiography of Mesenteric Bypass Surgery for the Treatment of Chronic Mesenteric Ischemia]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1445</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1439</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/5/1446?rss=1">
<title><![CDATA[Venous Doppler Sonography of the Extremities: A Window to Pathology of the Thorax, Abdomen, and Pelvis]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/5/1446?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Swelling of an extremity may be a sign of peripheral deep
venous thrombosis but may occasionally be due to more proximal or central
venous obstruction. Venous Doppler sonography of the extremities is a commonly
performed procedure to evaluate for the presence of deep venous thrombosis.
Pulsed-wave Doppler sonography is performed as part of this procedure to
evaluate for the presence of cardiac pulsatility or respiratory phasicity. The
importance of information provided by the pulsed-wave Doppler waveform must
not be undervalued. Thus, the purpose of this article is to discuss the
pathology of the thorax, abdomen, and pelvis that can be discovered by
identifying abnormal waveforms in the veins of the extremities.</p>
<p><b>CONCLUSION.</b> Abnormal waveforms provide information for compression
or obstruction of the proximal venous system in the thorax, abdomen, and
pelvis. When these waveforms are abnormal, previous imaging should be reviewed
or additional imaging performed to discover the cause.</p>
]]></description>
<dc:creator><![CDATA[Selis, J. E., Kadakia, S.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2640</dc:identifier>
<dc:title><![CDATA[Venous Doppler Sonography of the Extremities: A Window to Pathology of the Thorax, Abdomen, and Pelvis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1451</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1446</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1460?rss=1">
<title><![CDATA[Prenatal Clinic]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1460?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2965</dc:identifier>
<dc:title><![CDATA[Prenatal Clinic]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1460</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1460</prism:startingPage>
<prism:section>Medicine in American Art</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1461?rss=1">
<title><![CDATA[Colin B. Holman]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1461?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Earnest, F.]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3191</dc:identifier>
<dc:title><![CDATA[Colin B. Holman]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1462</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1461</prism:startingPage>
<prism:section>Other Content</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/5/1463?rss=1">
<title><![CDATA[Correction for Volume 193, p. W251]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/5/1463?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 20 Oct 2009 11:02:34 PDT</dc:date>
<dc:title><![CDATA[Correction for Volume 193, p. W251]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1463</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1463</prism:startingPage>
<prism:section>Other Content</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W259?rss=1">
<title><![CDATA[Periosteal Reaction]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W259?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Rana, R. S., Wu, J. S., Eisenberg, R. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3300</dc:identifier>
<dc:title><![CDATA[Periosteal Reaction]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W272</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W259</prism:startingPage>
<prism:section>Residents' Section</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W273?rss=1">
<title><![CDATA[Radiology in Italy: What Is Happening?]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W273?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Romano, S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2801</dc:identifier>
<dc:title><![CDATA[Radiology in Italy: What Is Happening?]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W277</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W273</prism:startingPage>
<prism:section>The Practice of Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W278?rss=1">
<title><![CDATA[Palliative Treatment of Malignant Esophagopulmonary Fistulas With Covered Expandable Metallic Stents]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W278?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to evaluate the safety and
clinical effectiveness of covered expandable metallic stents for palliative
treatment of malignant esophagopulmonary fistulas.</p>
<p><b>MATERIALS AND METHODS.</b> Between November 1990 and January 2008, 14
patients with fistulas between the esophagus and pulmonary parenchyma were
treated with covered expandable metallic esophageal stents. The fistulas were
caused by esophageal (<I>n</I> = 9) or bronchogenic (<I>n</I> = 5)
carcinomas. At the time of stent placement, all patients had aspiration
pneumonia and 11 had lung abscesses (79%). Technical and clinical success,
fistula reopening, complications, and survival rates were evaluated.</p>
<p><b>RESULTS.</b> Stent placement was technically successful in all cases,
and there were no immediate procedural complications. Complete fistula sealing
resulting in resolution of aspiration symptoms (i.e., clinical success)
occurred in 12 patients (86%). During follow-up (mean survival, 100.9 &plusmn;
79.9 days; median survival, 65.5 days; range, 16&ndash;275 days), the fistula
reopened in two of 12 clinical success patients. One patient (7%) experienced
complications resulting from dyspnea due to tracheal compression by the
esophageal stent. Although 13 patients died of aspiration pneumonia and the
remaining patient died of cancer bleeding, none of the mortalities was related
to the stent placement procedure.</p>
<p><b>CONCLUSION.</b> The use of covered expandable metallic stents appears to
be safe and feasible for the palliative treatment of malignant
esophagopulmonary fistulas.</p>
]]></description>
<dc:creator><![CDATA[Kim, K. R., Shin, J. H., Song, H.-Y., Ko, G.-Y., Kim, J. H., Yoon, H.-K., Sung, K.-B.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2176</dc:identifier>
<dc:title><![CDATA[Palliative Treatment of Malignant Esophagopulmonary Fistulas With Covered Expandable Metallic Stents]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W282</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W278</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W283?rss=1">
<title><![CDATA[CT-Guided Biopsy of Perivascular Tumor Encasement Using Simultaneous IV Contrast Enhancement]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W283?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to describe and review the
accuracy of a novel technique for difficult biopsy of arterial tumor
encasement using simultaneous IV contrast enhancement and helical CT guidance
for coaxial core needle biopsies.</p>
<p><b>CONCLUSION.</b> Diagnostic biopsy specimens can be obtained safely using
simultaneous IV contrast-enhanced CT guidance during difficult biopsies of
unresectable tumors encasing the celiac, superior mesenteric, or left renal
arteries.</p>
]]></description>
<dc:creator><![CDATA[Collins, J. M., Kriegshauser, J. S., Leslie, K. O.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1935</dc:identifier>
<dc:title><![CDATA[CT-Guided Biopsy of Perivascular Tumor Encasement Using Simultaneous IV Contrast Enhancement]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W287</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W283</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W288?rss=1">
<title><![CDATA[Left Inferior Phrenic Artery Feeding Hepatocellular Carcinoma: Angiographic Anatomy Using C-Arm CT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W288?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The left inferior phrenic artery (LIPA) is one of the
common extrahepatic collateral arteries that supply hepatocellular carcinomas
(HCCs). The purpose of this study is to describe the anatomy of the LIPA that
supplies HCCs using C-arm CT in 23 patients.</p>
<p><b>CONCLUSION.</b> The anteromedial limb of the ascending branch was
present in 14 patients and accessory gastric branches were noted in 11
patients. The use of angiography and C-arm CT of the LIPA showed 26 tumor
feeders in 23 patients. The feeders were seen in the anteromedial limb
(<I>n</I> = 12), lateral limb (<I>n</I> = 9), anterior limb (<I>n</I> =
3), and descending branch (<I>n</I> = 2). The anteromedial limb of the
ascending branch is a common tumor feeder of the LIPA and can supply HCCs
located in the right liver dome. Gastric staining is also frequently depicted
on LIPA angiography and should not be confused with tumor staining.</p>
]]></description>
<dc:creator><![CDATA[Kim, H.-C., Chung, J. W., An, S., Seong, N. J., Jae, H. J., Cho, B. H., Park, J. H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2417</dc:identifier>
<dc:title><![CDATA[Left Inferior Phrenic Artery Feeding Hepatocellular Carcinoma: Angiographic Anatomy Using C-Arm CT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W294</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W288</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W295?rss=1">
<title><![CDATA[Dynamic Contrast-Enhanced MRI of the Breast: Quantitative Method for Kinetic Curve Type Assessment]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W295?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The type of contrast enhancement kinetic curve (i.e.,
persistently enhancing, plateau, or washout) seen on dynamic contrast-enhanced
MRI (DCE-MRI) of the breast is predictive of malignancy. Qualitative estimates
of the type of curve are most commonly used for interpretation of DCE-MRI. The
purpose of this study was to compare qualitative and quantitative methods for
determining the type of contrast enhancement kinetic curve on DCE-MRI.</p>
<p><b>MATERIALS AND METHODS.</b> Ninety-six patients underwent breast DCE-MRI.
The type of DCE-MRI kinetic curve was assessed qualitatively by three
radiologists on two occasions. For quantitative assessment, the slope of the
washout curve was calculated. Kappa statistics were used to determine inter-
and intraobserver agreement for the qualitative method. Matched sample tables,
the McNemar test, and receiver operating characteristic (ROC) curve statistics
were used to compare quantitative versus qualitative methods for establishing
or excluding malignancy.</p>
<p><b>RESULTS.</b> Seventy-eight lesions (77.2%) were malignant and 23 (22.8%)
were benign. For the qualitative assessment, the intra- and interobserver
agreement was good ( = 0.76&ndash;0.88), with an area under the ROC
curve (AUC) of 0.73&ndash;0.77. For the quantitative method, the highest AUC
was 0.87, reflecting significantly higher diagnostic accuracies compared with
qualitative assessment (<I>p</I> &lt; 0.01 for the difference between the
two methods).</p>
<p><b>CONCLUSION.</b> Quantitative assessment of the type of contrast
enhancement kinetic curve on breast DCE-MRI resulted in significantly higher
diagnostic performance for establishing or excluding malignancy compared with
assessment based on the standard qualitative method.</p>
]]></description>
<dc:creator><![CDATA[El Khouli, R. H., Macura, K. J., Jacobs, M. A., Khalil, T. H., Kamel, I. R., Dwyer, A., Bluemke, D. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2483</dc:identifier>
<dc:title><![CDATA[Dynamic Contrast-Enhanced MRI of the Breast: Quantitative Method for Kinetic Curve Type Assessment]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W300</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W295</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W301?rss=1">
<title><![CDATA[Diffusion-Weighted MRI of Advanced Hepatocellular Carcinoma During Sorafenib Treatment: Initial Results]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W301?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to evaluate signal changes
of advanced hepatocellular carcinoma in diffusion-weighted MRI in the
early-response monitoring of oral therapy with the multikinase inhibitor
sorafenib.</p>
<p><b>CONCLUSION.</b> Hepatocellular carcinoma lesions exhibit characteristic
but unusual apparent diffusion coefficient (ADC) changes during sorafenib
therapy, consisting of early decrease in ADC after therapy onset followed by a
reincrease. The ADC changes seem to reflect the underlying pathophysiologic
mechanisms in tumor necrosis (most probably hemorrhagic) induced by this novel
targeted agent early after therapy onset and may indicate tumor reactivation
in the later follow-up period.</p>
]]></description>
<dc:creator><![CDATA[Schraml, C., Schwenzer, N. F., Martirosian, P., Bitzer, M., Lauer, U., Claussen, C. D., Horger, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2289</dc:identifier>
<dc:title><![CDATA[Diffusion-Weighted MRI of Advanced Hepatocellular Carcinoma During Sorafenib Treatment: Initial Results]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W307</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W301</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W308?rss=1">
<title><![CDATA[MRI Features of Pancreatic Colloid Carcinoma]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W308?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to retrospectively
investigate the MRI findings (diameter, location, contour and margin, signal
intensity characteristics, and enhancement patterns) in a series of eight
patients with pathologically proven colloid carcinoma of the pancreas.</p>
<p><b>CONCLUSION.</b> Colloid carcinomas of the pancreas appear as masses with
lobulating contours, indiscrete margins, and hyperintensity on T2-weighted
images (<I>n</I> = 8). In addition, all patients who underwent dynamic
studies (<I>n</I> = 4) showed peripheral and internal spongelike or meshlike
progressive delayed contrast enhancement.</p>
]]></description>
<dc:creator><![CDATA[Yoon, M. A., Lee, J. M., Kim, S. H., Lee, J. Y., Han, J. K., Choi, B. I., Choi, J.-Y., Park, S. H., Lee, M. W.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2347</dc:identifier>
<dc:title><![CDATA[MRI Features of Pancreatic Colloid Carcinoma]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W313</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W308</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W314?rss=1">
<title><![CDATA[CT-Guided Tube Pericardiostomy: A Safe and Effective Technique in the Management of Postsurgical Pericardial Effusion]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W314?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to analyze the efficacy and
examine the competitive cost of CT-guided tube pericardiostomy in the
management of symptomatic postsurgical pericardial effusion.</p>
<p><b>MATERIALS AND METHODS.</b> Over a 4-year period, 36 patients with
symptomatic pericardial effusion were treated with CT-guided percutaneous
placement of an indwelling pericardial catheter, for a total of 39 CT-guided
tube pericardiostomy procedures. Thirty-three patients (92%) had undergone
major cardiothoracic surgery, and three patients (8%) had undergone minimally
invasive procedures. The medical records were retrospectively reviewed for
clinical presentation, surgical history, imaging studies performed, procedural
details, fluid characterization, and outcome. Charge comparison was performed
with the American Medical Association Current Procedural Terminology codes and
information acquired from the billing department at our facility.</p>
<p><b>RESULTS.</b> All 39 CT-guided tube pericardiostomy procedures were
performed successfully without clinically significant complications. After 33
of the 39 procedures (85%), symptoms did not recur after the catheter was
removed. Three of 36 patients (8%) had a recurrence of pericardial effusion.
Comparison of procedure charges showed an 89% saving over intraoperative
pericardial window procedures and no significant difference compared with
ultrasound-guided tube pericardiostomy. Eight patients (21% of procedures)
needed pleural drainage procedures, all of which were performed in the CT
suite immediately after the tube pericardiostomy procedure.</p>
<p><b>CONCLUSION.</b> CT-guided tube pericardiostomy is a safe and effective
alternative to surgical drainage in the care of patients with clinically
significant pericardial effusion after cardiothoracic surgery and has the
additional benefit of substantial cost savings.</p>
]]></description>
<dc:creator><![CDATA[Palmer, S. L., Kelly, P. D., Schenkel, F. A., Barr, M. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1834</dc:identifier>
<dc:title><![CDATA[CT-Guided Tube Pericardiostomy: A Safe and Effective Technique in the Management of Postsurgical Pericardial Effusion]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W320</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W314</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W321?rss=1">
<title><![CDATA[Relation Between Signal Intensity on T2-Weighted MR Images and Presence of Microvascular Obstruction in Patients With Acute Myocardial Infarction]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W321?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> In experimental animal models and human autopsy studies,
hemorrhagic infarction caused by microvascular injury has been detected after
coronary reperfusion. The purpose of this study was to determine whether
detection of myocardial edema with T2-weighted MRI is influenced by the
presence of microvascular obstruction.</p>
<p><b>SUBJECTS AND METHODS.</b> Thirty-seven patients underwent black-blood
fat-suppressed T2-weighted, rest perfusion, and late gadolinium-enhanced MRI
5.4 &plusmn; 3.1 days after the onset of acute myocardial infarction. On
T2-weighted MR images, the signal intensity in relation to that of remote
myocardium was determined in the late gadolinium-enhanced and periinfarction
areas. Segment-based analysis was performed to determine whether the presence
of microvascular obstruction influences the detection of myocardial edema.</p>
<p><b>RESULTS.</b> The averaged signal intensity in the late
gadolinium-enhanced area without microvascular obstruction was significantly
higher than the signal intensity in remote normal myocardium (relative signal
intensity, 1.83 &plusmn; 0.50; <I>p</I> &lt; 0.001). In contrast, the signal
intensity in the microvascular obstruction area on T2-weighted images was not
significantly different from the signal intensity in remote myocardium
(relative signal intensity, 1.14 &plusmn; 0.26). The percentages of late
gadolinium-enhanced segments with high signal intensity on T2-weighted MR
images were 95% (73/77) without microvascular obstruction and 30% (22/73) with
microvascular obstruction.</p>
<p><b>CONCLUSION.</b> With T2-weighted MRI, infarction-associated edema can be
reliably detected in infarct lesions without microvascular obstruction.
Microvascular obstruction, however, does not necessarily exhibit high signal
intensity on T2-weighted MRI. Careful attention is required in interpretation
of cardiac MR images of patients who have experienced acute myocardial
infarction and undergone percutaneous coronary intervention. The findings on
T2-weighted MR images can be substantial underestimates of the extent of acute
myocardial infarction.</p>
]]></description>
<dc:creator><![CDATA[Mikami, Y., Sakuma, H., Nagata, M., Ishida, M., Kurita, T., Komuro, I., Ito, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2335</dc:identifier>
<dc:title><![CDATA[Relation Between Signal Intensity on T2-Weighted MR Images and Presence of Microvascular Obstruction in Patients With Acute Myocardial Infarction]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W326</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W321</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W327?rss=1">
<title><![CDATA[T2*-Weighted and Arterial Spin Labeling MRI of Calf Muscles in Healthy Volunteers and Patients With Chronic Exertional Compartment Syndrome: Preliminary Experience]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W327?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to assess temporal changes
with exercise in T2* and arterial spin labeling signals in patients with
chronic exertional compartment syndrome of the anterior compartment of the
lower leg and in control subjects using T2* mapping and arterial spin labeling
MRI.</p>
<p><b>SUBJECTS AND METHODS.</b> This prospective study was approved by the
institutional research ethics board. Ten control subjects (five women and five
men; mean age, 29.0 years) and nine patients with chronic exertional
compartment syndrome (three women and six men; mean age, 33.7 years) gave
informed written consent and underwent MRI of the calf muscles using an axial
T2*-weighted multiecho gradient-recalled echo and a flow-sensitive alternating
inversion recovery sequence with echo-planar imaging readouts before
(baseline) and 3, 6, 9, 12, and 15 minutes after exercise. T2* and arterial
spin labeling signal changes (T2* and ASL, respectively) over
time were calculated relative to the baseline examination. T2* and
ASL between patients and control subjects were compared using the
Student's <I>t</I> test.</p>
<p><b>RESULTS.</b> In both patients and control subjects, T2* and
ASL showed a peak at 3 minutes after exercise, followed by a decrease
over time. The maximum T2* was 26% and 29% for patients and control
subjects, respectively. The maximum ASL was 183% and 224% for patients
and control subjects, respectively. After 15 minutes, arterial spin labeling
signal returned to baseline; however, T2* remained elevated (8% in patients;
10% in control subjects). No statistically significant differences between
patients and control subjects in postexercise T2* and ASL were
found (<I>p</I> = 0.21&ndash;0.98).</p>
<p><b>CONCLUSION.</b> After calf muscle exercise, no statistically significant
differences in T2* relaxation times or arterial spin labeling signal,
indicative of differences in muscle oxygenation and perfusion status, were
found between patients with chronic exertional compartment syndrome and
control subjects.</p>
]]></description>
<dc:creator><![CDATA[Andreisek, G., White, L. M., Sussman, M. S., Langer, D. L., Patel, C., Su, J. W.-S., Haider, M. A., Stainsby, J. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1579</dc:identifier>
<dc:title><![CDATA[T2*-Weighted and Arterial Spin Labeling MRI of Calf Muscles in Healthy Volunteers and Patients With Chronic Exertional Compartment Syndrome: Preliminary Experience]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W333</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W327</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W334?rss=1">
<title><![CDATA[Anterior Ankle Impingement and Talar Bony Outgrowths: Osteophyte or Enthesophyte? Paleopathologic and Cadaveric Study With Imaging Correlation]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W334?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Bony "spurs" are a major component of
anterior ankle impingement syndrome. The two major accepted hypotheses on the
origin of these bony spurs are osteophyte formation due to repetitive
microtrauma and enthesophyte development because of recurrent capsular or
ligamentous traction. The purpose of this study was to provide a detailed
evaluation of the bony outgrowths that arise on the anterior aspect of the
talus and correlate them with the sites of capsular attachment.</p>
<p><b>MATERIALS AND METHODS.</b> Twenty-eight well-preserved talus bones from
the San Diego Museum of Man were assessed regarding the presence of outgrowths
on the anterior aspect of the talus. The distance of the outgrowths from the
talar head was measured. The results were correlated with measurements of
capsular attachment on the anterior aspect of the talus derived from MR
arthrographic images in 13 cadaveric ankles.</p>
<p><b>RESULTS.</b> The average distance of capsular attachment from the talar
head in the medial aspect of the bone was 10.63 mm and in the lateral part was
12.04 mm. The mean distance of bony spurs from the talar head in the medial
and lateral parts of the talus was 17.2 and 12.5 mm, respectively. Medially,
the talar spurs developed more proximally on the neck compared to the capsular
attachment (<I>p</I> &lt; 0.01). Laterally, this difference was not
significant (<I>p</I> = 0.26).</p>
<p><b>CONCLUSION.</b> On the medial part of the anterior talus, bone
development appears to occur in an intraarticular location (i.e.,
osteophytes). Laterally, the outgrowths develop extraarticularly and appear to
result from capsular and ligamentous traction (i.e., enthesophytes).</p>
]]></description>
<dc:creator><![CDATA[Hayeri, M. R., Trudell, D. J., Resnick, D.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2427</dc:identifier>
<dc:title><![CDATA[Anterior Ankle Impingement and Talar Bony Outgrowths: Osteophyte or Enthesophyte? Paleopathologic and Cadaveric Study With Imaging Correlation]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W338</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W334</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W339?rss=1">
<title><![CDATA[Accuracy of Cross-Table Lateral Knee Radiography for Evaluation of Joint Effusions]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W339?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to investigate the efficacy
of cross-table lateral knee radiography in the diagnosis of knee effusions
compared with an MRI reference standard, to evaluate reader experience in
effusion assessment, and to establish a new threshold for suprapatellar pouch
measurement for the diagnosis of effusion.</p>
<p><b>MATERIALS AND METHODS.</b> First- and third-year radiology residents and
an attending musculoskeletal radiologist retrospectively assessed 108
cross-table lateral knee radiographs for qualitative grading of joint fluid
and quantitative measurement of the suprapatellar pouch. Qualitative and
quantitative evaluation of ipsilateral knee MRI examinations performed within
1 week of radiography was performed by two attending musculoskeletal
radiologists as a reference standard.</p>
<p><b>RESULTS.</b> Qualitative visual grading of cross-table lateral
radiographs had a sensitivity of 90&ndash;92%, specificity of 39&ndash;54%,
and accuracy of 69&ndash;76% for joint effusion. Extrapolating from previous
work showing 4 mL of fluid distends the suprapatellar pouch to 4 mm on midline
sagittal MRI, the corresponding measurement on cross-table lateral radiographs
was predicted to be 7 mm. Using this new criterion of effusion, sensitivity,
specificity, and accuracy compared with an MR midline sagittal reference
standard were 76%, 83%, and 81%, respectively. Historical data for overhead
lateral radiographs had a sensitivity of 78%, specificity of 80%, and accuracy
of 79%.</p>
<p><b>CONCLUSION.</b> Qualitative visual assessment of cross-table lateral
knee radiographs is highly sensitive for the detection of joint effusion. By
performing quantitative evaluation with a new 7-mm criterion for suprapatellar
pouch measurement, sensitivity, specificity, and accuracy are equivalent to
that of overhead lateral radiography.</p>
]]></description>
<dc:creator><![CDATA[Tai, A. W., Alparslan, H. L., Townsend, B. A., Oei, T. N., Govindarajulu, U. S., Aliabadi, P., Weissman, B. N.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2562</dc:identifier>
<dc:title><![CDATA[Accuracy of Cross-Table Lateral Knee Radiography for Evaluation of Joint Effusions]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W344</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W339</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/W345?rss=1">
<title><![CDATA[Lymphocytic Thyroiditis on Fine-Needle Aspiration Biopsy of Focal Thyroid Nodules: Approach to Management]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/W345?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to determine the optimal
management strategy for thyroid nodules diagnosed as lymphocytic thyroiditis
on sonography-guided fine-needle aspiration biopsy (FNAB) of focal thyroid
nodules.</p>
<p><b>MATERIALS AND METHODS.</b> One hundred eleven patients were included in
this study: among 45 patients with follow-up sonography-guided FNAB, 21
underwent follow-up sonography more than 12 months after the initial
sonography and 24 were followed up with sonography and sonography-guided FNAB
within 12 months. Among 45 patients with follow-up sonography-guided FNAB,
seven underwent thyroid surgery. Follow-up sonography results and
cytopathologic results were used as reference standards.</p>
<p><b>RESULTS.</b> There were no malignancies among 71 probably benign lesions
on initial sonography. In contrast, of the 40 lesions that were suspicious
malignant on sonography, eight proved to be papillary thyroid carcinoma on
follow-up sonography-guided FNAB and histopathology.</p>
<p><b>CONCLUSION.</b> Lymphocytic thyroiditis can show variable features on
sonography. When a nodule shows probably benign features on sonography,
follow-up with sonography is sufficient. However, if a nodule shows suspicious
malignant features on sonography and shows no change or increase in size on
follow-up examination, follow-up sonography-guided FNAB should be
performed.</p>
]]></description>
<dc:creator><![CDATA[Moon, H. J., Kim, E.-K., Kim, M. J., Kwak, J. Y.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2413</dc:identifier>
<dc:title><![CDATA[Lymphocytic Thyroiditis on Fine-Needle Aspiration Biopsy of Focal Thyroid Nodules: Approach to Management]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W349</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W345</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W350?rss=1">
<title><![CDATA[Teaching Atlas of Abdominal Imaging]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W350?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Wilhelm, A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2690</dc:identifier>
<dc:title><![CDATA[Teaching Atlas of Abdominal Imaging]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W350</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W350</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W351?rss=1">
<title><![CDATA[Radiology Business Practice: How to Succeed]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W351?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Davila, J. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2714</dc:identifier>
<dc:title><![CDATA[Radiology Business Practice: How to Succeed]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W351</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W351</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W352?rss=1">
<title><![CDATA[MRI Normal Variants and Pitfalls]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W352?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Russell, J. M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2742</dc:identifier>
<dc:title><![CDATA[MRI Normal Variants and Pitfalls]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W352</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W352</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W354?rss=1">
<title><![CDATA[Free Gadolinium Is a Likely Trigger of Nephrogenic Systemic Fibrosis]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W354?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Abraham, J. L., Edward, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2194</dc:identifier>
<dc:title><![CDATA[Free Gadolinium Is a Likely Trigger of Nephrogenic Systemic Fibrosis]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W354</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W354</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W355?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W355?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kuo, P. H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2561</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W355</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W355</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W356?rss=1">
<title><![CDATA[Achilles Wiitis: Making the Case for Proprioceptive Training in Tendinopathy]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W356?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Knobloch, K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2696</dc:identifier>
<dc:title><![CDATA[Achilles Wiitis: Making the Case for Proprioceptive Training in Tendinopathy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W356</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W356</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W357?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W357?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Beddy, P., Dunne, R., de Blacam, C.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3014</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W357</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W357</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W358?rss=1">
<title><![CDATA[Accurate Nomenclature of the Veins of the Lower Extremities]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W358?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Canyigit, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2710</dc:identifier>
<dc:title><![CDATA[Accurate Nomenclature of the Veins of the Lower Extremities]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W358</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W358</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W359?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W359?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Lee, W., Chung, J. W.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3052</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W360</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W359</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W361?rss=1">
<title><![CDATA[Pharmacokinetics of 99mTc-MAG3]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W361?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Vivier, P.-H., Dacher, J.-N.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2755</dc:identifier>
<dc:title><![CDATA[Pharmacokinetics of 99mTc-MAG3]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W361</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W361</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/W362?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/W362?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Summerlin, A. L., Lockhart, M. E., Smith, J. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3000</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W362</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>W362</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/915?rss=1">
<title><![CDATA[Authorship: Did I Really Contribute?]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/915?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berquist, T. H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3533</dc:identifier>
<dc:title><![CDATA[Authorship: Did I Really Contribute?]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>916</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>915</prism:startingPage>
<prism:section>From the Editor's Notebook</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/920?rss=1">
<title><![CDATA[Interventional Radiology: An Ever-Changing Landscape]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/920?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mauro, M. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3532</dc:identifier>
<dc:title><![CDATA[Interventional Radiology: An Ever-Changing Landscape]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>921</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>920</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/922?rss=1">
<title><![CDATA[Deep Venous Thrombosis: The Opportunity at Hand]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/922?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The use of imaging-guided treatments for deep venous
thrombosis (DVT) is accelerating. Increased appreciation of the impact of
postthrombotic syndrome on DVT patients' quality of life and advances in
thrombolytic methods have together sparked an unprecedented degree of
interdisciplinary collaboration in developing contemporary DVT treatment
guidelines and a pivotal clinical trial to establish the risk&ndash;benefit
ratio of interventional DVT therapy.</p>
<p><b>CONCLUSION.</b> Radiologists should improve their DVT education, support
ongoing clinical trials, and collaborate with DVT-focused nonradiologists in
their institutions.</p>
]]></description>
<dc:creator><![CDATA[Vedantham, S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.3214</dc:identifier>
<dc:title><![CDATA[Deep Venous Thrombosis: The Opportunity at Hand]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>927</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>922</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/928?rss=1">
<title><![CDATA[CT and MRI in Diseases of the Aorta]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/928?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This review focuses on the role of CT and MRI in the
diagnosis, follow-up, and surgical planning of aortic aneurysms and acute
aortic syndromes, including aortic dissection, intramural hematoma, and
penetrating aortic ulcer. It also provides a systematic approach to the
definition, causes, natural history, and imaging principles of these
diseases.</p>
<p><b>CONCLUSION.</b> An understanding of the pathophysiology, natural
history, and imaging features is the key to successful diagnosis and
appropriate management of patients with these aortic diseases.</p>
]]></description>
<dc:creator><![CDATA[Litmanovich, D., Bankier, A. A., Cantin, L., Raptopoulos, V., Boiselle, P. M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2166</dc:identifier>
<dc:title><![CDATA[CT and MRI in Diseases of the Aorta]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>940</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>928</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/941?rss=1">
<title><![CDATA[Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/941?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to retrospectively
determine the effectiveness of hepatic transarterial chemotherapy using two
therapeutic protocols&mdash;mitomycin C alone and combined mitomycin C and
gemcitabine&mdash;on local tumor control and survival rate in patients with
liver metastases from neuroendocrine tumors.</p>
<p><b>MATERIALS AND METHODS.</b> This article describes a retrospective study
of 48 patients (age range, 37&ndash;77 years; mean age, 61.1 years; SD, 10.3)
with liver metastases from neuroendocrine tumors who underwent repetitive
selective hepatic artery chemotherapy using mitomycin C alone (group 1,
<I>n</I> = 18 patients who underwent 182 therapeutic sessions; mean, 10.11
sessions per patient) and combined mitomycin C and gemcitabine chemotherapy
agents (group 2, <I>n</I> = 30 patients who underwent 312 therapeutic
sessions; mean, 10.4 sessions per patient) with 4-week intervals between
treatment sessions.</p>
<p><b>RESULTS.</b> Both treatment protocols were well tolerated by all
patients. Only minor side effects occurred in both groups, and no major
complications developed. Local tumor control evaluation according to the
Response Evaluation Criteria in Solid Tumors (RECIST) revealed the following
for group 1: partial response, 11.1%; stable disease, 50%; and progressive
disease, 38.9%. RECIST criteria for group 2 indicated partial response in
23.33%, stable disease in 53.34%, and progressive disease in 23.33%. The
survival rate from the initial diagnosis to the fifth year for group 1 was
11.11% and for group 2, 46.67%. The median survival time from the initial
diagnosis of group 1 was 38.67 months, whereas in group 2 it was 57.1
months.</p>
<p><b>CONCLUSION.</b> Transarterial hepatic chemotherapy using mitomycin C and
gemcitabine can be an effective therapeutic protocol for controlling local
metastases and improving survival time in patients with hepatic metastases
from neuroendocrine tumors.</p>
]]></description>
<dc:creator><![CDATA[Vogl, T. J., Gruber, T., Naguib, N. N. N., Hammerstingl, R., Nour-Eldin, N.-E. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1879</dc:identifier>
<dc:title><![CDATA[Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>947</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>941</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/948?rss=1">
<title><![CDATA[Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/948?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to examine the results of
percutaneous radiofrequency ablation of both medium-sized hepatocellular
carcinoma (HCC) and the accompanying main portal venous tumor thrombus in
patients with cirrhosis.</p>
<p><b>SUBJECTS AND METHODS.</b> From January 2005 to January 2008, among 1,837
consecutively registered patients with HCC seen at our institution, 412 had
HCC and portal venous invasion; 27 of the 412 had a single HCC nodule
accompanied by main portal venous tumor thrombus. Thirteen patients (10 men,
three women; mean age, 70 years; range, 66&ndash;74 years) with 13 HCC nodules
3.7&ndash;5 cm in diameter extending into the main portal trunk underwent
percutaneous radiofrequency ablation. Fourteen matched patients (10 men, four
women; mean age, 69 years; range, 67&ndash;73 years) with 14 HCC nodules
3.6&ndash;4.8 cm in diameter extending into the main portal trunk refused
radiofrequency ablation and composed the control group. Diagnosis of main
portal venous tumor thrombus was made with fine-needle biopsy in all cases.
Radiofrequency ablation was performed first on the main portal venous tumor
thrombus and then on the HCC nodule. Efficacy of radiofrequency was defined as
complete necrosis of HCC and complete recanalization of the main portal trunk
and its branches. HCC necrosis was evaluated with enhanced CT. Recanalization
of portal vessels was analyzed with color Doppler and contrast-enhanced
ultrasound. Radiofrequency ablation was performed under ultrasound guidance
with a perfused needle electrode.</p>
<p><b>RESULTS.</b> Complete necrosis of the HCC associated with complete
recanalization of the main portal vein and its branches was achieved in 10
patients (efficacy, 77%). In the other three patients, necrosis of the HCC
ranged from 70% to 90%, and recanalization of the main portal trunk was not
complete. No major complications occurred. In three cases, mild to moderate
ascites and increased aspartate aminotransferase and alanine aminotransferase
levels were found. The follow-up periods ranged from 3 to 36 months among the
treated patients and 2 to 10 months among the untreated patients. The
cumulative survival rate was 77% 6, 12, and 36 months after procedure in the
treated group and 43% and 0% 6 and 12 months after diagnosis in the untreated
group (<I>p</I> &lt; 0.0001). All 10 successfully treated patients were
alive and the portal system was patent at the end of the follow-up period. All
three untreated patients died of progressive disease within 5 months of
diagnosis.</p>
<p><b>CONCLUSION.</b> Radiofrequency ablation can destroy both single
intraparenchymal medium-sized HCCs and the accompanying main portal venous
tumor thrombus with high efficacy and safety and a low rate of
complications.</p>
]]></description>
<dc:creator><![CDATA[Giorgio, A., Di Sarno, A., de Stefano, G., Farella, N., Scognamiglio, U., de Stefano, M., Giorgio, V.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2087</dc:identifier>
<dc:title><![CDATA[Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>954</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>948</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/955?rss=1">
<title><![CDATA[Prospective and Retrospective ECG Gating for Thoracic CT Angiography: A Comparative Study]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/955?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to compare radiation dose,
contrast load, thoracic aortic attenuation value, and image quality parameters
of MDCT thoracic aortography performed with prospective and retrospective
cardiac gating.</p>
<p><b>MATERIALS AND METHODS.</b> Studies were performed on 80 patients
(prospective ECG gating, <I>n</I> = 40; retrospective ECG gating, <I>n</I>
= 40) either being evaluated for thoracic aortic aneurysm (<I>n</I> = 23) or
aortic dissection (<I>n</I> = 36) or undergoing postsurgical or
postintervention follow-up (<I>n</I> = 21). Image acquisition parameters and
radiation dose (CT dose index volume [CTDI<SUB>vol</SUB>] and
dose&ndash;length product [DLP]) were obtained from image archival data.
Contrast load and aortic attenuation values were obtained from a data
registry. The comparative degrees of motion artifact and banding artifact were
assessed on parasagittal maximum-intensity-projection (MIP) images and
reformatted images in the plane of the aortic valve.</p>
<p><b>RESULTS.</b> CTDI<SUB>vol</SUB> and DLP in the prospective ECG-gating
group was 28.8 &plusmn; 2.12 mGy (mean &plusmn; SD) and 833.7 &plusmn; 115.77
mGy/cm, respectively, which are significantly lower (<I>p</I> &lt; 0.001)
than those values in the retrospective ECG-gating group (74.7 &plusmn; 13.42
mGy and 2,547.3 &plusmn; 553.27 mGy/cm). The average contrast load in the
prospective gating group was 109.1 &plusmn; 14.74 mL and in the retrospective
gating group, 101.3 &plusmn; 10.45 mL (<I>p</I> &lt; 0.05). The average
aortic attenuation values (in Hounsfield units) for the prospective and
retrospective ECG-gated groups were 447.6 and 350.2 HU, respectively, for the
mid ascending aorta, 413.6 and 325.7 HU for the mid aortic arch, 418.2 and
327.6 HU for the mid descending aorta, and 355.0 and 306.2 HU for the
supraceliac aorta. Subjective scores of motion artifact and banding artifact
were equivalent between the two groups.</p>
<p><b>CONCLUSION.</b> Compared with retrospective ECG-gated thoracic CT
angiography, prospective ECG-gated thoracic CT angiography was associated with
a lower radiation dose, slightly increased contrast load, increased aortic
attenuation values, and equivalent image quality.</p>
]]></description>
<dc:creator><![CDATA[Wu, W., Budovec, J., Foley, W. D.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2158</dc:identifier>
<dc:title><![CDATA[Prospective and Retrospective ECG Gating for Thoracic CT Angiography: A Comparative Study]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>963</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>955</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/964?rss=1">
<title><![CDATA[Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/964?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Management of hepatocellular carcinoma is a major problem
in the care of patients undergoing regular hemodialysis treatments, mainly
because of a high prevalence of hepatitis C virus infection. The purpose of
this study was retrospective assessment of the safety and efficacy of
percutaneous radiofrequency ablation of hepatocellular carcinoma in the care
of patients with end-stage renal disease undergoing regular hemodialysis
treatments.</p>
<p><b>MATERIALS AND METHODS.</b> Between October 2004 and June 2008, 14
carefully selected hemodialysis patients with hepatocellular carcinoma (five
na&iuml;ve, nine recurrent) underwent a total of 19 radiofrequency ablation
treatments. An internally cooled or expandable electrode was used. After tumor
ablation, the insertion site at the liver surface was subjected to additional
ablation to reduce the bleeding risk.</p>
<p><b>RESULTS.</b> The Child-Pugh score was 6 or better in all patients but
one. The number of tumors was one or two, and the tumor diameter was 35 mm or
less in all treatments. No complication such as intraperitoneal hemorrhage was
found in any treatment. Local tumor progression was found after one treatment
and was successfully managed with subsequent radiofrequency ablation. During
the mean observation period of 343 days, there was only one death, of heart
failure, among the five patients with na&iuml;ve tumors.</p>
<p><b>CONCLUSION.</b> The safety and effectiveness of radiofrequency ablation
were not compromised in this series of selected patients with hepatocellular
carcinoma who were undergoing hemodialysis. Radiofrequency ablation is a
promising option for small hepatocellular carcinomas in patients undergoing
regular hemodialysis treatments.</p>
]]></description>
<dc:creator><![CDATA[Kondo, Y., Yoshida, H., Tomizawa, Y., Tateishi, R., Shiina, S., Tagawa, K., Omata, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2236</dc:identifier>
<dc:title><![CDATA[Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>969</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>964</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/970?rss=1">
<title><![CDATA[Modifying Peripheral IV Catheters With Side Holes and Side Slits Results in Favorable Changes in Fluid Dynamic Properties During the Injection of Iodinated Contrast Material]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/970?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare a standard
peripheral end-hole angiocatheter with those modified with side holes or side
slits using experimental optical techniques to qualitatively compare the
contrast material exit jets and using numeric techniques to provide flow
visualization and quantitative comparisons.</p>
<p><b>MATERIALS AND METHODS.</b> A Schlieren imaging system was used to
visualize the angiocatheter exit jet fluid dynamics at two different flow
rates. Catheters were modified by drilling through-and-through side holes or
by cutting slits into the catheters. A commercial computational fluid dynamics
package was used to calculate numeric results for various vessel diameters and
catheter orientations.</p>
<p><b>RESULTS.</b> Experimental images showed that modifying standard
peripheral IV angiocatheters with side holes or side slits qualitatively
changed the overall flow field and caused the exiting jet to become less well
defined. Numeric calculations showed that the addition of side holes or slits
resulted in a 9&ndash;30% reduction of the velocity of contrast material
exiting the end hole of the angiocatheter. With the catheter tip directed
obliquely to the wall, the maximum wall shear stress was always highest for
the unmodified catheter and was always lowest for the four-side-slit
catheter.</p>
<p><b>CONCLUSION.</b> Modified angiocatheters may have the potential to reduce
extravasation events in patients by reducing vessel wall shear stress.</p>
]]></description>
<dc:creator><![CDATA[Weber, P. W., Coursey, C. A., Howle, L. E., Nelson, R. C., Nichols, E. B., Schindera, S. T.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2521</dc:identifier>
<dc:title><![CDATA[Modifying Peripheral IV Catheters With Side Holes and Side Slits Results in Favorable Changes in Fluid Dynamic Properties During the Injection of Iodinated Contrast Material]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>977</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>970</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/978?rss=1">
<title><![CDATA[Digital Subtraction Angiography-Guided Percutaneous Transcatheter Foam Sclerotherapy of Varicocele: A Novel Tracking Technique]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/978?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to describe a new tracking
technique for using sclerosing foam with radiologic guidance. Thirty-nine men
with varicocele underwent transcatheter foam sclerotherapy. Sclerosing foam
was produced by the Tessari technique using 5% sodium morrhuate solution, and
foam sclerotherapy was performed by the new tracking technique, the
filling-defects technique, under digital subtraction angiography (DSA)
guidance using a step-by-step process consisting of spermatic phlebography,
injection of sclerosing foam as a negative radiographic contrast material, and
rinse of the catheter.</p>
<p><b>CONCLUSION.</b> The DSA-guided filling-defects technique is a feasible
method for tracking the sclerosing foam and should be used in the treatment of
other venous disorders when using sclerosing foam with radiologic
guidance.</p>
]]></description>
<dc:creator><![CDATA[Li, L., Zeng, X.-Q., Li, Y.-H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2394</dc:identifier>
<dc:title><![CDATA[Digital Subtraction Angiography-Guided Percutaneous Transcatheter Foam Sclerotherapy of Varicocele: A Novel Tracking Technique]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>980</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>978</prism:startingPage>
<prism:section>Vascular and Interventional Radiology</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/986?rss=1">
<title><![CDATA[Is Breast MRI Helpful in the Evaluation of Inconclusive Mammographic Findings?]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/986?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the usefulness
of MRI of the breast in cases in which mammographic or sonographic findings
are inconclusive.</p>
<p><b>MATERIALS AND METHODS.</b> We retrospectively reviewed images from 115
MRI examinations of the breast performed from 1999 to 2005 for the indication
of problem-solving for inconclusive findings on a mammogram. Forty-eight of
the 115 women (41.8%) were at high risk. We discerned whether sonography or
MRI was used as an adjunctive tool and correlated the findings with those in
the pathology database.</p>
<p><b>RESULTS.</b> The equivocal findings most frequently leading to MRI were
asymmetry and architectural distortion. No suspicious MRI correlate was found
in 100 of 115 cases (87%). These cases were found stable at follow-up
mammography or MRI after a mean of 34 months. Fifteen enhancing masses (13%)
that corresponded to the mammographic abnormality were seen on MR images. All
masses identified at MRI were accurately localized for biopsy, and six
malignant lesions were identified. Four of six malignant tumors were seen in
one mammographic view only; two were seen on second-look ultrasound images.
MRI had a sensitivity of 100% and compared with mammography had significantly
higher specificity (91.7% vs 80.7%, <I>p</I> = 0.029), positive predictive
value (40% vs 8.7%, <I>p</I> = 0.032), and overall accuracy (92.2% vs 78.3%,
<I>p</I> = 0.0052). Eighteen incidental lesions (15.7%) were detected at
MRI, and all were subsequently found benign.</p>
<p><b>CONCLUSION.</b> We found breast MRI to be a useful adjunctive tool when
findings at conventional imaging were equivocal. Strict patient selection
criteria should be used because of the high frequency of incidental lesions
seen on MR images.</p>
]]></description>
<dc:creator><![CDATA[Moy, L., Elias, K., Patel, V., Lee, J., Babb, J. S., Toth, H. K., Mercado, C. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1229</dc:identifier>
<dc:title><![CDATA[Is Breast MRI Helpful in the Evaluation of Inconclusive Mammographic Findings?]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>993</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>986</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/994?rss=1">
<title><![CDATA[BI-RADS Lesion Characteristics Predict Likelihood of Malignancy in Breast MRI for Masses But Not for Nonmasslike Enhancement]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/994?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to evaluate the predictive
features of BI-RADS lesion characteristics and the risk of malignancy for
mammographically and clinically occult lesions detected initially on breast
MRI.</p>
<p><b>MATERIALS AND METHODS.</b> We reviewed 1,523 consecutive breast MRI
examinations performed from January 1, 2003, to June 30, 2005, to identify all
lesions initially detected on MRI and assessed as BI-RADS 4 or 5 for which the
patient underwent subsequent imaging-guided needle or excisional biopsy.
BI-RADS lesion features were recorded for each case, and the risk of
malignancy was assessed using generalized estimating equations. Separate
multivariate models were constructed for lesions classified as masses.</p>
<p><b>RESULTS.</b> Included in the analysis were 258 suspicious lesions in 196
women. Among all lesions, those of 1 cm or greater were significantly more
often malignant (50/147, 34%) than lesions of less than 1 cm (22/111, 20%;
odds ratio, 2.09; 95% CI, 1.13&ndash;3.83). For masses, size, BI-RADS margin,
and enhancement pattern predicted malignancy. In multivariate analysis of
combinations of features, masses of 1 cm or greater with heterogeneous
enhancement and irregular margins had a 68% probability of malignancy. Masses
of 1 cm or greater with smooth margins and homogeneous enhancement had the
lowest predicted probability of malignancy of 3%. BI-RADS descriptors and size
were not significant predictors of malignancy for nonmasslike enhancement
(NMLE).</p>
<p><b>CONCLUSION.</b> Combinations of BI-RADS lesion descriptors can predict
the probability of malignancy for breast MRI masses but not for NMLE. If our
model is validated, masses with a low probability of malignancy may be
eligible for short-interval follow-up rather than biopsy. Further research
focused on predictive features of NMLE is needed.</p>
]]></description>
<dc:creator><![CDATA[Gutierrez, R. L., DeMartini, W. B., Eby, P. R., Kurland, B. F., Peacock, S., Lehman, C. D.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1983</dc:identifier>
<dc:title><![CDATA[BI-RADS Lesion Characteristics Predict Likelihood of Malignancy in Breast MRI for Masses But Not for Nonmasslike Enhancement]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1000</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>994</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1001?rss=1">
<title><![CDATA[Radioguided Localization of Nonpalpable Breast Cancer Lesions: Randomized Comparison With Wire Localization in Patients Undergoing Conservative Surgery and Sentinel Node Biopsy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1001?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The aim of this investigation was to determine whether
radioguided occult lesion localization and routine wire localization differ in
respect to the effectiveness of complete excision of nonpalpable breast cancer
lesions.</p>
<p><b>SUBJECTS AND METHODS.</b> This prospective randomized study included
patients with breast cancer scheduled for conservative tumor excision and
sentinel node biopsy. Patients were randomized to either radioguided
localization or wire localization. Comparative radiologic, surgical, and
pathologic data were collected and analyzed to establish the duration, ease of
use, and accuracy of the two techniques for occult lesion localization. The
effectiveness of sentinel node biopsy also was assessed. One radiologist and
two surgeons participated in the study.</p>
<p><b>RESULTS.</b> Among 134 patients, 68 were treated with wire localization
and 66 with radioguided localization. The mean duration of radiologic
localization was significantly shorter for radioguided localization
(<I>p</I> &lt; 0.001). No statistical differences were found for the other
parameters studied. Radiography of the surgical specimen showed 100% lesion
excision with both techniques. Complete tumor excision with tumor-free margins
was achieved in 89.4% of patients who underwent radioguided localization group
and 82.4% of patients who underwent wire localization. Pathologic examination
showed the excised tissue volume was slightly larger (<I>p</I> = 0.371) and
lesion concentricity slightly less (<I>p</I> = 0.730) with radioguided
localization. The sentinel node detection rate was 91% with radioguided
localization and 84% with wire localization.</p>
<p><b>CONCLUSION.</b> The radioguided technique is as effective as the
standard wire technique for localization and excision of nonpalpable breast
cancer lesions and is somewhat faster and simpler to perform than wire
localization.</p>
]]></description>
<dc:creator><![CDATA[Mariscal Martinez, A., Sola, M., de Tudela, A. P., Julian, J. F., Fraile, M., Vizcaya, S., Fernandez, J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2005</dc:identifier>
<dc:title><![CDATA[Radioguided Localization of Nonpalpable Breast Cancer Lesions: Randomized Comparison With Wire Localization in Patients Undergoing Conservative Surgery and Sentinel Node Biopsy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1009</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1001</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1010?rss=1">
<title><![CDATA[Comparison of Digital Mammography and Screen-Film Mammography in Breast Cancer Screening: A Review in the Irish Breast Screening Program]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1010?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Clinical trials to date into the use of full-field
digital mammography (FFDM) for breast cancer screening have shown variable
results. The aim of this study was to review the use of FFDM in a
population-based breast cancer screening program and to compare the results
with screen-film mammography.</p>
<p><b>MATERIALS AND METHODS.</b> The study included 188,823 screening
examinations of women between 50 and 64 years old; 35,204 (18.6%) mammograms
were obtained using FFDM. All films were double read using a 5-point rating
scale to indicate the probability of cancer. Patients with positive scores
were recalled for further workup. The recall rate, cancer detection rate, and
positive predictive value (PPV) of FFDM were compared with screen-film
mammography.</p>
<p><b>RESULTS.</b> The cancer detection rate was significantly higher for FFDM
than screen-film mammography (6.3 vs 5.2 per 1,000, respectively; <I>p</I> =
0.01). The cancer detection rate for FFDM was higher than screen-film
mammography for initial screening and subsequent screening, for invasive
cancer and ductal carcinoma in situ, and across all age groups. The cancer
detection rate for cancers presenting as microcalcifications was significantly
higher for FFDM than for screen-film mammography (1.9 vs 1.3 per 1,000,
<I>p</I> = 0.01). The recall rate was significantly higher for FFDM than
screen-film mammography (4.0% vs 3.1%, <I>p</I> &lt; 0.001). There was no
significant difference in the PPVs of recall to assessment for FFDM and
screen-film mammography (15.7% and 16.7%, <I>p</I> = 0.383).</p>
<p><b>CONCLUSION.</b> FFDM resulted in significantly higher cancer detection
and recall rates than screen-film mammography in women 50&ndash;64 years old.
The PPVs of FFDM and screen-film mammography were comparable. The results of
this study suggest that FFDM can be safely implemented in breast cancer
screening programs.</p>
]]></description>
<dc:creator><![CDATA[Hambly, N. M., McNicholas, M. M., Phelan, N., Hargaden, G. C., O'Doherty, A., Flanagan, F. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2157</dc:identifier>
<dc:title><![CDATA[Comparison of Digital Mammography and Screen-Film Mammography in Breast Cancer Screening: A Review in the Irish Breast Screening Program]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1018</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1010</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1019?rss=1">
<title><![CDATA[Early First Trimester Fetal Dose Estimation Method in a Multivendor Study of 16- and 64-MDCT Scanners and Low-Dose Imaging Protocols]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1019?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to corroborate the relation
between the estimated absorbed fetal dose derived from directly measured
uterine doses early in the first trimester and the volume CT dose index
(CTDI<SUB>vol</SUB>) for 16- and 64-MDCT of the maternal chest, abdomen, and
pelvis.</p>
<p><b>MATERIALS AND METHODS.</b> Estimated absorbed fetal dose was measured
with a metal oxide semiconductor field effect transistor (MOSFET) dosimeter
placed in the expected uterine location in an anthropomorphic phantom of a
woman and scanned with 16- and 64-MDCT units of one vendor and a 64-MDCT unit
of another vendor. A trauma chest, abdomen, and pelvis protocol and an abdomen
and pelvis protocol were used. Absorbed uterine dose was measured directly
from the MOSFET detector. The CTDI<SUB>vol</SUB> for each protocol was
recorded from the scanner console. Correlation between mean uterine dose and
CTDI<SUB>vol</SUB> was tested with a goodness of fit model.</p>
<p><b>RESULTS.</b> The absorbed uterine dose ranged from 9.25 to 37.7 mGy.
Absorbed fetal dose in the early first trimester correlated with
CTDI<SUB>vol</SUB> in a linear regression equation. For the 16-MDCT scanner,
at 130 kVp, the fetal dose was 2.091 <FONT FACE="arial,helvetica">x</FONT> CTDI<SUB>vol</SUB> &ndash; 9.489.
For the 64-MDCT scanner from the same vendor, at 120 kVp, the fetal dose was
1.113 <FONT FACE="arial,helvetica">x</FONT> CTDI<SUB>vol</SUB> + 1.773. For the 64-MDCT scanner from the
other vendor, at 120 kVp, the fetal dose was 1.378 <FONT FACE="arial,helvetica">x</FONT> CTDI<SUB>vol</SUB>
&ndash; 1.014. The goodness of fit results (<I>R</I><sup>2</sup>) for the
equations were 0.97, 0.98, and 0.99.</p>
<p><b>CONCLUSION.</b> Estimated absorbed fetal dose during the first trimester
of pregnancy is linearly associated with CTDI<SUB>vol</SUB> regardless of beam
energy, detector configuration, and scanner manufacturer.</p>
]]></description>
<dc:creator><![CDATA[Jaffe, T. A., Neville, A. M., Anderson-Evans, C., Long, S., Lowry, C., Yoshizumi, T. T., Toncheva, G.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2274</dc:identifier>
<dc:title><![CDATA[Early First Trimester Fetal Dose Estimation Method in a Multivendor Study of 16- and 64-MDCT Scanners and Low-Dose Imaging Protocols]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1024</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1019</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1025?rss=1">
<title><![CDATA[Targeted Ultrasound of the Breast in Women With Abnormal MRI Findings for Whom Biopsy Has Been Recommended]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1025?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> This study was performed to identify characteristics of
suspicious lesions seen on breast MRI that are most likely to have an
ultrasound correlate and to determine how often the presumed ultrasound
correlate actually corresponds to the MRI finding.</p>
<p><b>MATERIALS AND METHODS.</b> From September 2005 through December 2007,
targeted ultrasound was performed for 519 suspicious MRI-detected lesions in
361 women. Retrospective review was performed to determine lesion type (mass
vs nonmass), lesion descriptors, lesion size, BI-RADS category, indication for
MR examination, patient age, and biopsy outcome. The results of 80 follow-up
MRI examinations among 154 cases with concordant benign results on
ultrasound-guided biopsy were noted.</p>
<p><b>RESULTS.</b> A presumed ultrasound correlate was found in 290 (56%) of
the 519 lesions with masses more likely than nonmass lesions to be seen with
ultrasound (62% of masses and 31% of nonmass lesions). Increasing lesion size,
assessment of BI-RADS category 5 versus BI-RADS category 4, rim enhancement in
masses, and clumped enhancement in nonmass lesions were also significantly
more likely to have an ultrasound correlate. On follow-up imaging in 80
benign, concordant ultrasound-guided biopsies, the sonographic lesion did not
correspond to the MRI finding in 10. Nine of these 10 lesions underwent
subsequent MRI-guided biopsy and five cancers were diagnosed.</p>
<p><b>CONCLUSION.</b> The MR characteristics of lesions most likely to be seen
with an ultrasound correlate were mass versus nonmass, increasing size, and
increased level of suspicion of the lesion. Clip placement and follow-up
imaging after ultrasound-guided biopsy that yields benign concordant results
should be performed to detect cases in which the presumed ultrasound correlate
is inaccurate to detect unsuspected false-negative biopsies.</p>
]]></description>
<dc:creator><![CDATA[Meissnitzer, M., Dershaw, D. D., Lee, C. H., Morris, E. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2480</dc:identifier>
<dc:title><![CDATA[Targeted Ultrasound of the Breast in Women With Abnormal MRI Findings for Whom Biopsy Has Been Recommended]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1029</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1025</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1030?rss=1">
<title><![CDATA[Assessment of Breast Lesions With Diffusion-Weighted MRI: Comparing the Use of Different b Values]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1030?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Our purpose was to study the utility of
diffusion-weighted MRI in differentiating benign from malignant breast lesions
by assessing the best b values.</p>
<p><b>SUBJECTS AND METHODS.</b> Forty-five women (mean age, 46.1 years) with
52 focal mass breast lesions underwent diffusion-weighted imaging with
different b values. The apparent diffusion coefficient (ADC) value of each
lesion was calculated from the ADC maps done using five b values (0, 250, 500,
750, and 1,000 s/mm<sup>2</sup>) and using b values of 0 s/mm<sup>2</sup> with
each other b value separately (0 and 250 s/mm<sup>2</sup>, 0 and 500
s/mm<sup>2</sup>, 0 and 750 s/mm<sup>2</sup>, 0 and 1,000 s/mm<sup>2</sup>).
The mean ADC values were correlated with imaging findings and histopathologic
diagnoses. The cutoff ADC value, sensitivity, and specificity of
diffusion-weighted imaging to differentiate benign and malignant lesions were
calculated in all b value combinations. A <I>p</I> value of &lt; 0.05 was
considered statistically significant.</p>
<p><b>RESULTS.</b> The mean ADC value was significantly lower for malignant
lesions compared to benign lesions (<I>p</I> &lt; 0.0001) in all b value
combinations. No statistical difference was seen between the ADC obtained from
different b value combinations (<I>p</I> = 0.2581) in the differentiation
between benign and malignant lesions. The ADC calculated from b 0 and 750
s/mm<sup>2</sup> was slightly better than the other b value combinations,
showing a sensitivity of 92.3% and a specificity of 96.2%.</p>
<p><b>CONCLUSION.</b> Diffusion-weighted imaging is a potential resource as a
coadjutant of MRI in the differentiation between benign and malignant lesions.
Such imaging can be performed without a significant increase in examination
time, especially because it can be done with lower b values.</p>
]]></description>
<dc:creator><![CDATA[Pereira, F. P. A., Martins, G., Figueiredo, E., Domingues, M. N. A., Domingues, R. C., da Fonseca, L. M. B., Gasparetto, E. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2522</dc:identifier>
<dc:title><![CDATA[Assessment of Breast Lesions With Diffusion-Weighted MRI: Comparing the Use of Different b Values]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1035</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1030</prism:startingPage>
<prism:section>Women's Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1037?rss=1">
<title><![CDATA[B-Mode Ultrasound With Algorithm Based on Statistical Analysis of Signals: Evaluation of Liver Fibrosis in Patients With Chronic Hepatitis C]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1037?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to evaluate the degree of
liver fibrosis in patients with chronic hepatitis C by use of a method in
which the homogeneity of the tissue texture of the liver on B-mode ultrasound
images is analyzed on the basis of results of a statistical chi-square test of
the echo amplitudes. The method includes an algorithm for removing small
structures, such as cross sections of the thin vessels, in the background
texture to minimize differences in analysis results between users.</p>
<p><b>SUBJECTS AND METHODS.</b> Analysis was performed on images of 148
patients with histologically proven chronic hepatitis C without cirrhosis. The
peak value of the <f>C<SUB>m</SUB><sup>2</sup></f> (modified chi-square
distribution) histogram was calculated from B-mode ultrasound images, and the
resulting value was compared with the histologic fibrosis grade.</p>
<p><b>RESULTS.</b> The peak <f>C<SUB>m</SUB><sup>2</sup></f> histogram value
for grade F3 fibrosis was higher than that for grades F0 and F1 (<I>p</I>
&lt; 0.0001) and F2 (<I>p</I> = 0.0003). The value for grade F2 was higher
than that for grades F0 and F1 (<I>p</I> = 0.0027). The values gradually
increased with an increase in liver fibrosis grade, although no difference was
found between grades F0 and F1.</p>
<p><b>CONCLUSION.</b> The grades of liver fibrosis in patients with chronic
hepatitis C are well discriminated with the B-mode ultrasound&ndash;based
analysis algorithm without discrimination between grades F0 and F1. Findings
on conventional ultrasound images may reflect progression of liver fibrosis
even in the absence of cirrhosis.</p>
]]></description>
<dc:creator><![CDATA[Toyoda, H., Kumada, T., Kamiyama, N., Shiraki, K., Takase, K., Yamaguchi, T., Hachiya, H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.07.4047</dc:identifier>
<dc:title><![CDATA[B-Mode Ultrasound With Algorithm Based on Statistical Analysis of Signals: Evaluation of Liver Fibrosis in Patients With Chronic Hepatitis C]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1043</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1037</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1044?rss=1">
<title><![CDATA[Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1044?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare, with
histopathologic examination of the liver explant as the reference standard,
diffusion-weighted MRI with contrast-enhanced subtraction MRI in the
assessment of necrosis of hepatocellular carcinoma (HCC) after trans arterial
chemoembolization (TACE).</p>
<p><b>MATERIALS AND METHODS.</b> The cases of 21 patients with HCC who
underwent MRI after TACE were evaluated. Two independent observers calculated
the apparent diffusion coefficient (ADC) of HCC and measured percentage tumor
necrosis on subtraction images. The ADCs of necrotic and viable tumor tissues
were compared. ADC and percentage necrosis on subtraction images were
correlated with percentage necrosis found at pathologic examination. Receiver
operating characteristics analysis was performed on the diagnosis of complete
tumor necrosis.</p>
<p><b>RESULTS.</b> Twenty-eight HCCs (mean diameter, 2.3 cm) were evaluated.
There were significant differences between the ADC of viable tissue and that
of necrotic tumor tissue (1.33 &plusmn; 0.41 vs 2.04 &plusmn; 0.38 <FONT FACE="arial,helvetica">x</FONT>
10<sup>&ndash;3</sup> mm<sup>2</sup>/s, <I>p</I> &lt; 0.0001). There was
significant moderate correlation between ADC and the pathologic finding of
percentage necrosis (<I>r</I> = 0.64, <I>p</I> &lt; 0.001) and significant
strong correlation between subtraction image and pathologic percentage
necrosis (<I>r</I> = 0.89&ndash;0.91, depending on the phase; <I>p</I>
&lt; 0.001). In the diagnosis of complete tumor necrosis, ADC had an area
under the curve, sensitivity, and specificity of 0.85, 75%, and 87.5% compared
with 0.82&ndash;0.89, 100%, and 58.3&ndash;79.1% for subtraction imaging
(<I>p</I> &gt; 0.5 between ADC and subtraction imaging).</p>
<p><b>CONCLUSION.</b> Compared with diffusion-weighted imaging,
contrast-enhanced MRI with subtraction technique had more significant
correlation with the histopathologic findings in the evaluation of necrosis of
HCC after TACE. There was no difference, however, between the two methods in
diagnosis of complete tumor necrosis.</p>
]]></description>
<dc:creator><![CDATA[Mannelli, L., Kim, S., Hajdu, C. H., Babb, J. S., Clark, T. W. I., Taouli, B.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1461</dc:identifier>
<dc:title><![CDATA[Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1052</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1044</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1053?rss=1">
<title><![CDATA[Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1053?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to prospectively evaluate
quantitatively and qualitatively the enhancement patterns of cirrhotic liver
tissue and hepatocellular carcinoma (HCC) after administration of the
hepatocyte-specific contrast agent gadolinium ethoxybenzyl diethylenetriamine
pentaacetic acid (Gd-EOB-DTPA) on dynamic MRI and to determine the time point
of maximum liver-to-lesion contrast.</p>
<p><b>SUBJECTS AND METHODS.</b> Twenty-five patients with HCC in liver
cirrhosis underwent 1.5-T MRI. T2-weighted turbo spin-echo and T1-weighted 3D
gradient-echo sequences before and between 15 seconds and 20 minutes after the
injection of 10 mL of Gd-EOB-DTPA were performed. Signal-to-noise ratios
(SNRs) of liver parenchyma and liver-to-lesion contrast-to-noise ratios (CNRs)
were calculated and plotted over time. Enhancement patterns of HCC were
characterized qualitatively by two radiologists.</p>
<p><b>RESULTS.</b> The SNR of liver parenchyma increased significantly at 15
seconds and 60 seconds after contrast injection and remained stable
thereafter. HCC showed positive CNR during the arterial phase and increasingly
negative CNR during the further time course (<I>p</I> &lt; 0.05). The
maximum absolute CNR was found at 20 minutes after contrast injection. There
was no correlation between the degree of enhancement at any time point and
tumor grade. On qualitative evaluation, 16 HCCs showed arterial enhancement
with early washout, and five showed arterial enhancement with late washout. In
the remaining four HCCs, enhancement persisted until 20 minutes. Lesion
conspicuity at 20 minutes after contrast injection was at least equal to or
higher than it was on the remaining sequences in 19 of the 25 patients.</p>
<p><b>CONCLUSION.</b> After Gd-EOB-DTPA injection, most HCCs showed typical
arterial enhancement with early washout. Liver-to-lesion contrast was best at
20 minutes.</p>
]]></description>
<dc:creator><![CDATA[Frericks, B. B., Loddenkemper, C., Huppertz, A., Valdeig, S., Stroux, A., Seja, M., Wolf, K.-J., Albrecht, T.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1946</dc:identifier>
<dc:title><![CDATA[Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1060</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1053</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1061?rss=1">
<title><![CDATA[Differential CT Features of Intraductal Biliary Metastasis and Double Primary Intraductal Polypoid Cholangiocarcinoma in Patients With a History of Extrabiliary Malignancy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1061?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to discern clinical and
imaging features for differentiating intraductal metastasis from double
primary intraductal cholangiocarcinoma in patients with a history of
extrabiliary malignant disease.</p>
<p><b>MATERIALS AND METHODS.</b> Over a 10-year period, the cases of 14
patients with histopathologically proven intraductal metastasis (<I>n</I> =
8) or double primary intraductal cholangiocarcinoma (<I>n</I> = 6) who had a
history of extrabiliary malignancy were identified. Two radiologists
retrospectively reviewed CT (<I>n</I> = 14) and MR (<I>n</I> = 6) images
for the size and appearance of the intraductal lesion, presence of a
parenchymal mass, multiplicity, attenuation on arterial and portal phase
images, and presence of calcification. Clinical findings such as the location
of extrabiliary malignancy and presence of <I>Clonorchis sinensis</I>
infestation also were recorded. Univariate tests were used to differentiate
the two disease entities.</p>
<p><b>RESULTS.</b> Histopathologic confirmation was obtained by surgical
resection (<I>n</I> = 12) or ultrasound-guided biopsy (<I>n</I> = 2). All
intraductal metastatic lesions were of colorectal cancer, and all intraductal
cholangiocarcinomas were associated with extracolonic malignant disease,
including three cases of gastric cancer (<I>p</I> &lt; 0.0001). All
cholangiocarcinomas manifested themselves as purely intraductal masses, but
five of the eight intraductal metastatic lesions were contiguous with
parenchymal masses (<I>p</I> = 0.031). The appearance of the intraductal
lesion was predominantly expansile in cases of metastasis (seven of eight
cases) but not in cases of cholangiocarcinoma (one of six cases) (<I>p</I> =
0.026). Other findings were not statistically significant in differentiating
the two disease entities.</p>
<p><b>CONCLUSION.</b> When an intraductal lesion is found in a patient with
extrabiliary malignancy, the presence of a contiguous parenchymal mass, an
expansile nature of the intraductal lesion, and a history of colorectal cancer
may suggest the presence of intraductal metastasis rather than double primary
intraductal cholangiocarcinoma.</p>
]]></description>
<dc:creator><![CDATA[Lee, Y. J., Kim, S. H., Lee, J. Y., Kim, M. A, Lee, J. M., Han, J. K., Choi, B. I.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2089</dc:identifier>
<dc:title><![CDATA[Differential CT Features of Intraductal Biliary Metastasis and Double Primary Intraductal Polypoid Cholangiocarcinoma in Patients With a History of Extrabiliary Malignancy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1069</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1061</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1070?rss=1">
<title><![CDATA[Pitfalls in Abdominal Diffusion-Weighted Imaging: How Predictive is Restricted Water Diffusion for Malignancy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1070?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> As diffusion-weighted imaging is increasingly implemented
into routine protocols of abdominal MRI, abnormal findings in expected and
unexpected locations become more common. The aim of our retrospective study
was to investigate the specificity of restricted diffusion in differentiation
of benign from malignant abdominal disease.</p>
<p><b>MATERIALS AND METHODS.</b> Two hundred thirty consecutively registered
patients underwent abdominal MRI including diffusion-weighted imaging
(single-shot spin-echo echo-planar sequence) with b values of 0, 150, 500, and
1,000 s/mm<sup>2</sup>. Lesions were detected by two blinded readers using
only the images with a b value of 1,000 s/mm<sup>2</sup>, and representative
apparent diffusion coefficients were measured. Lymph nodes were not
documented.</p>
<p><b>RESULTS.</b> Fifty-two of the 230 patients had a total of 55 lesions
with restricted diffusion (23.9%). The mean apparent diffusion coefficient was
809 mm<sup>2</sup>/s. Forty-three lesions (78.2%) were malignant. The 12
benign lesions were liver hemangioma, liver adenoma, autoimmune pancreatitis,
pancreatic teratoma, two abscesses, three cases of inflammatory bowel wall
thickening due to Crohn's disease, Bartholin cyst, hemorrhagic ovarian cyst,
and renal Rosai-Dorfman disease.</p>
<p><b>CONCLUSION.</b> Restricted diffusion is generally considered to be
associated with malignant tumors because of the high cellularity of these
tumors. However, in interpretation of diffusion-weighted images, it should be
kept in mind that a number of benign lesions, as many as 22% in our cohort,
can exhibit restricted diffusion on images with high b values, thus mimicking
malignant lesions.</p>
]]></description>
<dc:creator><![CDATA[Feuerlein, S., Pauls, S., Juchems, M. S., Stuber, T., Hoffmann, M. H. K., Brambs, H.-J., Ernst, A. S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2093</dc:identifier>
<dc:title><![CDATA[Pitfalls in Abdominal Diffusion-Weighted Imaging: How Predictive is Restricted Water Diffusion for Malignancy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1076</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1070</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1077?rss=1">
<title><![CDATA[Spontaneous Abdominal Hemorrhage: Causes, CT Findings, and Clinical Implications]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1077?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to present the most common
causes of spontaneous abdominal hemorrhage and to review the CT findings that
are important in establishing the correct diagnosis and in guiding appropriate
therapy.</p>
<p><b>CONCLUSION.</b> Knowledge of the common CT manifestations of various
causes of spontaneous abdominal hemorrhage allows their accurate diagnosis and
has a direct impact on clinical decision making.</p>
]]></description>
<dc:creator><![CDATA[Furlan, A., Fakhran, S., Federle, M. P.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.2231</dc:identifier>
<dc:title><![CDATA[Spontaneous Abdominal Hemorrhage: Causes, CT Findings, and Clinical Implications]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1087</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1077</prism:startingPage>
<prism:section>Gastrointestinal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1090?rss=1">
<title><![CDATA[Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Perfusion CT Evaluation of Chemotherapy and Radiation Therapy]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1090?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objectives of this study were to prospectively
evaluate changes in tumor perfusion after chemoradiation therapy and to
investigate the feasibility of perfusion CT for prediction of early tumor
response and prognosis of non&ndash;small cell lung cancer.</p>
<p><b>SUBJECTS AND METHODS.</b> Perfusion CT was performed on an MDCT scanner
with 50 mL of iodinated contrast material injected at 4 mL/s. The quality of
each functional map was rated from 0 to 3 for 123 patients with confirmed lung
cancer. A subset of images was independently reviewed by two radiologists to
measure interobserver and intraobserver variability. Perfusion parameters and
tumor response were assessed for 35 patients with non&ndash;small cell lung
cancer who underwent chemoradiation therapy. Progression-free survival and
overall survival were analyzed for 22 patients who underwent repeated
perfusion CT after therapy.</p>
<p><b>RESULTS.</b> Image quality was graded 2 (moderate) or 3 (good) in 68.2%
of cases. High interobserver and intraobserver correlations of perfusion
parameters were found on qualified images. The patients who responded to
chemoradiation therapy had significantly greater blood flow (<I>p</I> =
0.023) than patients who did not respond. The median progression-free survival
period of the patients with an increased permeability&ndash;surface area
product was 4.7 months, significantly lower than the median progression-free
survival period of 19.0 months among patients with a decreased
permeability&ndash;surface area product (<I>p</I> &lt; 0.001). The median
overall survival period was 10.6 months for the group with an increased
permeability&ndash;surface area product, significantly lower than the 19.3
months for the group with a decreased permeability&ndash;surface area product
(<I>p</I> = 0.004).</p>
<p><b>CONCLUSION.</b> Non&ndash;small cell lung cancer with higher perfusion
is more sensitive to chemoradiation therapy than that with lower perfusion.
After chemoradiation therapy, findings at perfusion CT are a significant
predictor of early tumor response and overall survival among patients with
non&ndash;small cell lung cancer.</p>
]]></description>
<dc:creator><![CDATA[Wang, J., Wu, N., Cham, M. D., Song, Y.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1367</dc:identifier>
<dc:title><![CDATA[Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Perfusion CT Evaluation of Chemotherapy and Radiation Therapy]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1096</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1090</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1097?rss=1">
<title><![CDATA[Myocardial Ischemia in Acute Coronary Syndrome: Assessment Using 64-MDCT]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1097?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> We investigated the performance of 64-MDCT myocardial
imaging in assessing myocardial ischemia in acute coronary syndrome (ACS).</p>
<p><b>MATERIALS AND METHODS.</b> Cardiac CT was performed in 35 patients with
ACS: 24 patients with acute myocardial infarction (AMI) and 11 patients with
unstable angina pectoris (UAP). We reconstructed 2D myocardial images at
diastolic and systolic phases using the same raw data as those used for
coronary CT angiography. The CT number in the myocardium was used as an
estimate of ischemia. The myocardium was shown using a color scale that
depicts faint low-density areas more clearly than gray scale. We evaluated the
variations in myocardial enhancement during the cardiac cycle in the territory
of the culprit lesion. In addition, we classified patients on the basis of the
transmurality of myocardial enhancement and examined whether this feature
correlates with myocardial damage.</p>
<p><b>RESULTS.</b> Myocardial imaging at systole showed myocardial
hypoenhancement in territories of the culprit lesion in 91% of patients with
ACS, 96% of patients with AMI, and 75% of patients with UAP. The
hypoenhancement areas at systole tended to be more extensive than those at
diastole. The transmural extent of hypoenhancement at systole correlated with
myocardial damage, which was shown by myocardial biomarkers.</p>
<p><b>CONCLUSION.</b> CT myocardial imaging can be used to assess myocardial
ischemia in the appropriate region of ACS with high sensitivity.</p>
]]></description>
<dc:creator><![CDATA[Nagao, M., Matsuoka, H., Kawakami, H., Higashino, H., Mochizuki, T., Uemura, M., Shigemi, S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1965</dc:identifier>
<dc:title><![CDATA[Myocardial Ischemia in Acute Coronary Syndrome: Assessment Using 64-MDCT]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1106</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1097</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1107?rss=1">
<title><![CDATA[Anomalies of Visceroatrial Situs]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1107?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Visceroatrial situs refers to the position and
configuration of the cardiac atria, the tracheobronchial tree, and the
thoracoabdominal viscera. Accurate determination of situs is essential because
anomalies of situs are associated with an increased incidence of complex
congenital heart disease.</p>
<p><b>CONCLUSION.</b> We propose a methodical diagnostic approach to
determining the visceroatrial situs and cardiac configuration that predicts
the probability and types of associated congenital heart disease.</p>
]]></description>
<dc:creator><![CDATA[Ghosh, S., Yarmish, G., Godelman, A., Haramati, L. B., Spindola-Franco, H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2411</dc:identifier>
<dc:title><![CDATA[Anomalies of Visceroatrial Situs]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1117</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1107</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1118?rss=1">
<title><![CDATA[CT Findings in Hydrocarbon Pneumonitis After Diesel Fuel Siphonage]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1118?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to assess CT findings in a
series of patients with hydrocarbon pneumonitis after diesel fuel
siphonage.</p>
<p><b>CONCLUSION.</b> The characteristic CT findings of hydrocarbon
pneumonitis after diesel fuel siphonage are the presence of air&ndash;space
consolidations with predominant right middle lobe involvement and areas of low
attenuation within consolidation. Occasionally, bronchoalveolar lavage is
needed to confirm the diagnosis of hydrocarbon pneumonitis by the presence of
lipid-laden macrophages on the basis of a history of diesel fuel
aspiration.</p>
]]></description>
<dc:creator><![CDATA[Yi, M. S., Kim, K.-I., Jeong, Y. J., Park, H. K., Lee, M. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2471</dc:identifier>
<dc:title><![CDATA[CT Findings in Hydrocarbon Pneumonitis After Diesel Fuel Siphonage]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1121</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1118</prism:startingPage>
<prism:section>Cardiopulmonary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1">
<title><![CDATA[Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to determine the frequency
and characteristics of adverse effects of low-osmolar iodinated and gadolinium
contrast agents in a single-center experience with a large number of
cases.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective review of all intravascular
doses of low-osmolar iodinated and gadolinium contrast materials administered
from 2002 through 2006 was conducted. Adverse effects were identified through
the use of radiologist and nurse event recording. Adverse effects were
examined for type and severity of reaction, treatment required, and
outcome.</p>
<p><b>RESULTS.</b> A total of 456,930 contrast doses (298,491 low-osmolar
iodinated, 158,439 gadolinium) were administered over the study period. A
total of 522 cases of adverse effects (0.11% of total) were identified (458
low-osmolar iodinated, 64 gadolinium). The most common adverse effects were
hives (274, 52.5%) and nausea (92, 17.6%). Of all adverse effects, 79 of
low-osmolar iodinated and 15 of gadolinium contrast material necessitated
treatment. Most treatments were performed in the radiology department alone.
Only 16 cases of adverse effects necessitated transfer for further observation
or treatment. Epinephrine was used to manage an adverse effect in nine
instances. Thirty-two of the adverse effects of low-osmolar iodinated contrast
material (6.9%) occurred in patients with a history of allergy who received
premedication. Only two of these premedication reactions necessitated transfer
to the emergency department. The one death in the study period occurred after
administration of low-osmolar iodinated contrast material. The patient had no
symptoms during the contrast administration or imaging but died suddenly
within 30 minutes of receiving the dose.</p>
<p><b>CONCLUSION.</b> Both iodinated and gadolinium contrast agents are
associated with a very low rate of adverse effects. Most adverse effects are
mild and can be managed in the radiology department. Transfer for additional
treatment or observation is rarely needed.</p>
]]></description>
<dc:creator><![CDATA[Hunt, C. H., Hartman, R. P., Hesley, G. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2520</dc:identifier>
<dc:title><![CDATA[Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1127</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1124</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1">
<title><![CDATA[Adrenal Imaging with MDCT: Nonneoplastic Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The adrenal gland can enlarge or alter morphology in the
presence of a range of nonneoplastic entities, including hyperplasia,
hemorrhage, infection, or cystic mass. This article presents a description and
representative CT images for each of these disorders.</p>
<p><b>CONCLUSION.</b> Proper characterization is essential to ensure that
life-threatening sequelae from Addisonian crisis are averted in infection and
hemorrhage, or to identify "leave-alone" lesions such as
pseudocyst and chronic calcification.</p>
]]></description>
<dc:creator><![CDATA[Johnson, P. T., Horton, K. M., Fishman, E. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2551</dc:identifier>
<dc:title><![CDATA[Adrenal Imaging with MDCT: Nonneoplastic Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1135</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1128</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1136?rss=1">
<title><![CDATA[Trends in Work Hours and Vacation Time Among Radiologists in the United States]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1136?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to describe recent trends
in weekly work hours and annual vacation days among full-time radiologists in
the United States with separate data for academic radiologists, radiologists
in multispecialty groups, and radiologists in private practice.</p>
<p><b>MATERIALS AND METHODS.</b> We tabulated non&ndash;individually
identified responses from the American College of Radiology 1995, 2003, and
2007 surveys of radiologists. These stratified random sample surveys had,
respectively, 2,025, 1,924, and 487 responses and response rates of 75%, 63%,
and 20%. Responses were weighted to make them representative of all U.S.
radiologists. Respondents were assured of confidentiality.</p>
<p><b>RESULTS.</b> Mean weekly hours worked increased from 1995 to 2003 and
from 2003 to 2007. The total increase was approximately 5 hours, or 10%. Mean
vacation days also increased in both subperiods, from 27 in 1995 to 39 in
2007, yielding an approximately 5% decrease in days worked per year. The
overall result was a mean increase of approximately 5% in annual work hours.
In 2007, the 25th percentile of weekly hours was 45, and the 75th percentile
was 55. The 25th percentile of annual vacation days was 25, and the 75th
percentile was 50. Full-time radiologists responding about their own weekly
hours reported, at the mean, working 10% more hours than they believed was the
average for other full-time radiologists in the practice.</p>
<p><b>CONCLUSION.</b> Weekly hours and annual vacation days both have
increased. The percentiles give radiologists a basis for comparison with other
radiologists. Radiologists apparently often overestimate their work hours
relative to the hours of others in their practices. Misperceptions of this
kind might give rise to friction in radiology practices.</p>
]]></description>
<dc:creator><![CDATA[Sunshine, J. H., Lewis, R. S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2508</dc:identifier>
<dc:title><![CDATA[Trends in Work Hours and Vacation Time Among Radiologists in the United States]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1140</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1136</prism:startingPage>
<prism:section>Health Care Policy and Quality</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1141?rss=1">
<title><![CDATA[Radiation Dose for Body CT Protocols: Variability of Scanners at One Institution]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1141?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to determine, using an
anthropomorphic phantom, whether patients are subject to variable radiation
doses based on scanner assignment for common body CT studies.</p>
<p><b>MATERIALS AND METHODS.</b> Twenty metal oxide semiconductor field effect
transistor dosimeters were placed in a medium-sized anthropomorphic phantom of
a man. Pulmonary embolism and chest, abdomen, and pelvis protocols were used
to scan the phantom three times with GE Healthcare scanners in four
configurations and one 64-MDCT Siemens Healthcare scanner. Organ doses were
averaged, and effective doses were calculated with weighting factors.</p>
<p><b>RESULTS.</b> The mean effective doses for the pulmonary embolism
protocol ranged from 9.9 to 18.5 mSv and for the chest, abdomen, and pelvis
protocol from 6.7 to 18.5 mSv. For the pulmonary embolism protocol, the mean
effective dose from the Siemens Healthcare 64-MDCT scanner was significantly
lower than that from the 16- and 64-MDCT GE Healthcare scanners (<I>p</I>
&lt; 0.001). The mean effective dose from the GE 4-MDCT scanner was
significantly lower than that for the GE 16-MDCT scanner (<I>p</I> &lt;
0.001) but not the GE 64-MDCT scanner (<I>p</I> = 0.02). For the chest,
abdomen, and pelvis protocol, all mean effective doses from the GE scanners
were significantly different from one another (<I>p</I> &lt; 0.001), the
lowest mean effective dose being found with use of a single-detector CT
scanner and the highest with a 4-MDCT scanner. For the chest, abdomen, and
pelvis protocols, the difference between the mean effective doses from the GE
Healthcare and Siemens Healthcare 64-MDCT scanners was not statistically
significant (<I>p</I> = 0.89).</p>
<p><b>CONCLUSION.</b> According to phantom data, patients are subject to
different radiation exposures for similar body CT protocols depending on
scanner assignment. In general, doses are lowest with use of 64-MDCT
scanners.</p>
]]></description>
<dc:creator><![CDATA[Jaffe, T. A., Yoshizumi, T. T., Toncheva, G., Anderson-Evans, C., Lowry, C., Miller, C. M., Nelson, R. C., Ravin, C. E.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2330</dc:identifier>
<dc:title><![CDATA[Radiation Dose for Body CT Protocols: Variability of Scanners at One Institution]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1147</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1141</prism:startingPage>
<prism:section>Medical Physics and Informatics</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1148?rss=1">
<title><![CDATA[MRI-Guided Injection Procedures of the Temporomandibular Joints in Children and Adults: Technique, Accuracy, and Safety]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1148?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of our study was to test the hypothesis that
real-time MRI-guided, selective injection procedures of the temporomandibular
joints are feasible, accurate, and safe when performed on a clinical open-bore
1.5-T MR system.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective analysis of 67 injection
procedures of the temporomandibular joints (55% [37/67] were therapeutic
injections, 27% [18/67] were diagnostic injections, and 18% [12/67] were
arthrocentesis procedures), performed in 31 patients (58% [18/31] female, 42%
[13/31] male; mean age, 14 years; age range, 3&ndash;34 years), was made.
Seven of 38 (18%) subjects had two temporally separate procedures.
Determinations of skin entry points, puncture, and injection were performed
under real-time MRI. Data were assessed for rate of successful injections,
quantitative and qualitative image quality, time requirements, and occurrence
of complications.</p>
<p><b>RESULTS.</b> Drug delivery was successful in all procedures. The quality
of real-time FLASH 2D MR images was sufficient in all cases. Real-time MRI
proved to be helpful to achieve high rates of intraarticular injections.
Contrast-to-noise ratios were sufficiently high for good delineation of
relevant structures. Average length of time was 25 minutes (range, 16&ndash;53
minutes). No major complications occurred.</p>
<p><b>CONCLUSION.</b> We accept the hypothesis that real-time MRI-guided
selective injection procedures of the temporomandibular joints are feasible,
accurate, and safe when performed on a clinical open-bore 1.5-T MR system.</p>
]]></description>
<dc:creator><![CDATA[Fritz, J., Thomas, C., Tzaribachev, N., Horger, M. S., Claussen, C. D., Lewin, J. S., Pereira, P. L.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2473</dc:identifier>
<dc:title><![CDATA[MRI-Guided Injection Procedures of the Temporomandibular Joints in Children and Adults: Technique, Accuracy, and Safety]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1154</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1148</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1155?rss=1">
<title><![CDATA[Value of 3D CT in Defining Skeletal Complications of Orthopedic Hardware in the Postoperative Patient]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1155?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Conventional CT of the postoperative patient with metal
hardware is frequently limited by beam-hardening artifacts. With the evolution
of 3D CT, CT is an increasingly effective means of examining the postsurgical
patient for the integrity of their hardware and the course of their
healing.</p>
<p><b>CONCLUSION.</b> Potential postsurgical complications such as nonunion,
osteolysis, infection, and heterotopic ossification are all well assessed by
3D CT.</p>
]]></description>
<dc:creator><![CDATA[Fayad, L. M., Patra, A., Fishman, E. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2610</dc:identifier>
<dc:title><![CDATA[Value of 3D CT in Defining Skeletal Complications of Orthopedic Hardware in the Postoperative Patient]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1163</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1155</prism:startingPage>
<prism:section>Musculoskeletal Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1167?rss=1">
<title><![CDATA[Comparison of Test Performance Characteristics of MRI, MR Angiography, and CT Angiography in the Diagnosis of Carotid and Vertebral Artery Dissection: A Review of the Medical Literature]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1167?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> Initial assessment of patients with suspected dissection
of the carotid or vertebral arteries typically is made by MRI, alone or in
combination with MR angiography (MRA) or CT angiography (CTA). We reviewed the
medical literature to determine, based on test performance characteristics
such as sensitivity, specificity, positive predictive value, and negative
predictive value, whether evidence could be found to support routine use of
one imaging technique over the other for assessment of suspected
dissection.</p>
<p><b>CONCLUSION.</b> Test characteristics for MR techniques such as MRI and
MRA were relatively similar to those for CTA in diagnosis of carotid and
vertebral artery dissection.</p>
]]></description>
<dc:creator><![CDATA[Provenzale, J. M., Sarikaya, B.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1688</dc:identifier>
<dc:title><![CDATA[Comparison of Test Performance Characteristics of MRI, MR Angiography, and CT Angiography in the Diagnosis of Carotid and Vertebral Artery Dissection: A Review of the Medical Literature]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1174</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1167</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1175?rss=1">
<title><![CDATA[Fine-Needle Aspiration Biopsy of Thyroid Nodules: Experience in a Cohort of 944 Patients]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1175?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of our study was to determine the
likelihood of malignancy in thyroid nodules and the risk of a nondiagnostic
fine-needle aspiration biopsy (FNAB) on the basis of the demographic
characteristics of the patients and sonographic features of the nodules.</p>
<p><b>MATERIALS AND METHODS.</b> Between January 2002 and November 2007, 2,338
ultrasound-guided thyroid, thyroid bed, and cervical lymph node FNABs were
performed at a tertiary referral center. Entry criteria for our retrospective
study were adult patients who underwent thyroid nodule FNAB and had previously
undergone diagnostic sonography. From previous reports for 944 thyroid nodules
(739 nodules in women and 205 nodules in men), four sonographic features were
recorded: longest dimension, morphology, presence of microcalcifications, and
presence of lymphadenopathy. The final diagnosis of each nodule was classified
as benign, malignant, or nondiagnostic on the basis of surgical pathology when
available and cytology otherwise and was analyzed for correlation with
individual sonographic features and combinations of features.</p>
<p><b>RESULTS.</b> The prevalence of malignancy and of nondiagnostic FNAB in
this study was 11.0% and 11.8%, respectively. Statistically significant
(<I>p</I> &lt; 0.05) findings in malignant nodules were younger patient age
(&le; 45 years; odds ratio [OR], 1.54) and solid nodule morphology (OR, 2.38).
The significant predictors of a nondiagnostic-quality FNAB were older patient
age (&gt; 75 years; OR, 1.95) and a nodule &ge; 10 mm (OR, 1.45). Adding
information about the other evaluated ultrasound features did not lead to a
significant result.</p>
<p><b>CONCLUSION.</b> Malignant thyroid nodules tend to be solid (86.5%).
Patients older than 75 years showed a clearly increased risk of nondiagnostic
FNAB, but to predict a higher risk of malignancy or of nondiagnostic FNAB
using ultrasound remains difficult.</p>
]]></description>
<dc:creator><![CDATA[Baier, N. D., Hahn, P. F., Gervais, D. A., Samir, A., Halpern, E. F., Mueller, P. R., Harisinghani, M. G.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1840</dc:identifier>
<dc:title><![CDATA[Fine-Needle Aspiration Biopsy of Thyroid Nodules: Experience in a Cohort of 944 Patients]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1179</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1175</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1180?rss=1">
<title><![CDATA[Imaging Findings of Head and Neck Inflammatory Pseudotumor]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1180?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this article is to describe imaging
features of head and neck inflammatory pseudotumor in the brain, orbit,
sinonasal cavity, temporal bone or skull base, and other rare locations.</p>
<p><b>CONCLUSION.</b> Although the radiologic differentiation from malignancy
is not clearly possible, we suggest that familiarity with the manifestations
of inflammatory pseudotumor can help avoid unnecessary radical surgery before
histopathologic proof of malignancy.</p>
]]></description>
<dc:creator><![CDATA[Park, S. B., Lee, J. H., Weon, Y. C.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2398</dc:identifier>
<dc:title><![CDATA[Imaging Findings of Head and Neck Inflammatory Pseudotumor]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1186</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1180</prism:startingPage>
<prism:section>Neuroradiology/Head and Neck Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/1188?rss=1">
<title><![CDATA[Mammographic Screening in Younger Women at High Risk]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/1188?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hall, F. M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2753</dc:identifier>
<dc:title><![CDATA[Mammographic Screening in Younger Women at High Risk]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1188</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1188</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/1189?rss=1">
<title><![CDATA[Reply]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/1189?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Berg, W. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2974</dc:identifier>
<dc:title><![CDATA[Reply]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1189</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1189</prism:startingPage>
<prism:section>Letters</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/full/193/4/1190?rss=1">
<title><![CDATA[Correction for Volume 193, p. 764]]></title>
<link>http://www.ajronline.org/cgi/content/full/193/4/1190?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hara, A. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:title><![CDATA[Correction for Volume 193, p. 764]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1190</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1190</prism:startingPage>
<prism:section>Other Content</prism:section>
</item>

</rdf:RDF>